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Neuronal communication is important for nervous system function. In the brain and 
spinal cord, nerve cells (otherwise known as neurons) form many connections with 
each other to communicate in complex circuits. A neuron sends electrical signals 
along a long cable-like projection called an axon, which triggers the transmission of 
information to the next neuron(s) in the circuit. Many axons are myelinated; this 
means that they have sheaths of fatty membrane called myelin wrapped around them. 
Myelin sheaths make axons send electrical signals much faster than unmyelinated 
axons. Myelin is very important for nervous system function, which is highlighted by 
the fact that development of myelinated parts of the brain correlates with cognitive 
development in childhood, and that loss of myelin in diseases such as Multiple 
Sclerosis can lead to neurological symptoms and permanent disability. 
Recent research suggests that modification of myelin throughout life plays an 
important role in the learning of new skills. It has been proposed that our experiences 
can shape the myelin in our brains, which will change the speed of electrical signals 
along axons. This could affect how neurons communicate to one another, and 
ultimately, lead to changes in cognition. However, a great deal of evidence for the role 
of myelin in learning comes from brain imaging studies in humans, which can only see 
very broad changes in myelin-rich parts of the brain. There is a need to study myelin 
at the microscopic cellular level in order to understand precisely how myelin sheaths 
can change along axons over time, and how this might affect communication between 
neurons.  
The best way to study how myelin sheaths change along an axon is to image 
myelinated axons in a living animal at a high magnification (live imaging). By imaging 
the same cells multiple times in a living animal at different ages, we can observe how 
myelin changes along axons over time. Many studies of myelin biology use rodents, 
but live imaging myelin in the brains of mice requires complex experimental set-ups, 
such as a ‘window’ in the skull to image the outer parts of the brain. Larval zebrafish 
provide a much simpler- and non-invasive alternative method of live imaging 
myelinated axons in the brain and spinal cord. Larval zebrafish are completely 
transparent, which means that cells can be easily live imaged repeatedly without any 
adverse effects. Zebrafish also share many of their genes with mammals, and so 
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findings from studies of myelin in zebrafish are likely to have some relevance to myelin 
biology in mammals, such as humans. 
During this project, I have live imaged myelinated axons in the zebrafish spinal cord 
to investigate how myelin changes over time in detail. I found that myelin changes 
along axons within a specific time period of development, after which myelin sheaths 
do not change significantly. I described how myelin changes along the axons of 
different kinds of neurons, predicting that they would show diverse changes in their 
myelin sheaths. However, I found that that the axons of different kinds of neurons 
show very similar myelin changes over time. 
It has been proposed that brain activity is what shapes myelin in the nervous system. 
However, it is not known precisely how the electrical activity of neurons affects myelin 
sheaths themselves. I used genetic tools to stimulate electrical activity in neurons, 
and then performed live imaging to investigate how this affected myelin sheaths. I 
found that increasing the electrical activity along axons promotes the growth of myelin 
sheaths, but only within a specific period during development. After this time period, 
changing the electrical activity of neurons did not affect myelin sheath development. 
Collectively, this research helps us to understand how myelin changes in the nervous 
system at a cellular level, and how the electrical activity of neurons affects the 
development of myelin sheaths. Future research will focus on understanding precisely 
how the cellular changes to myelin that I have described in this project affect neuronal 





Myelin is a crucial component of the vertebrate nervous system, both in facilitating 
rapid conduction of action potentials and in metabolically supporting axons. Recent 
research has theorised that myelin sheaths play a more intricate role in nervous 
system function by regulating circuits in response to experience. The number, length, 
thickness, and distribution of myelin sheaths along an axon all influence its underlying 
conduction properties. Thus, establishing or changing particular myelin patterns along 
axons could refine the precise timing of signals to change circuit outputs. Yet, how 
the myelin patterns along single axons are established, how myelin is remodelled over 
time, and how neuronal activity affects these processes, is not yet fully understood. I 
sought to investigate how myelin is formed, remodelled and maintained over time 
along individual axons in the larval zebrafish central nervous system. 
I first characterised the formation of myelin patterns along two different subtypes of 
axon in the larval zebrafish spinal cord. Using transgenic tools and confocal 
microscopy, I performed live imaging of single axons over a period of time during 
developmental myelination. Reticulospinal (RS) axons are involved in locomotor 
circuits, and are myelinated in a synaptic vesicle release-dependent manner; 
whereas, Commissural Primary Ascending (CoPA) axons are involved in sensory 
processing circuits, and are myelinated in a synaptic vesicle release-independent 
manner. I hypothesised that myelin patterns along axons are formed in a circuit-
dependent fashion, and, therefore, that axons from different circuits would exhibit 
different myelin patterns. However, I found that both RS and CoPA axons have very 
similar myelin patterns, in terms of their myelin sheath number, length, myelin 
coverage, and nodal gap length, and that these patterns are established within a 
defined time window after the onset of myelination. 
I, then, assessed how myelin sheaths are remodelled along RS and CoPA axons over 
time, and found that myelin sheaths could either grow or shrink in length, or could be 
fully retracted from the axon itself. I hypothesised that myelin remodelling would occur 
along axons which use activity-related signals to regulate their myelination, and 
therefore, that RS axons would exhibit more myelin remodelling than CoPA axons. 




Finally, I used a chemogenetic tool and live imaging by confocal microscopy to 
investigate how increasing activity in individual RS axons affects the dynamics of 
myelin sheath growth and the formation of myelin patterns. I found that increasing 
neuronal activity promotes the early growth of myelin sheaths within a critical period; 
after this period, neuronal activity no longer affects myelin sheath dynamics along RS 
axons. By promoting this early sheath growth, activity can change the myelin pattern 
established along individual RS axons. 
Collectively, this research begins to elucidate how individual myelinated axons are 
formed and maintained during nervous system development, and the cellular 
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Table of Commonly Used Abbreviations 
 
BDNF  brain derived neurotrophic factor 
BoNT botulinum toxin 
CiD circumferential descending 
CNS central nervous system 
CoPA commissural primary ascending 
dpf  days post-fertilisation 
DRG dorsal root ganglion 
DTI diffusion tensor imaging 
FA fractional anisotropy 
FP-Cntn1a fluorescent protein-Contactin1a 
hpf hours post-fertilisation 
IQR interquartile range 
MBP myelin basic protein 
(m)PFC (medial) prefrontal cortex 
MS Multiple Sclerosis 
OPC oligodendrocyte precursor cell 
PLP myelin proteolipid protein 
PNS peripheral nervous system 
RB Rohon-Beard 
RS reticulospinal 
SCoRe spectral confocal reflectance microscopy 
SD standard deviation 
TeNT tetanus toxin 
TTX  Tetrodotoxin 
UAS Upstream activator sequence 
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1.1. Aim of this Thesis 
The aim of this thesis is to investigate the dynamics of how myelinated axons 
form in the central nervous system (CNS), and how myelination is regulated 
by the activity of these underlying axons. In this introduction, I will discuss the 
evidence that: myelin is a crucial component of the CNS; that dynamic 
regulation of myelination may regulate the function of circuits in the nervous 
system; and that neuronal activity may be a critical signal in the development 
and regulation of myelinated axons to mediate circuit function.  
1.2. The Importance of Myelin 
Rapid communication between neurons is crucial for animal survival. When a 
neuron fires an action potential it is propagated along the axon by voltage-
gated Na+ channels. These channels are opened once the axonal membrane 
depolarises to the threshold membrane potential, causing Na+ influx and a 
sharp depolarisation. This is quickly followed by activation of voltage-gated K+ 
channels which allow K+ efflux to hyperpolarise the membrane back to resting 
potential. The presence of voltage-gated Na+ and K+ channels diffusely along 
the entire axon ensures that once a single action potential fires it is propagated 
in a wave down the axon towards the synapse. 
Two core strategies have evolved to speed up electrical impulse transmission 
in the nervous system. The first is to increase axon diameter, as axial 
resistance of an axon decreases proportionally with increasing fibre diameter. 
‘Giant’ axons are found in many different species – including squid, fish, 
crayfish, and insects – and are often involved in startle or escape responses 
(Bullock, 1984).  
The second strategy is myelination, where specialised plasma membrane is 
wrapped concentrically around axons and then compacted to form multi-
layered sheaths. These lipid-rich myelin sheaths act as electrical insulators by 
reducing the axon membrane capacitance. Myelinated axons are punctuated 
by short unmyelinated gaps (usually 1-2 μm in length) between the sheaths 
known as nodes of Ranvier, where the voltage-gated Na+ channels are 
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clustered (along with several other nodal proteins). Myelin sheaths are thought 
to help localise and maintain these Na+ channels and other ion channels at 
discrete positions to facilitate proper conduction (Rasband and Peles, 2016). 
Action potentials occur only at the exposed axon membrane of the nodes, and 
so the electrical impulse ‘jumps’ from node to node along the myelinated axon 
(Hartline and Colman, 2007) – this is known as saltatory conduction. 
Myelinated axons therefore conduct impulses much faster than equivalently-
sized unmyelinated axons (Waxman, 1980) and allow for fast information 
processing without drastic increases in nervous system size. Myelin is present 
in almost all vertebrates (although it is absent from the earliest vertebrates, 
such as hagfish and lampreys (Bullock et al., 1984)), and was likely a crucial 
evolutionary step in the emergence of increasingly complex nervous systems 
within the vertebrate lineage. 
1.2.1. Myelinating Cells 
Myelin sheaths are made by Schwann cells in the peripheral nervous system 
(PNS) and oligodendrocytes in the CNS. Each myelinating Schwann cell forms 
just one myelin sheath and is closely associated with its ensheathed axon, 
whereas oligodendrocytes extend many processes into their surrounding 
environment and usually form multiple myelin sheaths on several different 
axons (Figure 1). Conduction speeds do not just depend on whether an axon 
is myelinated; various electrophysiological and mathematical modelling 
studies have shown that the length and thickness of myelin sheaths along an 
axon also influences that axon’s conduction velocity (reviewed by Waxman, 
1980). Myelin sheath number, length, and thickness may be tuned to optimise 
the speed of signal conduction. In the PNS, axonal expression of neuregulin-
1 determines whether an axon becomes myelinated by Schwann cells 
(Taveggia et al., 2005), and also regulates the thickness of the sheaths formed 
(Michailov et al., 2004), so that sheath thickness correlates with axon size 
(Friede and Samorajski, 1967). Schwann cell sheath length is believed to be 
regulated by the growth of the axons themselves (Hildebrand et al., 1994; 
Simpson et al., 2013). In the CNS, the number, length, and thickness of 
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sheaths made by oligodendrocytes can vary significantly. Some spinal cord 
oligodendrocytes form a single sheath up to 1.5 mm in length (Remahl and 
Hildebrand, 1990), while oligodendrocytes in the cortex or corpus callosum can 
form up to 80 sheaths between 20-200 μm in length (Chong et al., 2012; 
Snaidero and Simons, 2014). CNS myelin sheath length (Murray and 
Blakemore, 1980) and thickness (Hildebrand and Hahn, 1978) generally 
increase with the diameter of the axon being myelinated, although sheath 
length along a single axon of a given diameter can still vary extensively. 
 
Figure 1 – oligodendrocytes, the myelinating cells of the CNS. 
Oligodendrocytes can form multiple myelin sheaths by wrapping membrane 
concentrically around axons in the CNS. The short gaps between myelin sheaths 




1.2.2. Additional Roles for Myelin 
Myelin was assumed to be just a static insulator for many years. However, 
recent research demonstrates that myelinating cells are required for more than 
just increasing conduction speeds. In the CNS, metabolic coupling between 
axons and oligodendrocytes is important for maintaining healthy neurons. 
Axons can uptake lactate from oligodendrocytes to facilitate axonal ATP 
production (Fünfschilling et al., 2012), and loss of the lactate transporter MCT1 
(which is expressed mainly by oligodendrocytes in the CNS) leads to 
neurodegeneration (Y. Lee et al., 2012). Oligodendrocytes provide essential 
trophic support, to potentially sustain the required levels of neuronal activity in 
the circuits being myelinated (Saab et al., 2016). Oligodendrocytes also 
maintain healthy neuronal function by regulating K+ homeostasis, presumably 
after K+ efflux during action potential firing. Although loss of the inward-
rectifying K+ channel Kir4.1 in oligodendroglial cells does not affect 
oligodendrocyte development or myelination, it does lead to elevated 
extracellular K+ levels within the forebrain (Larson et al., 2018). This causes 
increased seizure susceptibility, impaired recovery of axons after high 
frequency activity, neurodegeneration, and increased mortality (Larson et al., 
2018; Schirmer et al., 2018). It is possible that future research will continue to 
identify additional functions of myelinating cells in maintaining a healthy 
functioning nervous system. 
1.2.3. Myelin Dysfunction in the CNS 
Loss or damage to myelin has been documented in numerous conditions. In 
spinal cord injury, the primary mechanical injury is followed by a secondary 
injury of excitotoxic damage, apoptosis, and inflammation; this includes 
oligodendrocyte death and demyelination of surviving axons over the weeks 
after injury itself (Silva et al., 2014). In the disease Multiple Sclerosis (MS), 
peripheral immune cells are thought to infiltrate the CNS and trigger 
oligodendrocyte death and myelin damage in focal lesions throughout both 
grey and white matter (the evidence for the roles of different immune cells in 
MS has been reviewed by Baecher-Allan et al., 2018). During immune attacks 
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(or relapses) patients experience symptoms such as weakness, fatigue, 
impaired balance and co-ordination, vision deficits or cognitive impairment. A 
number of drugs targeting immune cells are used to reduce the rate of relapses 
(summarised by Baecher-Allan et al., 2018).  
Demyelination in injury or disease can cause conduction block, but conduction 
can be restored upon remyelination of affected axons (Smith et al., 1981). 
These new myelin sheaths are thought to be thinner and shorter than healthy 
myelin sheaths (Blakemore, 1974; Lasiene et al., 2008; Prineas and Connell, 
1979; Totoiu and Keirstead, 2005). As mentioned above, the specific number, 
length, and thickness of myelin sheaths along an axon is predicted to adjust 
conduction velocity (Waxman, 1980); the regeneration of thinner, shorter 
sheaths during remyelination may change the conduction speed of affected 
neurons (whether this has an impact on overall nervous system function is not 
clear). In MS, the disease usually transitions to a progressive stage where 
demyelinated axons degenerate, causing steady accumulation of disability 
with no recovery. In contrast to the many drugs licensed for use in relapsing-
remitting stages of MS, only one drug has been licensed for use in progressive 
MS. There is some evidence that remyelination may be protective against 
neurodegeneration (Irvine and Blakemore, 2008; Mei et al., 2016), potentially 
through the crucial metabolic support provided by oligodendrocytes to axons. 
Subsequently, several chemical screens have been performed to identify 
various drugs which promote remyelination in animal models of demyelination 
(reviewed by Cole et al., 2017). Clinical trials of remyelination-enhancing 
therapies are ongoing, which may elucidate whether remyelination can prevent 
neurodegeneration. 
Myelin pathologies have also been observed in numerous other conditions.  
Leukodystrophies are a group of heritable disorders causing progressive 
cognitive and motor symptoms which are typically fatal in childhood or 
adolescence (Bonkowsky et al., 2010). Some leukodystrophies have been 
associated with mutations in key myelin proteins such as myelin proteolipid 
protein (PLP), suggesting that disruption to myelin formation and maintenance 
may play a role in at least some cases (Schiffmann and Knaap, 2004). 
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Oligodendrocyte pathology and demyelination has been observed in 
amyotrophic lateral sclerosis (ALS) patients. Oligodendrocyte loss occurs in 
an animal model of ALS and oligodendrocyte-specific deletion of the disease-
causing mutation delays both disease onset and death (Kang et al., 2013; 
Philips et al., 2013). In an animal model of Huntington’s disease, expression 
of mutant huntingtin protein in oligodendrocytes causes demyelination and 
neurodegeneration (Huang et al., 2015). In Alzheimer’s disease, neuroimaging 
studies have identified white matter abnormalities even during preclinical 
stages prior to significant neurodegeneration (Nasrabady et al., 2018; Sachdev 
et al., 2013). Myelin abnormalities are even associated with neuropsychiatric 
disorders such as schizophrenia (Takahashi et al., 2011). The aetiology of the 
myelin phenotypes in these disorders remains unclear. It is possible that 
myelin disruption is a poorly-understood contributor to neurological disease, 
and may somehow trigger neuronal dysfunction. Alternatively, myelin 
disruption may be a secondary effect of neuronal pathology. Further research 
into myelin and myelinating cells is required to fully understand if and how 
regulation of myelination maintains nervous system health and function. 
1.3. Oligodendrocyte Development 
1.3.1. Generation of the Oligodendroglial Lineage 
During embryonic development, specification of the various neural and glial 
progenitors in the neural tube is established by key transcription factors. The 
ventral-inducing signal Sonic hedgehog (Shh) is secreted from the floorplate, 
while the dorsal-inducing bone morphogenic proteins (BMPs) and Wnt proteins 
are secreted from the roof plate; the opposing gradients of Shh and both BMP 
and Wnt induce patterning along the dorsoventral axis of the neural tube to 
create distinct domains which give rise to different progenitors (Rowitch, 2004). 
In the pMN domain of the ventral neural tube Shh induces the expression of 
the basic helix-loop-helix transcription factor Olig2 and is required for the 
generation of pMN domain progeny (Ligon et al., 2006; Lu et al., 2000; Orentas 
et al., 1999). The pMN domain progenitors first give rise to motor neurons (at 
E9.5 in rodents), before switching to generating oligodendrocyte progenitor 
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cells (OPCs) (from E12.5 in rodents; Rowitch, 2004). In rodents there are 
additional waves of OPC generation from more dorsal regions of the brain and 
spinal cord (Bergles and Richardson, 2016; Richardson et al., 2006); despite 
this, the majority of OPCs in the spinal cord are ventrally-derived (Tripathi et 
al., 2011).   
OPCs express transcription factors such as Sox10 and Olig1, as well as 
proteins NG2 and PDGFRα, which are typically used as identifying markers for 
OPCs in experimental studies. These cells are highly migratory and 
proliferative. They respond to numerous attractive and repulsive cues to 
migrate from the pMN domain and populate the entire CNS (Bergles and 
Richardson, 2016; Rowitch, 2004). OPCs use vasculature as a scaffold to 
migrate – this migration requires Wnt-Cxcr4 signalling, and disruption of 
vasculature development prevents proper OPC dispersal from the ventral 
progenitor domains (Tsai et al., 2016). As OPCs migrate to their destinations, 
they explore their surrounding environment via the rapid extension and 
retraction of filopodium-like processes (Hughes et al., 2013; Kirby et al., 2006). 
OPCs are a dynamic population of cells – they maintain a constant density and 
will initiate migration and proliferation if neighbouring OPCs are lost either due 
to differentiation or cell death (Hughes et al., 2013; Kirby et al., 2006).  
OPC differentiation is accompanied by significant transcriptional changes; 
many transcription factors are either supressed or enhanced to regulate the 
transition from OPC to oligodendrocyte. An extensive overview of the 
transcriptional regulation of OPC differentiation is beyond the scope of this 
thesis introduction; however, the key transcription factors are summarised in 
Figure 2. The transcriptional regulation of OPC differentiation has been 
comprehensively reviewed elsewhere (Emery and Lu, 2015; Goldman and 
Kuypers, 2015; Snaidero and Simons, 2017). Interestingly, a surplus of 
oligodendrocytes are generated in rodents during both early post-natal 
development and adulthood; as many as half of newly-differentiated 
oligodendrocytes die without forming myelin sheaths (this is discussed in more 




Figure 2 – summary of the known key signals involved in oligodendroglial 
development. 
A brief summary of the signals known to be involved in the production of 
OPCs from the pMN domain of the spinal cord, the differentiation of OPCs 
into oligodendrocytes, and the selection of axons for myelination (Black text 
= transcription factors; green text = attractive signals; red text = repulsive 
signals). 
 
1.3.2. Axon Selection 
As an OPC differentiates into an oligodendrocyte, the rapidly extending and 
retracting filopodia which make contact with their surrounding environment 
must select the appropriate axons upon which to initiate myelin sheath 
formation. Physical cues such as axonal diameter can regulate this process. 
In the PNS, axons over 1 μm diameter are myelinated by Schwann cells 
(Hildebrand et al., 1993) and experimentally increasing the diameter of 
normally unmyelinated axons is sufficient to initiate myelination (Voyvodic, 
1989). The relationship between axonal diameter and myelination in the CNS 
is not as clear. The smallest myelinated axons in the CNS range from 0.2-0.8 
μm in diameter; but there is considerable overlap in the range of diameters of 
myelinated versus unmyelinated axons (Hildebrand et al., 1993). Therefore, 
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axon diameter is not the only signal which regulates target selection for 
myelination in the CNS. 
Molecular signals can also regulate target selection for myelination. In the 
PNS, axonal expression of Nrg1 type III, which is detected by ErbB2/3 receptor 
complex in Schwann cells, controls which axons are to be myelinated 
(Taveggia et al., 2005). It has been suggested that the levels of axonal Nrg1 
act as a biochemical indicator of axon diameter to Schwann cells, and thus 
only axons of diameter > 1 μm express sufficient levels of Nrg1 to initiate 
myelin sheath formation (Michailov et al., 2004). However, the role of Nrg-ErbB 
signalling in regulating CNS myelination appears to be more complicated. 
Some evidence indicates that Nrg-ErbB signalling can influence OPC 
migration (Ortega et al., 2012) and survival (Fernandez et al., 2000), and loss 
of Nrg1 reduces the myelination of dorsal root ganglion (DRG) neurons by 
oligodendrocytes in vitro (Taveggia et al., 2008). Inhibiting Nrg1-ErbB 
signalling, either by expression of a dominant-negative ErbB4 receptor (Roy et 
al., 2007) or oligodendrocyte-specific knock-out of ErbB3 (Makinodan et al., 
2012), reduces myelination in vivo. Despite this, Brinkmann et al., 2008 
reported that, using numerous different approaches, loss of Nrg1-ErbB 
signalling in the CNS has no significant effect on CNS myelination in vivo. Nrg-
ErbB signalling may not be required but is sufficient to influence axonal 
selection in CNS myelination; there are additional attractive signals which can 
also regulate this process. Indeed, signals such as laminin-integrin interactions 
(Taveggia et al., 2010) and neuronal activity have been shown to affect onset 
of myelination. Different signals may even work together to influence axon 
selection. For example, oligodendrocytes cultured in the presence of Nrg1 
respond to neuronal activity-related signals more than oligodendrocytes 
cultured without Nrg1 (Lundgaard et al., 2013). The role of neuronal activity 
will be discussed in greater detail in section ‘1.6 Neuronal Activity can Influence 
Myelination’. 
There are also repulsive cues which influence the selection of axons for 
myelination. There is evidence to suggest that PSA-NCAM expression in 
axons prevents myelination. This molecule is initially expressed in all axons 
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and is down-regulated on axons destined to be myelinated (Charles et al., 
2000). Decreasing axonal expression of PSA-NCAM in vitro also enhances 
myelination (Charles et al., 2000). Axonal expression of LRR and Ig domain-
containing, Nogo receptor-interacting protein (LINGO-1) inhibits myelination 
both in DRG neuron-oligodendrocyte co-cultures and in vivo in the rodent 
spinal cord (Lee et al., 2007). Notch-Jagged1 signalling may also inhibit 
myelination. Jagged1 is primarily expressed on unmyelinated axons, and loss 
of Notch1 leads to increased myelination throughout the CNS (Givogri et al., 
2002). Additionally, some repulsive cues prevent inappropriate myelination of 
non-axonal targets. JAM2 is a repulsive signal which is expressed on the 
dendrites and cell bodies of certain neurons to prevent inappropriate 
myelination of these structures (Redmond et al., 2016).  
Some signals may demonstrate both attractive and repulsive effects on axon 
selection depending on the signalling environment. Ephrins are cell surface 
ligands which bind to Eph tyrosine kinase receptors. Eph-ephrin interactions 
are capable of bidirectional signalling, where forward signalling occurs in the 
Eph-expressing cell and reverse signalling occurs in the ephrin-expressing 
cell. Neurons and oligodendrocytes express both Eph receptors and ephrin 
ligands, and so both forward and reverse Eph-ephrin signalling is possible in 
each cell type. In vitro analysis has shown that EphA and EphB forward 
signalling in oligodendrocytes inhibits myelin membrane formation, while 
ephrin-B reverse signalling in oligodendrocytes enhances myelination 
(Linneberg et al., 2015). The specific combination of Eph receptors and ephrin 
ligands expressed by axons could either attract or repel their selection by 
oligodendrocytes for myelination (Almeida, 2018). 
Hence, unlike the PNS, no single molecular signal has been identified to 
regulate the selection of axons for myelination in the CNS. Instead, a complex 
network of attractive and repulsive molecular signals, in conjunction with 
physical cues of axon diameter, controls the selection of appropriate axons for 
myelination in the CNS (Figure 2). The precise interplay of these various 
signals, or how they might cross-talk to control myelination throughout life, is 
still not fully understood. 
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1.3.3. Myelin Sheath Formation 
Once an oligodendrocyte has selected an appropriate axon, the 
oligodendrocyte contact must wrap concentrically around the axon to form the 
compact, multi-layered structure of the mature myelin sheath. Numerous 
models for the wrapping process have been proposed, including the ‘carpet 
crawler’ (Bunge et al., 1989), the ’liquid croissant’ (Sobottka et al., 2011), and 
the ‘ofiomosaic’ models (Ioannidou et al., 2012). The most current model was 
proposed by Snaidero et al. in 2014, whereby the leading edge of the myelin 
sheet which wraps around the axon is the innermost layer, while the outer 
layers grow longitudinally along the axon (Figure 3). This means that the 
innermost layer of myelin is shortest, while the outermost layer is the longest; 
this is in line with previous observations that the number of myelin wraps 
around an axon can vary along the sheath (Knobler et al., 1974).  
The polarised growth of the inner tongue around the axon is driven by turnover 
of actin filaments at the leading edge (Nawaz et al., 2015). The myelin layers 
are compacted by myelin basic protein (MBP), which is translated locally in the 
myelin sheath itself (Colman et al., 1982; Wake et al., 2011), and prevents the 
diffusion of proteins into the compacted membrane layers (Aggarwal et al., 
2011). Improved ultrastructural preservation using high-pressure freezing 
electron microscopy has revealed that there are uncompacted cytoplasmic 
channels in growing myelin sheaths which provide cytoplasmic access 
between the inner tongue and the connecting oligodendrocyte process 
(Snaidero et al., 2014). These cytoplasmic channels are found in sheaths even 
in adulthood, and are formed due to actin bundling which counters the 
compacting forces of MBP to hold channels open in otherwise compact 
sheaths. 2’,3’-cyclic nucleotide 3’-phosphodiesterase (CNP) induces this actin 
bundling, and so is required for the formation and maintenance of cytoplasmic 
channels (Snaidero et al., 2017). Loss of CNP leads to fewer cytoplasmic 
channels (Snaidero et al., 2017) and causes neurodegeneration (Lappe-Siefke 
et al., 2003).  
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The neurodegeneration in CNP mutants can be rescued by restoring a normal 
number of cytoplasmic channels in myelin sheaths via reduced expression of 
MBP (Snaidero et al., 2017). It is hypothesised that the cytoplasmic channels 
in myelin sheaths are crucial, not just for oligodendrocytes to provide metabolic 
support to axons, but also for myelin sheath growth. Snaidero et al., 2014 
found that sheaths in the adult rodent CNS have fewer cytoplasmic channels 
than during active myelination, but that inducible stimulation of the 
PI3K/AKT/mTOR pathway first increases the number of cytoplasmic channels, 
and then leads to increased sheath thickness. It is not known whether the 
reopening of these channels and subsequent radial sheath growth affects the 
metabolic support or conduction properties of the underlying axon, nor whether 
these channels reopen in normal physiological conditions in response to 
signals such as neuronal activity. 
 
Figure 3 – the most up-to-date model of myelin wrapping in the CNS. 
Schematics based on the model proposed by Snaidero et al., 2014. A) The 
outermost layers of the sheath grow longitudinally to increase sheath length, 
making the outer layers longer than the inner layers during active growth. B) A 
cross-section (shown by the red dotted line in A) reveals that a growing zone on 
the innermost layer (dark purple) of the myelin sheath wraps around the axon 
(green). C) The structure of a growing sheath when unwrapped – the growing zone 






1.3.4. Domains of Myelinated Axons 
Myelin sheaths accelerate the conduction velocity of the underlying axon due 
to the formation of discrete axonal domains. Each of these axonal domains 
contain a localised complex network of proteins (Figure 4). On a fully 
myelinated axon, the gaps between myelin sheaths (nodes of Ranvier) are 
where the action potentials are propagated. These nodes are where voltage-
gated Na+ channels are clustered, as well as various K+ channels; cell 
adhesion molecules such as neurofascin isoform 186 (NF-186) and Nr-CAM; 
and scaffolding proteins such as Ankyrin-G and βIV-spectrin (Rasband and 
Peles, 2016; Salzer, 2003). The paranodes are the axon-glial contact sites, 
where the uncompacted ends of the myelin layers form paranodal loops which 
adhere to the axon via septate-like junctions. Axo-glial adhesion is mediated 
via the binding of glial neurofascin isoform 155 (NF-155) to axonal 
Caspr/Contactin-1 complexes. The axonal protein complex is bound to 
cytoskeletal proteins such as protein 4.1B, αII-, and βII-spectrin (Rasband and 
Peles, 2016; Salzer, 2003). The juxtaparanode is the region immediately 
adjacent to the paranode, and is characterised by the clustering of voltage-
gated K+ channels (Kv channels), cell adhesion molecules Caspr2 and 
Contactin-2, ADAM22, and PDZ-domain proteins PSD-93 and -95 (Rasband 
and Peles, 2016; Salzer, 2003). The internode is the domain underneath the 
myelin sheath (the term ‘internode’ is often used synonymously with ‘myelin 
sheath’; however, internode refers to the domain of the axon itself, whereas 
myelin sheath refers to the membrane structure around the axon which 
generated by myelinating cells. The term ‘myelin sheath’ will be used 
throughout this thesis).  
Disruption to the organisation of these discrete domains is associated with a 
number of neurological conditions (discussed by Salzer, 2003). For example, 
demyelination leads to changes in the expression and distribution of voltage-
gated Na+ channel subtypes, and production of antibodies targeting proteins 
such as Kv channels leads to neurological symptoms – such as 
hyperexcitability. Alterations to the expression, localisation, and function of ion 
channels in axonal domains affect the conduction properties of the axon, and 
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therefore, accurate formation of these domains is crucial for proper nervous 
system function. 
 
Figure 4 – the different domains of myelinated axons. 
Myelination leads to the formation of distinct axonal domains based on protein 
complex localisation. Zoomed in image shows a longitudinal cross-section through 
the myelinated axon. Voltage-gated Na+ channels (orange) are clustered with other 
proteins at the nodes of Ranvier (N) between myelin sheaths. The paranodal loops 
of the myelin sheath adhere to the axon at the paranode (PN) via septate-like 
junctions. Adjacent to the PN is the juxtaparanode (JPN), where voltage-gated K+ 
channels (blue) are found. The region under the myelin sheath is the internode (IN). 
1.3.5. Oligodendrocyte Heterogeneity 
There is significant heterogeneity in oligodendroglial cells throughout the CNS. 
OPCs found in different CNS regions can behave differently to one another. 
For example, OPCs residing in white matter regions such as the corpus 
callosum and optic nerve proliferate and differentiate more than OPCs in the 
cortex or spinal cord grey matter (Rivers et al., 2008; Young et al., 2013). There 
is evidence to suggest that these differences are intrinsically regulated. 
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Transplantation of the more proliferative white matter OPCs into grey matter 
regions does not affect their proliferation, while transplantation of grey matter 
OPCs into white matter does not increase their proliferative capacity (Viganò 
et al., 2013). This indicates that extracellular cues alone are not sufficient to 
regulate the behaviour of OPCs in distinct regions. The myelinating capacity 
of daughter oligodendrocytes also appears to be intrinsically programmed into 
OPCs. Rodent OPCs cultured in the presence of synthetic fibres with 
dimensions similar to axons will differentiate into oligodendrocytes and form 
myelin sheaths around these fibres (Bechler et al., 2015; S. Lee et al., 2012). 
In this in vitro system, devoid of any neuronal signalling cues, cortex-derived 
oligodendrocytes make sheaths smaller than those made by spinal cord-
derived oligodendrocytes – this is reflective of the myelin sheath lengths 
observed in vivo (Bechler et al., 2015). 
The intrinsic differences between different oligodendroglial cells suggests that 
there may be distinct populations of oligodendrocytes. In recent years, single 
cell RNA sequencing has become an extremely powerful tool for identifying 
different cell populations in the CNS based on intercellular transcriptional 
variation (Zeisel et al., 2015). Marques et al., 2016 identified six distinct 
populations of myelinating oligodendrocyte in regions throughout the adult 
rodent CNS. This transcriptional heterogeneity is found in the human CNS as 
well. Post-mortem single cell RNA sequencing analysis of white matter from 
healthy individuals or MS patients revealed that there are multiple populations 
of oligodendrocyte which can be defined by the expression of population-
specific markers (Jäkel et al., 2019). Comparison of healthy and MS-afflicted 
tissue found that there is an altered distribution of oligodendroglial populations 
in the latter – MS-afflicted tissue had a significantly smaller proportion of OPCs 
and oligodendrocyte populations 1 and 6, yet a higher proportion of 
oligodendrocyte populations 2, 3, and 5. These findings suggest that the 
remyelination of demyelinated lesions in MS does not just require 
oligodendrocyte production, but also the production of the correct populations 
of oligodendrocyte. Additionally, this could explain the significant variation in 
remyelination seen in the disease – for example, it has been observed that 
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grey matter lesions remyelinate more efficiently than white matter lesions 
(Albert et al., 2007). However, it is not clear whether these population 
differences are the consequence or the cause of the disease. It may be that 
individuals with higher numbers of certain oligodendrocyte populations are 
more susceptible to developing MS.  
Do the different populations of oligodendrocyte represent distinct subtypes, or 
transient cell states? It is not yet known whether there are transcriptionally 
distinct subtypes of OPC, possibly defined by developmental origin. 
Transcriptomic analysis of the white matter and grey matter OPCs known to 
display behavioural differences and their daughter oligodendrocytes could 
determine if this is the case. Alternatively, these transcriptionally distinct 
groups of oligodendrocytes may represent cell states where an 
oligodendrocyte can transition from one state to another depending on the 
signals it receives. In support of this, Jäkel et al., 2019 performed “pseudotime” 
analysis on their transcriptomic data to identify the developmental trajectories 
predicted by transcriptional similarities between individual cells. This identified 
that oligodendrocyte population 6 likely represents an early myelinating 
oligodendrocyte, while oligodendrocyte populations 1 and 5 are more mature 
oligodendrocytes. Longitudinal analysis of the expression of population-
specific markers could confirm whether these identified groups represent 
transient cell states which can change over time. Regardless of whether they 
represent states or subtypes, the functional consequences of these distinct 
populations are not fully understood. One possibility is that certain 
oligodendrocyte populations respond to certain pro-myelinating signals versus 
others; this may explain why there are numerous molecular cues which can 
regulate CNS myelination. Oligodendrocyte diversity could also reflect the 
variety of circuits which are myelinated; perhaps certain oligodendrocyte 
populations myelinate specific neuronal subtypes to respond to particular 
demands of the underlying axons (for example, some axons may require more 
metabolic support than others, or some axons may use neuronal activity to 
remodel myelin sheaths more than others). Further research into these distinct 
oligodendrocyte populations will help to elucidate any functional differences. 
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1.4. Myelination is a Lifelong Process 
1.4.1. Myelination in Humans 
In humans, myelination take place in a well-characterised spatiotemporal 
manner, beginning just prior to birth (Brody et al., 1987). Rapid production of 
oligodendrocytes and extensive myelination occurs during the first few years 
of life, followed by more gradual myelin formation throughout adolescence 
(Yakovlev and Lecours, 1967; Yeung et al., 2014).Yet, evidence now indicates 
that myelination is a lifelong process which continues into adulthood. OPCs 
are found within the adult human brain, indicating that a source of new 
oligodendrocytes is present throughout life (Chang et al., 2000). Studies from 
as early as the mid-twentieth century noted that myelin continues to 
accumulate beyond the third decade of life in associative areas of the cerebral 
cortex (Yakovlev and Lecours, 1967). More recently, diffusion tensor imaging 
(DTI) has been used to measure changes in the myelin-rich white matter 
regions of the brain over time. DTI measures the diffusion of water molecules 
in a given tissue; water molecules will exhibit different diffusion properties in 
different tissue microstructures. The diffusion properties measured by DTI 
provide a fractional anisotropy (FA) value, which is a ratio of the anisotropy 
(direction-dependent diffusion) versus isotropy (direction-independent 
diffusion) of a tissue. Water molecules in white matter tracts (where the tissue 
consists of long cable-like structures) will diffuse more in a parallel direction 
than a perpendicular direction, giving a higher FA value than grey matter. 
Subsequently, DTI can be used to image the white and grey matter regions of 
the brain, and detect changes in white matter as changes in the FA value over 
time. Lebel and Beaulieu, 2011 imaged individuals ranging from 5-32 years of 
age multiple times to observe white matter maturation during childhood, 
adolescence, and young adulthood. They measured changes in the FA of 
various tracts as a read-out of white matter maturation. They found that while 
projection and commissural tracts stopped changing by late adolescence, the 
association tracts continue to change during young adulthood. However, FA 
increases both with myelination and increasing axon diameter and density 
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(Beaulieu, 2002) – thus these observed changes do not necessarily reflect 
changes in myelination.  
Carbon dating analysis has also shed some light regarding the formation of 
myelin in the human brain throughout life. Yeung et al., 2014 performed carbon 
dating of both biochemically-purified myelin and oligodendrocyte nuclei from 
post-mortem tissue of individuals ranging from 0.2-92 years of age. This 
technique takes advantage of the nuclear bomb tests from the mid-twentieth 
century which led to a sharp increase in global atmospheric levels of the 
isotope 14C. When a cell replicates its DNA, this will incorporate 14C into the 
new DNA strands at levels approximately comparable to atmosphere at the 
time of S-phase. As 14C levels have been exponentially decreasing at a known 
rate since the 1960s, the birth-date of a cell (or any carbon-containing 
molecule) can be determined by comparing the 14C levels of the DNA (or other 
carbon-based molecules) with the known atmospheric levels (Spalding et al., 
2005). Yeung et al. found that the birth date of purified myelin from the corpus 
callosum is comparable to the time of death even in older adults. This could 
be due to rapid formation or turnover of myelin sheaths themselves throughout 
life, or due to the continuous turnover of carbon-containing molecules within 
stable myelin sheaths. Carbon dating oligodendrocyte nuclei from the frontal 
cortex showed that new oligodendrocytes are born until the fourth decade of 
life. There may be regional differences in the rates of lifelong myelination – 
carbon dating of oligodendrocyte nuclei from the corpus callosum determined 
that all callosal oligodendrocytes are born during early childhood. 
Immunohistochemistry of human post-mortem brain tissue also suggests 
regional variation in the production of oligodendrocytes. Staining for BCAS1 (a 
novel marker for newly-differentiated oligodendrocytes) revealed very few new 
oligodendrocytes in white matter tracts beyond the third decade of life. Yet 
there were several new oligodendrocytes observed in the frontal cortex even 
in old age (Fard et al., 2017).  
Why are there regional differences in lifelong oligodendrocyte production? 
Such differences may reflect the diversity of circuits which are myelinated in 
the CNS. Different circuits may have differing demands throughout life. For 
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example, oligodendrocytes may be produced throughout life in the frontal 
cortex because cortical axons require increasing metabolic support, whereas 
as oligodendrocyte production is negligible in the adult corpus callosum 
because callosal axons do not have such metabolic requirements. Further 
work is required to understand how myelination throughout life differs between 
distinct circuits in the CNS. 
Nevertheless, the caveats of the carbon dating method in assessing 
oligodendrocyte production throughout life must be considered (Mount and 
Monje, 2017). The birth date reflects the time point of S-phase of the OPC, and 
so this method assumes that all oligodendrocytes are differentiated from 
recently-divided OPCs. There is evidence that rodent OPCs can differentiate 
directly into oligodendrocytes without a prior cell division (or at least, OPCs 
can differentiate a prolonged period of time after their most recent cell division 
(Hughes et al., 2013)). If OPCs born in childhood differentiate without any 
further division into oligodendrocytes during adulthood, then the date of 
oligodendrocyte differentiation cannot be determined by carbon dating. If 
oligodendrocyte production during adulthood does, indeed, occur in both the 
frontal cortex and corpus callosum, then the carbon dating results may indicate 
that OPCs in these distinct areas behave differently. For example, in 
adulthood, the OPCs of the frontal cortex may always differentiate after cell 
division, whereas the OPCs of the corpus callosum may differentiate into 
oligodendrocytes a prolonged period of time after their last cell division. 
Additionally, this method provides an average birth date of a pool of nuclei, 
rather than individual nuclei, which could potentially mask variation in birth 
dates within the oligodendrocyte population (although the authors state that 
they used mathematical models that should account for this possible source of 
error) (Yeung et al., 2014). It is possible that the rate of oligodendrocyte 
production (and subsequent myelination) in the adult human brain may be 





1.4.2. Myelination in Other Mammals 
Much research has used rodent models to investigate the timescales of 
oligodendrocyte production and myelination throughout life. In rodents, 
myelination begins in the ventral spinal cord around birth, and, as in humans, 
progresses in a stereotyped manner (Baumann and Pham-Dinh, 2001; Foran 
and Peterson, 1992). Robust myelination is observed throughout the rodent 
CNS by approximately two months of age (P60), coinciding with young 
adulthood. During this developmental period, a surplus of oligodendrocytes is 
generated. These newly-differentiated oligodendrocytes compete for survival 
factors and many cells die without forming myelin sheaths. In the rat optic 
nerve, up to 50% of newly-differentiated oligodendrocytes die between P8-
P12. This cell death is due to competition for survival factors such as IGFs and 
PDGF (Barres et al., 1992). Similarly, 20% of newly-differentiated 
oligodendrocytes in the rat cerebral cortex degenerate between P7-21, while 
oligodendrocytes that form myelin sheaths show no sign of cell death (Trapp 
et al., 1997). This extensive oligodendrocyte cell death is mediated by the pro-
apoptotic transcription factor TFEB, which is highly expressed in newly-
differentiated oligodendrocytes (Sun et al., 2018). Oligodendrocyte-specific 
loss of TFEB leads to a significant increase in the number of oligodendrocytes 
due to reduced apoptosis, and precocious myelination in both grey and white 
matter regions of the CNS as early as P6. Transcriptomic analysis revealed 
that TFEB promotes expression of PUMA which triggers oligodendrocyte cell 
death via the Bax-Bak axis (Sun et al., 2018). It remains unknown whether a 
similar degree of oligodendrocyte overproduction and subsequent cell death 
occurs during childhood and adolescence in humans.   
OPCs continue to proliferate and differentiate into oligodendrocytes beyond 
P60 in many grey and white matter regions of the rodent CNS (Rivers et al., 
2008; Young et al., 2013). More recent studies have used longitudinal live 
imaging of transgenic mice expressing fluorescent reporters in 
oligodendrocytes to follow the production of oligodendrocytes at various 
stages of adulthood (Hill et al., 2018; Hughes et al., 2018). These studies used 
cranial imaging windows to perform two-photon microscopy of the upper layers 
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of the somatosensory cortex in anaesthetised animals. Hughes et al., 2018 
imaged the cortex of young adult (~P60-120), middle-aged (~P330-420), and 
old-aged (~P630-720) mice, and found that the oligodendrocyte density of the 
upper layers almost doubles between young adult and middle age. They also 
performed repeated imaging in middle-aged transgenic mice with 
fluorescently-labelled OPCs and oligodendrocytes to follow the fate of 
differentiating OPCs. By imaging over 50 days, they found that many newly-
differentiated oligodendrocytes failed to form myelin sheaths and rapidly 
underwent cell death – reminiscent of the cell death observed in early 
myelination. Oligodendrocyte overproduction therefore continues throughout 
life in rodents. 
Hill et al. 2018 imaged the cortex of juvenile (P30), young adult, middle-aged, 
and old-aged (reaching up to P950) mice, and similarly found that 
oligodendrocyte numbers increase throughout adulthood, reaching a peak at 
P630. They also performed the label-free imaging technique Spectral Confocal 
Reflectance microscopy (SCoRe) which has previously been used to image 
compact myelin sheaths without the need for any fluorescent protein 
expression (Schain et al., 2014). SCoRe takes advantage of the reflective 
properties of myelin sheaths by using multiple confocal lasers and detecting 
the reflected light in order to visualise compact myelin along axons, even in 
living tissue. Hill et al., 2018 observed that myelin detected by SCoRe 
accumulates in the cortex similarly to oligodendrocyte number. Both 
oligodendrocyte number and myelin levels detected by SCoRe decline from 
their peak at P630 to P950 – suggesting that death of myelinating 
oligodendrocytes occurs in old age. Age-related myelin loss will likely have an 
impact on the conduction of the underlying axons, could significantly disrupt 
the function of previously-myelinated circuits, and ultimately contribute to age-
associated cognitive decline. It is not currently known whether oligodendrocyte 
number also declines in humans with old age. However, MRI studies have 
shown that the white matter microstructure (a parameter known to correlate 
with fluid intelligence (Ritchie et al., 2015)) of various tracts does deteriorate 
in old age (Cox et al., 2016).  
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Overall, there is significant evidence that myelination is a protracted process 
which can span well into adulthood. Why does myelination continue throughout 
life? Given that myelin sheaths are known to accelerate the conduction of the 
underlying axon, one possibility is that axons require lifelong tuning of their 
conduction properties. Adjustments to the conduction of individual axons is 
likely important in the overall function of circuits, and thus protracted 
myelination may represent a powerful means by which circuit function can be 
regulated throughout life. Alternatively, it may be that axons require more 
metabolic support with age, which could be achieved by increasing the myelin 
coverage along axons over time.  
1.5. Myelin and the Regulation of Circuit Function 
Myelination significantly changes the conduction properties of axons and is 
therefore likely to have a dramatic impact on circuit function. Indeed, 
myelination correlates with the emergence of various cognitive processes. 
Numerous MRI studies in children show that white matter volume (which is 
influenced by myelination) correlates with development of processes such as 
language acquisition (Pujol et al., 2006), reaction time (Walhovd and Fjell, 
2007), information processing speed (Mabbott et al., 2006), working memory, 
and reading ability (Nagy et al., 2004). 
There is considerable variability in the number, length, thickness, and 
distribution of myelin sheaths along axons in the CNS. For example, myelin 
sheaths in the spinal cord tend to be longer than sheaths in the corpus 
callosum (Remahl and Hildebrand, 1990), while sheaths in the cerebral cortex 
tend to be the shortest on average (Chong et al., 2012). Although sheath length 
is known to correlate with axon diameter, this may not be the only determinant 
of sheath length. Murray and Blakemore, 1980 noted that many sheaths in the 
cat spinal cord are double or half the length predicted by axon diameter alone. 
Additionally, there are many different patterns of myelination in the CNS. 
Tomassy et al., 2014 imaged serial sections of the mouse cortex by electron 
microscopy, and then made reconstructions of single axons to visualise 
myelinated axon morphology at high resolution. They identified several 
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different myelin patterns along the axons of pyramidal neurons in the cortex of 
young adult (P60) mice. Many axons in layers II/III of the visual cortex display 
intermittent or sparse patterns of myelin where myelin sheaths are separated 
by stretches of unmyelinated axon much longer than conventional nodes of 
Ranvier. These intermittent myelin patterns have also been found in deeper 
layers of the visual cortex imaged by combined lattice light-sheet protein-
retention expansion microscopy (Gao et al., 2019). Intermittent myelin patterns 
may be a feature of specific neural circuits – while layer V/VI axons of the 
visual cortex are intermittently myelinated (Gao et al., 2019), layer V/VI axons 
of the somatosensory cortex are continuously myelinated at the same age 
(Tomassy et al., 2014). Sparsely myelinated axons are also seen in layer I of 
the somatosensory cortex of middle-aged mice (Hill et al., 2018; Hughes et al., 
2018). Repeated imaging demonstrated that new myelin sheaths form on 
these sparsely myelinated axons in adulthood (Hill et al., 2018); this suggests 
that sparse myelination reflects axons undergoing very gradual protracted 
myelination.  
What is the functional consequence of this myelin pattern variability in the 
CNS? Changing the sheath length, thickness, or number will have predictable 
effects on the conduction velocity of the underlying axon (Waxman, 1980). In 
the context of circuit function, it is important to not only ensure rapid signal 
conduction, but also to synchronise the precise timing of signal arrival at 
synaptic targets. Establishing a particular pattern of myelin along an axon is 
one such way in which the timing of signals could be fine-tuned to facilitate 
synchronisation of activity (Pajevic et al., 2014), and therefore different myelin 
patterns may reflect the different conduction requirements of distinct circuits. 
1.5.1. Myelin is Involved in Signal Synchronisation in the Auditory System 
Sound localisation requires synchronous arrival of input from each ear onto an 
array of coincidence detector neurons. In birds, nucleus magnocellularis (NM) 
neurons receive monoaural input from the ipsilateral auditory nerve. The NM 
neuron has a bifurcating axon; one branch projects to the ipsilateral nucleus 
laminaris (NL), while the other branch projects to the contralateral NL. 
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Coincidence detector neurons in each NL receive input from both ears. The 
slight temporal difference in signal arrival at the NL means that a particular 
neuron in the coincidence detector array will be stimulated, which allows 
computation of sound localisation. However, this still requires input from both 
ears to arrive at the NL with approximate synchrony. The ipsilateral projection 
of the NM neuron is much shorter than the contralateral projection; this means 
that the contralateral auditory input to the NL has a much greater distance to 
travel before reaching the coincidence detector array. To ensure that the 
contralateral input arrives at the NL to coincide with the ipsilateral input, the 
contralateral projections of the NM neurons have larger axon diameters and 
longer myelin sheaths (Seidl et al., 2010). This allows the contralateral 
projection to conduct at a higher velocity than the ipsilateral projection (Seidl 
et al., 2014) (Figure 5A). 
Similar axonal morphologies have been described in mammals. In the 
mammalian auditory system, bushy cells receive input in the cochlea and then 
project to the contralateral medial superior olive (MSO) nucleus. Excitatory 
spherical bushy cells (SBCs) project axons directly to the MSO. Granular 
bushy cells (GBCs) synapse onto the contralateral medial nucleus of the 
trapezoid body (MNTB), which sends inhibitory projections to the MSO. GBC-
mediated inhibitory input arrives at the MSO before the excitatory SBC input, 
despite the synaptic delay at the MNTB (Roberts et al., 2013). This is because 
GBC axons have larger diameter and longer myelin sheaths than SBC axons 
(Ford et al., 2015). Intriguingly, a subset of GBC neurons exhibit tuning of 
myelin sheath length independent of axon diameter. GBC axons projecting to 
the lateral MNTB (which encode low frequency sound) have a larger axon 
diameter but a shorter myelin sheath length than the GBC axons projecting to 
the medial MNTB (which encode high frequency sound). These axons also 
exhibit decreasing myelin sheath length and increasing node diameter along 
distal regions of the axon close to the presynaptic terminal, which is 
hypothesised to ensure precise timing of presynaptic depolarisation (Ford et 




Figure 5 – specific myelin patterns facilitating synchronous activity in the 
auditory system. 
A) A simplified diagram of nuclei in the auditory system of birds. Nucleus 
magnocellularis (NM) neurons receive auditory input and send impulses along a 
bifurcating axon; one branch projects to the ipsilateral nucelus laminaris (NL), the 
other branch projects to the contralateral NL. The contralateral axon has a larger 
diameter and longer myelin sheaths to increase conduction velocity relative to 
ipsilateral axon. This means that each NL receives ipsilateral and contralateral 
auditory inputs at approximately the same time, despite the disparity in the length 
of the two axons. B) A simplified diagram of the nuclei in the mammalian auditory 
system. Spherical bushy cells (SBCs) project from the cochlea directly to the 
contralateral medial superior olive (MSO), while Granular bushy cells (GBCs) 
project to the contralateral medial nucleus of the trapezoid body (MNTB) which then 
projects onto the MSO. GBC signals arrive at the MSO faster (despite the synaptic 
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delay) due to increased axon diameter and myelin sheath length along GBCs 
compared to SBCs. Additionally, both axons have reducing sheath length towards 
the distal end of the axon which is predicted to ensure precise signal timings. 
1.5.2. Characterising Myelin Patterns along Single Axons In Vivo 
Establishing specific myelin patterns may be crucial in the synchronisation of 
signals in many other circuits of the CNS. To begin to understand how myelin 
patterns might regulate circuit function, there is a need to characterise the 
myelin patterns along single axons within identified circuits and correlate these 
patterns with known circuit properties. Do certain subtypes of axon exhibit 
particular myelin patterns? The interplay of the many signals which regulate 
the selection of axons for myelination (discussed in section ‘1.3.2 Axon 
Selection’) may play a role in myelin pattern establishment. Certain subtypes 
of axon may use specific signals to regulate their myelination and myelin 
pattern formation versus other signals. For example, two neuronal subtypes in 
the zebrafish spinal cord have been shown to regulate their initial myelination 
differently. Reticulospinal axons are myelinated in a synaptic vesicle release-
dependent manner, whereas CoPA axons are not (Koudelka et al., 2016). In 
Chapter 3 of this thesis, I will characterise the myelin patterns established 
along individual axons of different neuron subtypes in the zebrafish spinal cord, 
and assess whether neuron subtypes from different circuits exhibit different 
myelin patterns. 
1.5.3. Experience Affects Myelination 
Experience can impact on myelination, particularly during key developmental 
time windows, and lack of experience can have long-lasting consequences on 
both myelination and cognitive function. Social experience is one poignant 
example; Romanian orphans who experienced severe socio-emotional neglect 
during early childhood have significant alterations to numerous white matter 
tracts associated with the medial prefrontal cortex (mPFC), as assessed by 
DTI (Eluvathingal et al., 2006). Numerous social isolation experiments have 
been performed in rodents to investigate the cellular level effects of social 
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deprivation. Mice which are socially isolated after weaning display long-lasting 
cognitive deficits in sociability and working memory (Makinodan et al., 2012). 
Although isolated mice show no change in the number of oligodendrocytes in 
the mPFC, there is a significant reduction in both the number and thickness of 
myelin sheaths that each oligodendrocyte generates. Neither the myelin nor 
the behavioural phenotypes are rescued by re-socialising the mice, indicating 
that experience deprivation during juvenile development has sustained effects 
on cognitive function. The molecular mechanism for these phenotypes may be 
via Nrg1-ErbB signalling; social isolation leads to reduced expression of Nrg1 
type III, while inducible deletion of the Nrg1 receptor ErbB3 from 
oligodendrocytes replicates the behavioural and myelin phenotypes of socially 
isolated mice (Makinodan et al., 2012). Given previous research which 
suggests that Nrg1 is required for oligodendrocytes to respond to neuronal 
activity (Lundgaard et al., 2013), it is possible that Nrg1 signalling to 
oligodendrocytes is required for experience-related signals – such as neuronal 
activity – to influence myelination and regulate circuit function. 
Social experience is capable of altering myelin in adulthood, too; social 
isolation of adult mice leads to thinner myelin sheaths and reduced myelin 
protein expression in the mPFC (Liu et al., 2012). These effects appear to be 
circuit-specific, as the myelin phenotypes were not seen in other regions such 
as the nucleus accumbens, corpus callosum, or cerebellum. Interestingly, 
resocialisation after isolation in adulthood does reverse both the transcriptional 
and behavioural phenotypes observed, which contrasts with the lack of change 
seen when juvenile mice are resocialised. These findings suggest that there is 
a critical period during development when experience can permanently shape 
myelination and alter circuit function, whereas changes to myelin and circuit 
function during adulthood may be more transient or reversible. 
Rescuing the myelin phenotype appears to rescue the cognitive deficits 
caused by social isolation. Mei et al., 2014 performed a large-scale chemical 
screen for drugs which promote myelination, where they identified clemastine, 
an anti-muscarinic compound which promotes oligodendrocyte differentiation 
(Mei et al., 2014). Treating socially isolated adult mice with clemastine 
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increases the number of mature oligodendrocytes, the number of myelinated 
axons, and myelin sheath thickness in the PFC compared to vehicle 
treatments (Liu et al., 2016). Clemastine treatment also increases the social 
interaction test score of isolated mice so that their sociability is identical to 
normally-housed mice. Thus, social experience is required to shape the myelin 
patterns of the PFC, and these myelin patterns may, in turn, affect circuit 
functional output.  
Sensory experience can also influence myelination. Hill et al., 2014 studied 
survival of oligodendroglial lineage cells in the somatosensory barrel cortex of 
P10-12 mice in a sensory deprivation paradigm. A sub-population of OPCs 
was labelled at P6 with YFP by Cre-ERT2-mediated lineage tracing, and then 
the whiskers from one side were trimmed daily to reduce sensory stimulation 
from P6-P10/12. The overall number of caspase-3+ cells and the number of 
YFP+ caspase-3+ cells at P12 was significantly higher in the deprived sensory 
cortex compared to the spared cortex, indicating that sensory deprivation 
increased the death of either OPCs, or newly-differentiated oligodendrocytes 
derived from P6-labelled OPCs. There was no change in the total number of 
CC1+ cells nor the number of caspase-3+ CC1+ cells, suggesting that despite 
reduced survival of OPCs or newly-differentiated oligodendrocytes, there was 
no effect on either the production or survival of myelinating oligodendrocytes. 
It is possible that a more prolonged period of sensory deprivation would 
eventually lead to reduced production of myelinating oligodendrocytes and 
hypomyelination.  
Hughes et al., 2018 observed that sensory stimulation increased the 
production of oligodendrocytes in the somatosensory cortex. They performed 
longitudinal imaging of fluorescently-labelled oligodendrocytes in the upper 
sensory cortex of adult mice undergoing a sensory stimulation paradigm. 
These mice were housed in cages with strings of beads hung inside, so that 
when the mice moved around the cage their whiskers were stimulated 
regularly. Hughes et al. imaged a region of the cortex both before and after 3 
weeks of sensory stimulation and found that stimulation increased the 
production of new myelinating oligodendrocytes compared to unstimulated 
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control mice. This was due to the sensory stimulation itself, as mice housed in 
the sensory cages, but without any whiskers, did not have elevated numbers 
of new myelinating oligodendrocytes. 
It remains to be seen if myelin phenotypes caused by changing sensory 
experience alter circuit function and change animal behaviour, as occurs with 
social experience.  
1.5.4. Myelin may Contribute to Learning 
Learning requires circuit plasticity. The strengthening of synaptic connections 
through long-term potentiation has long been known to play a vital role in 
learning and memory (Bliss and Collingridge, 1993). Evidence now suggests 
that myelination may also be involved in learning processes. In principle, 
establishing certain patterns of myelin could synchronise signals on a common 
target; changes to the myelin pattern along axons may facilitate the 
strengthening of circuits in learning. There is significant evidence that white 
matter alterations occur with learning. DTI studies have shown that practicing 
a musical instrument correlates with white matter tract organisation in 
childhood, adolescence and adulthood (Bengtsson et al., 2005; Steele et al., 
2013). Scholz et al., 2009 performed DTI in individuals before and after a 
period of time spent learning to juggle, and found that individuals who 
performed this visuo-motor task displayed white matter changes in the intra-
parietal sulcus. Similarly, Schlegel et al., 2012 found that individuals who 
undertook an intensive language course displayed white matter changes in 
language-associated brain areas. As previously discussed, the measurements 
obtained from DTI studies are not necessarily caused by changes to myelin. 
To address whether learning causes changes in myelin, Sampaio-Baptista et 
al., 2013 performed DTI and immunohistochemistry in rats which were taught 
a skilled reaching motor task. They found that both the FA measurements and 
myelination as assessed by MBP staining correlated with the animals’ learning 




Is myelination required for learning? To investigate this, McKenzie et al., 2014 
conditionally deleted the transcription factor MyRF gene from OPCs in adult 
mice to prevent any further oligodendrocyte production. These mice were 
unable to learn a complex running wheel motor task as efficiently as their wild-
type littermates. More detailed analysis revealed that when wild-type mice 
undergo motor learning, this leads to production of newly-differentiated 
oligodendrocytes in the motor cortex and subcortical white matter just a few 
hours after training (Xiao et al., 2016).  
Collectively, these examples suggest that myelin can regulate the function of 
circuits to mediate efficient learning; such regulation could explain the gradual 
formation of myelin which has been observed throughout life. 
1.5.5. How Does Myelin Change? De Novo Myelination versus Myelin 
Remodelling    
If establishing particular myelin patterns along axons is crucial to circuit 
function and is involved in learning, then changes to myelin patterns in circuits 
must occur throughout life. This could be done by producing new myelin 
sheaths, modifying existing myelin sheaths, or a combination of both 
strategies. 
New myelin sheaths would most likely be produced by newly-differentiated 
oligodendrocytes. Live imaging in in vitro co-cultures (Watkins et al., 2008) and 
in vivo in zebrafish larvae (Czopka et al., 2013) has demonstrated that newly-
differentiated oligodendrocytes can only form new myelin sheaths within a 
restricted time window on the order of hours. Myelin sheath number per 
oligodendrocyte does not increase beyond this time period (Czopka et al., 
2013; Tripathi et al., 2017).  
There is significant evidence that new oligodendrocytes are generated 
throughout adulthood in at least some regions of the human and rodent CNS 
(see section ‘1.4 Myelination is a Lifelong Process’ above). This suggests that 
new oligodendrocytes (and subsequently, the addition of new myelin sheaths) 
are required for learning. Although McKenzie et al., 2014 found that MyRF 
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knock-out mice exhibit significant motor learning deficits compared to wild-type 
mice, the knock-outs still show improvement in the complex wheel task over 
eight days. Therefore, inhibiting de novo myelination does not completely 
prevent learning. 
Modification (or remodelling) of existing myelin sheaths could also affect the 
conduction properties of underlying axons to fine-tune signal timing. This could 
be done by changing the length or thickness of existing myelin sheaths. 
Hughes et al., 2018 and Hill et al., 2018 both followed individual myelin sheaths 
in their cortical live imaging experiments to assess if sheath length is altered 
over time. They found that, although a small subset of sheaths exhibited 
changes (both sheath growth and sheath shrinkage were observed), the 
majority of sheaths showed no discernible change in length over several 
weeks. Sheath length stability may actually increase with age – Hill et al. found 
that approximately 80% of sheaths analysed were stable in P60-90 mice, while 
Hughes et al. found that 99% of sheaths were stable in P365 mice. Sheath 
length remodelling is unchanged by repeated sensory stimulation of whiskers 
(Hughes et al., 2018). It is not clear whether more myelin sheaths are 
remodelled during earlier developmental time windows or in other regions of 
the CNS, nor whether experience or circuit activity can induce sheath 
remodelling in other regions or at other developmental stages. It also remains 
unclear if the sheaths which do remodel in length at middle age belong to a 
particular subset of dynamic oligodendrocytes. Hill et al. followed individual 
oligodendrocytes and identified examples of cells which exhibited different 
behaviours in sheath length changes. One cell showed no sheath length 
changes, one showed some sheaths which grew, and one showed both sheath 
growth and sheath shrinkage. Alternatively, sheath length remodelling may 
only occur along a subset of axons throughout life. 
Research in zebrafish larvae also indicates that at least some sheaths are 
relatively stable in length. Auer et al., 2018 performed repeated imaging of the 
spinal cords of larvae with fluorescently-labelled oligodendrocytes and myelin 
sheaths to follow changes in sheath length over time. They found that in the 
first few days after sheaths are formed, they grow rapidly (although growth rate 
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was variable between different sheaths). After this initial period of rapid growth, 
sheaths then become stable in length; however, they are capable of adjusting 
length when required. For example, as the animal grows (and subsequently, 
the axons in the spinal cord elongate), myelin sheaths will grow at the same 
rate to ensure that myelin coverage along the axon is sustained. 
Sheath thickness may also be modified over time to influence conduction 
velocity. The gold-standard technique for measuring myelin sheath thickness 
is by cross-sectional analysis via transmission electron microscopy of ultra-
thin sections (70-80 nm in thickness). Sheath thickness is typically reported as 
a g-ratio, which is the ratio between the diameter of the axon alone and the 
diameter of the axon plus the myelin sheath. Transmission electron 
microscopy can also be used to count the number of membrane wraps in a 
myelin sheath. Recent technological advancements (for example, high-
pressure freezing techniques) have significantly improved the quality of tissue 
fixation to provide ultra-detailed images of sheath structure (Möbius et al., 
2016). However, this technique limits sheath thickness measurement to a 
single time-point; live imaging techniques are required to properly assess 
whether myelin sheath thickness can be modified over time. Some techniques 
are emerging which may allow assessment of sheath thickness dynamics in 
living animals, such as: third harmonic generation microscopy (Lim et al., 
2014) and spectral reflectometry (Kwon et al., 2017).  
Nevertheless, there is some electron microscopy evidence that sheath 
thickness can change over time. Snaidero et al., 2014 investigated how 
manipulating the PI3K/AKT/mTOR pathway in adult mice affects sheath 
growth. To do this, they inducibly deleted the PTEN gene in myelinating 
oligodendrocytes of adult (P100) mice to elevate PIP3 levels (and 
subsequently stimulate the PI3K/AKT/mTOR pathway). They found that, 30 
days after gene deletion, myelin sheaths in the optic nerve had many more 
cytoplasmic channels than wild-type animals (a feature of growing sheaths in 
early developmental myelination), but were of similar sheath thickness. When 
they looked at myelinated optic nerve axons even later (90 days after gene 
deletion), not only did sheaths in the knock-out animals have many more 
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cytoplasmic channels, these myelin sheaths contained significantly more 
wraps of myelin. These results indicate that upregulation of the 
PI3K/AKT/mTOR pathway in adult myelin sheaths re-initiates the wrapping 
process to increase sheath thickness. It remains to be seen if this occurs 
naturally in vivo in response to experience and learning. 
1.5.6. Myelin Pattern Remodelling Along Single Axons In Vivo 
Experience (and therefore, circuit activity) may remodel myelin patterns to 
influence circuit function. Understanding how myelin remodelling might 
influence circuit function requires characterisation of how myelin is remodelled 
over time along individual axons within known circuits. Although recent work 
in rodents suggests that myelin sheaths in the adult somatosensory cortex do 
not remodel (Hill et al., 2018; Hughes et al., 2018), it remains unknown if myelin 
remodelling occurs elsewhere or at other time points during development. If 
myelin is remodelled in response to the activity or demands of an individual 
circuit, then do axons from different circuits exhibit different types and extents 
of myelin remodelling? Using the cranial window imaging techniques utilised 
by both Hill et al., 2018 and Hughes et al., 2018 to investigate these questions 
is technically challenging. The larval zebrafish is an ideal system to perform 
non-invasive repeated live imaging of myelin sheaths along single axons in 
vivo. In Chapter 3 of this thesis, I will investigate how and when myelin is 
remodelled along individual axons of distinct neuron subtypes in the zebrafish 
spinal cord, and assess whether axons from different circuits exhibit different 
types and extents of myelin remodelling. 
1.6. Neuronal Activity can Influence Myelination 
Changes to myelin occur in response to experience, affecting cognitive 
function and, potentially, mediating learning. What are the signals which cause 
these changes to myelin? A significant body of research has demonstrated 
that neuronal activity itself can influence oligodendroglial development and 
myelination. The first evidence came from studies of visual system 
development when visual input is altered. The optic nerve is normally 
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extensively myelinated within the first few weeks of post-natal development. 
Raising mice in the dark decreases the number of axons which are myelinated 
during this time period (Gyllensten and Malmfors, 1963), while prematurely 
opening the eyes of rabbits at P5 accelerates optic nerve myelination (Tauber 
et al., 1980). Since then, much work has been done to understand the 
signalling mechanisms connecting neuronal activity to myelination. Here I will 
first discuss the evidence that manipulating the electrical activity of neurons 
can impact various aspects of oligodendrocyte development; then, I will 
discuss various molecular signals proposed to mediate the effects of activity 
on oligodendroglial cells. 
1.6.1. Electrical Activity of Neurons Affects Numerous Stages of 
Oligodendroglial Lineage Development 
OPC Proliferation and Differentiation 
Barres and Raff, 1993 studied how electrical activity in the optic nerve affects 
oligodendroglial development by injecting tetrodotoxin (TTX) into the eye of P8 
rats. TTX blocks voltage-gated Na+ channels and thus silences the electrical 
activity of neurons by preventing action potentials from firing (Narahashi and 
Scott, 1964). Inhibiting optic nerve electrical activity leads to significantly 
reduced levels of OPC proliferation, as assessed by BrdU incorporation, which 
can be reversed by implanting cells which over-express PDGF (Barres and 
Raff, 1993).  
Direct electrical stimulation can enhance OPC proliferation and differentiation 
in vivo. Li et al., 2010 surgically implanted an electrode onto the medullary 
pyramid of rats in order to electrically stimulate the corticospinal tract and then 
observe the effects of stimulation on oligodendroglial lineage cells. They found 
that, after a 10-day stimulation period, the number of proliferating cells was 
elevated at numerous positions in the spinal cord compared to sham controls 
(assessed by BrdU incorporation during the stimulation period). Enhanced 
OPC proliferation and differentiation was confirmed as the number of BrdU+ 




More recent research utilising optogenetics has confirmed that electrical 
activity in cortical neurons also stimulates OPC proliferation and differentiation 
(Gibson et al., 2014). In brief, light-sensitive channelrhodopsin cation channels 
are expressed in neurons of interest in vivo, and then exposure of these 
neurons to a particular wavelength of light opens the light-gated 
channelrhodopsins, subsequently activating the expressing neuron (Boyden et 
al., 2005). Channelrhodopsins were expressed in cortical layer V projection 
neurons of mice with an optical fibre implanted beneath the pial membrane at 
the premotor cortex, and the expressing neurons were stimulated with blue 
light for 30 minutes (Gibson et al., 2014). Proliferation was measured by EdU 
incorporation three hours after stimulation, and showed that OPC proliferation 
is substantially increased in both the premotor cortex and in the adjacent 
region of the corpus callosum. Repeated optogenetic stimulation also 
enhances the differentiation of OPCs into oligodendrocytes. Daily optogenetic 
stimulation of cortical neurons for seven days leads to a significant increase in 
the number of EdU+ oligodendrocytes (new cells generated from recently-
proliferating OPCs) four weeks later. 
Similar results have been reported using chemogenetics to stimulate neurons 
in the somatosensory cortex (Mitew et al., 2018). Designer Receptors 
Exclusively Activated by Designer Drugs (DREADDs) are modified G-protein 
coupled receptors (GPCRs) with reduced affinity for their endogenous ligand, 
and high affinity for a synthetic ligand (Alexander et al., 2009). Mitew et al. 
expressed the DREADD hM3Dq in somatosensory cortical neurons and found 
that stimulating these neurons by administering the ligand clozapine-N-oxide 
elevated the levels of OPC proliferation in the corpus callosum, as assessed 
by EdU incorporation. Stimulation also increased the number of EdU+ 
oligodendrocytes in the corpus callosum. Importantly, DREADD stimulation 
increased OPC proliferation and differentiation in both juvenile (P19) and 
young adult (P60) mice.  
One issue which has not been addressed in these experiments is whether 
neuronal activity directly influences both OPC proliferation and differentiation. 
The OPC population appears to be tightly regulated, with OPCs colonising the 
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CNS uniformly and proliferating in response to disruption of the population 
(such as OPC death or differentiation (Hughes et al., 2013; Kirby et al., 2006)). 
It is possible that neuronal activity only directly influences one phenomenon, 
and that the other is altered indirectly as a consequence. For example, 
neuronal activity may directly promote the proliferation of OPCs, and this 
imbalance in the OPC population may drive OPCs to differentiate. 
Alternatively, neuronal activity may increase OPC differentiation, which, in 
turn, could lead to proliferation of remaining OPCs to restore the population. 
Yet, some evidence indicates that neuronal activity can trigger either 
proliferation or differentiation of OPCs in a frequency-dependent manner. In 
vivo manipulation of neuronal activity in the mouse corpus callosum using an 
implanted electrode array demonstrated that lower frequencies of activity (5 
Hz) promote the differentiation of OPCs into oligodendrocytes, whereas higher 
frequencies (25 Hz and 300 Hz) promote the proliferation of OPCs (Nagy et 
al., 2017). It is not yet clear how this relates to physiological firing frequencies 
in different circuits throughout development, and thus whether physiological 
neuronal activity influences OPCs in a similar manner. 
 Myelin Sheath Formation and Growth 
Neuronal activity also affects the formation of myelin sheaths by 
oligodendrocytes. In neuron-oligodendrocyte co-cultures, TTX treatment to 
silence neuronal activity does not affect the number of mature 
oligodendrocytes or the number of neurons, but drastically reduces the number 
of myelin segments identified by MBP staining (Demerens et al., 1996). This 
has also been confirmed in vivo. TTX injection into the right eye of P4 mice 
followed by analysis of optic nerve myelination at P6 revealed that silencing 
neuronal activity does not change the number of mature oligodendrocytes 
expressing MBP. Despite this, it does significantly reduce the number of MBP+ 
oligodendrocytes with a myelinating morphology (Demerens et al., 1996). 
Malone et al., 2013 observed similar results when they electrically stimulated 
DRG neuron-oligodendrocyte co-cultures. They found that the number of 
myelin sheaths formed significantly increases with electrical stimulation in a 
frequency-dependent manner, and that this could be completely blocked by 
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TTX treatment. Oligodendrocytes will actually preferentially form myelin 
sheaths on active axons. Chemogenetic stimulation of somatosensory cortical 
neurons using DREADDs elevates the number of myelinated axons 
significantly when compared to unstimulated control animals (Mitew et al., 
2018). Closer analysis revealed that, in the stimulated animals, there was a 
3.4-fold increase in the number of stimulated axons which were myelinated, 
whereas there was only a 0.3-fold increase in the number of unstimulated 
axons which were myelinated. They then used Cre-ERT2-mediated lineage 
tracing to identify oligodendrocytes born during the chemogenetic stimulation 
period, and found that these new oligodendrocytes make more myelin sheaths 
on the stimulated axons versus the unstimulated axons. Hence, neuronal 
activity not only enhances myelination, but can specifically target the formation 
of new myelin on electrically active circuits.  
Can neuronal activity regulate the growth of existing myelin sheaths? The 
signals which regulate the growth of individual myelin sheaths are still poorly 
understood. Research has determined that different myelin sheaths made by 
the same oligodendrocyte can have very different elongation rates, which 
suggests that local signals can influence myelin sheath growth (Mensch, 
2014). Calcium imaging of individual oligodendrocytes in the zebrafish larval 
spinal cord using genetically-encoded calcium indicators has shown that 
calcium transients occur in myelin sheaths during early stages of dynamic 
growth (Baraban et al., 2018; Krasnow et al., 2018). Electrically stimulating the 
hindbrain to globally increase neuronal activity in the spinal cord increases the 
number of calcium transients observed in sheaths. Conversely, injecting TTX 
into the hindbrain to inhibit neuronal activity significantly reduces the number 
of calcium transients (Krasnow et al., 2018). The frequency of these calcium 
transients positively correlated with the growth of myelin sheaths in length 
(Baraban et al., 2018), so that stimulating neuronal activity increases sheath 
growth, while inhibiting neuronal activity reduces sheath growth (Krasnow et 
al., 2018). This result highlights the fact that at least some of the calcium 
transients in growing myelin sheaths are induced by neuronal activity, and 
suggests that neuronal activity can influence the elongation of myelin sheaths. 
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It is not clear whether neuronal activity has a global effect on sheath growth, 
or whether the activity of a single neuron locally regulates the growth of myelin 
sheaths along its axon. It is possible that myelin patterns are established along 
individual axons by axonal activity signalling locally to its myelin sheaths to 
control their growth. Manipulation of activity along individual axons is required 
to assess whether axonal activity locally influences myelin pattern formation 
by regulating sheath growth. 
Neuronal activity may also regulate sheath thickness. Both optogenetic 
stimulation of motor cortical neurons (Gibson et al., 2014) and chemogenetic 
stimulation of somatosensory cortical neurons (Mitew et al., 2018) increases 
sheath thickness of axons in the corpus callosum. Mitew et al. performed 
immunogold electron microscopy to identify axons which express the 
DREADD (and therefore identify the specific population of axons which were 
stimulated), and found that these stimulated axons had thicker myelin sheaths 
than neighbouring unstimulated axons. Does neuronal activity stimulate the 
radial growth of existing myelin sheaths? Or does neuronal activity promote 
the formation of new myelin sheaths which become thicker than other pre-
existing sheaths? Developing imaging techniques to accurately measure 
sheath thickness dynamics over time will allow the investigation of these two 
possibilities. 
1.6.2. Neurotransmitter Signalling from Neurons to Oligodendroglia 
How do oligodendroglial lineage cells detect changes in neuronal activity? 
Action potentials stimulate the synaptic release of neurotransmitters to 
facilitate neuron-neuron communication within circuits. However, there is 
significant evidence for neurotransmitter signalling between neurons and 
oligodendroglial cells as well. 
OPCs and Oligodendrocytes Express Neurotransmitter Receptors 
Many studies have tested oligodendroglial lineage cells for expression of 
glutamatergic receptors, both ionotropic (AMPA, kainate, and NMDA 
receptors) and metabotropic (mGluR1-5). Cultured OPCs isolated from the 
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rodent optic nerve exhibit inward currents in response to treatment with the 
excitatory neurotransmitter glutamate, which can be blocked by the 
AMPA/kainate receptor antagonist CNQX (Barres et al., 1990). OPCs treated 
with NMDA did not give any current response. Both cerebellar and optic nerve 
OPCs in culture elicited current responses upon quisqualate (a potent AMPA 
receptor agonist) and kainate treatment, but not upon NMDA treatment (Wyllie 
et al., 1991). Oligodendrocytes recorded in corpus callosum slice also exhibit 
inward currents when exposed to glutamate or kainate, but not when treated 
with NMDA (Berger et al., 1992). Northern blot analysis showed that purified 
OPCs and oligodendrocytes express mRNAs for AMPA and kainate receptors 
(Patneau et al., 1994), which suggests that OPCs and oligodendrocytes detect 
glutamate via AMPA and kainate receptors, but not NMDA receptors. 
However, Barres et al. noted that the digestion step in their cell isolation 
protocol likely damages or removes NMDA receptors, as NMDA receptor-
expressing neurons treated with the same digestion also do not respond to 
NMDA treatment (Barres et al., 1990). Several studies have since shown that 
OPCs and oligodendrocytes do indeed express active NMDA receptors. Wang 
et al., 1996 identified OPCs which expressed the NMDA receptor subunit NR1 
in a posterior pituitary gland explant culture. These OPCs elicited an inward 
current upon NMDA administration which could be blocked by MK-801 or Mg2+ 
(known antagonists of NMDA receptors). Both OPCs and oligodendrocytes 
recorded in rat spinal cord slices responded to glutamate, kainate, or NMDA 
application (Žiak et al., 1998). Further immunohistochemistry revealed that 
mature oligodendrocytes in the optic nerve express NMDA receptor subunits 
(Salter and Fern, 2005). Recordings in both cerebellar and corpus callosum 
mature oligodendrocytes showed that they respond to NMDA, and these 
responses were blocked by the NMDA receptor antagonist AP-5 (Káradóttir et 
al., 2005).  
OPCs can exhibit diversity in their responsiveness to neuronal activity. 
Káradóttir et al., 2008 found that in the P7 rat brain, only half of OPCs express 
voltage-gated Na+ channels. These Na+ channel-expressing OPCs respond to 
glutamate or NMDA treatment, whereas OPCs which do not express Na+ 
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channels exhibit very little response to glutamate or NMDA (Káradóttir et al., 
2008). More recent research has shown that expression of ionotropic 
glutamatergic receptors in OPCs can change with age and CNS region. In 
rodents, after P9 OPCs in the cortex increase their AMPA/kainate receptor 
density and decrease their NMDA receptor density, whereas OPCs in the 
corpus callosum show no change in either AMPA or NMDA receptor density 
(Spitzer et al., 2019). After the onset of myelination (until P330), OPC AMPA 
receptor density remains fairly consistent while OPC NMDA receptor density 
decreases in corpus callosum, cortex, and cerebellum. OPCs of the 
subventricular zone maintain consistent levels of NMDA receptors throughout 
life, suggesting a functional difference in this specific population of OPCs 
(Spitzer et al., 2019). 
Oligodendroglial lineage cells also express metabotropic glutamate receptors 
(mGluRs). RT-PCR analysis in rat OPCs and oligodendrocytes identified 
expression of mGluR3 and mGluR5 (Luyt et al., 2003). Expression of mGluR5 
was confirmed by immunocytochemistry, and calcium imaging showed that the 
group I mGluR agonist DHPG increases the intracellular Ca2+ levels of OPCs. 
Immunocytochemistry of cultured forebrain oligodendrocytes showed 
expression of mGluR1-5, but expression levels decrease as the cells mature 
(Deng et al., 2004).  
There is also evidence that oligodendroglial lineage cells can respond to 
neurotransmitters other than glutamate. Both OPCs and oligodendrocytes 
elicit inward currents in response to GABA treatment which can be prevented 
by bicuculline treatment (an ionotropic GABAA receptor antagonist) (von 
Blankenfeld et al., 1990; Williamson et al., 1998). Similarly, Berger et al., 1992 
identified GABA-induced currents in corpus callosum oligodendrocytes. OPCs 
can also detect adenosine; this reduces OPC proliferation and promotes 
differentiation into myelinating oligodendrocytes in vitro (Stevens et al., 2002). 
In DRG-OPC co-cultures neuronal stimulation inhibits OPC proliferation and 
increases myelin formation in an adenosine signalling-dependent manner 
(Stevens et al., 2002). Whether different neurotransmitters mediate different 
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developmental processes, or are involved in myelination of distinct circuits or 
CNS regions, is not yet known. 
OPCs Form Neuro-glial Synapses 
OPCs form synaptic-like structures with neurons in vivo. Glutamatergic neuro-
glial synapses were first described by Bergles et al., 2000, who identified 
labelled OPC processes tightly adjacent to presynaptic boutons by electron 
microscopy. Electrically stimulating the stratum radiatum in hippocampal slices 
triggers responses in OPCs which can be blocked by AMPA receptor 
antagonist CNQX (Bergles et al., 2000). Applying glutamate to the CA3 elicits 
excitatory post-synaptic currents (EPSCs) in CA1 OPCs which can be blocked 
by TTX, indicating that the evoked OPC EPSCs are dependent on neuronal 
activity. The frequency of spontaneous EPSCs in OPCs increases between 
P4-20, which may represent functional integration of OPCs into hippocampal 
networks (Mangin et al., 2008). These neuro-glial synapses can even undergo 
long-term potentiation; theta burst stimulation of Schaeffer collaterals in 
hippocampal slices induces a calcium-dependent (but NMDA independent) 
increase in OPC EPSC amplitudes (Ge et al., 2006). Functional GABA-ergic 
neuro-glial synapses have also been described in the hippocampus (Lin and 
Bergles, 2004).  
Glutamatergic neuro-glial communication is downregulated with 
oligodendroglial lineage progression. Although pre-myelinating and mature 
oligodendrocytes are still responsive to glutamate, they exhibit fewer 
spontaneous EPSCs than OPCs (Kukley et al., 2010). Both neuronal 
stimulation and glutamate uncaging experiments also trigger smaller AMPA-
mediated EPSCs in pre-myelinating and mature oligodendrocytes than in 
OPCs (De Biase et al., 2010; Kukley et al., 2010).  
Neuro-glial synaptic connections are hypothesised to form along the axon 
rather than at the traditional presynaptic terminal. Both Kukley et al. 2007 and 
Ziskin et al. 2007 identified activity-dependent responses in OPCs within the 
rodent corpus callosum (a white matter tract devoid of neuronal soma or 
synaptic terminals). Both studies analysed the OPC responses in corpus 
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callosum slices, finding that electrical stimulation of callosal axons induces 
currents within OPCs which can be blocked by pharmacological inhibition of 
AMPA receptors. Callosal OPCs in TTX-treated cultures also exhibit miniature 
EPSCs when synaptic vesicle release is stimulated in callosal axons either by 
ruthenium red (Kukley et al., 2007) or by α-latrotoxin (Ziskin et al., 2007). 
Transmission electron microscopy identified distinct synaptic structures 
between labelled OPCs and callosal axons, such as: pools of vesicles at the 
axonal membrane adjacent to the OPC process (Kukley et al., 2007); 
immunogold labelling for vesicular glutamate transporter 1 in the axon 
(vGLUT1, a presynaptic protein); and the presence of electron-dense material 
at the OPC post-synaptic membrane (Ziskin et al., 2007). Measuring the 
conduction velocities of axons which produce current responses in OPCs 
showed that these axons are unmyelinated (Ziskin et al., 2007). Axon-OPC 
synapses may play a role in the early stages of myelination, where neuronal 
activity in unmyelinated axons can signal to OPCs, possibly to regulate 
differentiation into mature oligodendrocytes and the formation of myelin 
sheaths. 
Blocking Vesicular Release of Neurotransmitters Inhibits Myelination 
Inhibiting neurotransmitter signalling via the blockade of neurotransmitter 
release can impact myelination. This is typically done using clostridial 
neurotoxins, which encompasses tetanus toxin (TeNT) and seven distinct 
types of Botulinum toxin (BoNT). These toxins inhibit the release of 
neurotransmitters via proteolytic cleavage of SNARE proteins required for 
synaptic vesicle exocytosis. 
Wake et al., 2011 used in vitro DRG-OPC co-cultures to investigate how 
inhibiting synaptic vesicle release affects the initiation of myelination. They 
found that pre-treating the DRG neurons with either BoNT-A or TeNT prior to 
the addition of OPCs led to significant reduction in the number of myelin 
segments formed on DRG axons. Ca2+ imaging analysis showed that Ca2+ 
transients in OPCs are reduced when synaptic vesicle release is inhibited by 
BoNT-A. The local translation of MBP protein in the processes of OPCs is also 
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reduced in co-cultures containing BoNT-A-treated neurons, suggesting that 
synaptic vesicle release promotes this local translation, and therefore, the 
initiation of myelin sheath formation. This is believed to be glutamate-
mediated, as AMPA and NMDA receptor inhibition reduces OPC Ca2+ 
transients, and NMDA receptor or group I mGluR inhibition reduces the local 
translation of MBP protein. AMPA receptor inhibition does not affect local 
translation of MBP protein; which raises the intriguing possibility that different 
types of glutamate receptor regulate different stages of oligodendrocyte 
development and myelination. 
Neurotransmitter release outside of axo-glial synapses may also regulate 
myelination. In a similar DRG-OPC co-culture system, Wake et al., 2015 found 
there was no evidence for synaptic communication between the axons and 
OPCs, yet BoNT-A treatment still inhibits myelin sheath formation. Electrical 
stimulation of the neurons failed to elicit any current responses in recorded 
OPCs. Transmission electron microscopy analysis of these cultures revealed 
that although OPCs form close contacts with axons, these connections lack 
the hallmarks of synapses. It is possible that neurotransmitter signalling occurs 
extrasynaptically to promote myelination.  
Regardless of whether synaptic vesicle release occurs at neuro-glial synapses 
or extrasynaptically, it is clear that these neurotoxins can also inhibit 
myelination in vivo. Global manipulations of synaptic vesicle release in larval 
zebrafish can be done by microinjection of TeNT mRNA into the 1-cell stage 
egg; this mRNA will be translated to produce TeNT protein throughout the 
entire animal, and effectively silences synaptic transmission in the CNS for at 
least the first four days of development (Mensch et al., 2015). Spinal cord 
neurons in these animals develop normally. Despite this, there is an 
approximately 40% reduction in the number of myelinated axons in the spinal 
cord compared to unsilenced animals. Further investigation revealed that this 
is due to a combination of effects: firstly, a 10% reduction in the number of 
oligodendrocytes in the spinal cord; and secondly, a 30% reduction in the 
number of sheaths made per individual oligodendrocyte. Timelapse analysis 
found that the reduction in oligodendrocyte number may be due to reduced 
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generation of OPCs from the pMN domain rather than reduced proliferation of 
the OPC population, as there are fewer OPCs, but OPC proliferation is 
unchanged in TeNT-expressing animals. The reduction in the number of 
sheaths made per oligodendrocyte could be due to reduced initial formation of 
myelin sheaths, or increased retraction of sheaths from axons. Timelapse 
analysis confirmed that the number of sheath retractions is also unchanged, 
indicating that global inhibition of neurotransmitter release reduces the initial 
formation of myelin sheaths. Crucially, TeNT exerts this effect in an 
oligodendrocyte-independent manner. Oligodendrocytes transplanted from 
control animals into TeNT-expressing animals also form fewer sheaths than in 
full control conditions, whereas TeNT-expressing oligodendrocytes 
transplanted into control animals generate a normal number of sheaths 
(Mensch et al., 2015). 
Similar results were reported by Hines et al., 2015, who generated transgenic 
zebrafish larvae expressing TeNT in all neurons and found that axons 
expressing TeNT are significantly less myelinated compared to control axons. 
This TeNT expression also leads to oligodendrocytes making fewer myelin 
sheaths. Unlike the findings from Mensch et al., 2015, this is due to an increase 
in the retraction of nascent myelin sheaths. This discrepancy in findings can 
be explained by the different definitions of a ‘myelin sheath’ used in each study. 
When analysing sheath retractions, Mensch et al. defined myelin sheaths as 
oligodendrocyte contacts on an axon which were greater than 5 μm in length, 
whereas Hines et al. included contacts shorter than 5 μm in their retraction 
analysis. One explanation might be that synaptic vesicle enhances the 
stabilisation of short oligodendrocyte contacts (< 5 μm), but once these 
contacts exceed 5 μm in length, synaptic vesicle does not affect sheath 
retraction. 
Both Hines et al., 2015 and Mensch et al., 2015 globally inhibited synaptic 
vesicle release. It remains unknown if the vesicular release from a single axon 
locally regulates the stabilisation of its myelin sheaths. Additionally, it is not 
clear whether synaptic vesicle release affects the growth of myelin sheaths 
after initial formation. Global increases in activity promote sheath growth 
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(Krasnow et al., 2018), but whether this is mediated via neurotransmitter 
signalling is not known. Although myelinating oligodendrocytes do express 
neurotransmitter receptors, their responsiveness to neurotransmitter signalling 
is significantly lower than in OPCs (De Biase et al., 2010; Kukley et al., 2010). 
Manipulation of synaptic vesicle release along individual axons, coupled with 
longitudinal analysis of their myelin sheaths, could determine whether local 
neurotransmitter signalling regulates sheath fate, and whether 
neurotransmitter signalling continues to regulate sheath growth. 
Does synaptic vesicle release regulate the myelination of all axons? To 
investigate this, Koudelka et al., 2016 expressed TeNT in two different 
neuronal subtypes and assessed how this affected their myelination during the 
first week of development. They found that expressing TeNT in individual 
reticulospinal axons significantly inhibits their myelination (fewer and shorter 
myelin sheaths), whereas the myelination of individual commissural primary 
ascending (CoPA) axons expressing TeNT is completely unaffected. Why 
might some neurons regulate their myelination in a synaptic vesicle-dependent 
manner, while others do not? Both reticulospinal and CoPA neurons have 
axons of approximately similar calibre, are myelinated within the same time 
period (Koudelka et al., 2016), and are both glutamatergic (Higashijima et al., 
2004). One possibility is that only certain circuits require their myelination to 
be regulated by neuronal activity. Additional signals may be required to 
facilitate activity-dependent myelination, and thus selective expression of 
these additional signals in certain circuits could restrict activity-mediated 
regulation of myelination to where it is necessary. Comparison of the 
transcriptomes between reticulospinal and CoPA neurons might reveal the 
presence of molecular signal(s) which facilitate activity-dependent myelination 
in reticulospinal axons. 
Function of Neurotransmitter Signalling? 
How exactly does neurotransmitter signalling affect the development of 
oligodendroglial cells and myelination? Given the significant evidence that 
oligodendroglial cells can detect and respond to glutamate, numerous studies 
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have disrupted either AMPA or NMDA receptors specifically in OPCs or 
oligodendrocytes to understand receptor function in more detail. 
Kougioumtzidou et al., 2017 confirmed that OPCs express the AMPA receptor 
sub-units GluA2-4 before deleting each sub-unit from OPCs using Cre-Lox 
technology. They found that deleting just GluA2 or 3 alone had no significant 
impact on OPC survival, proliferation, or differentiation into myelinating 
oligodendrocytes. However, deleting both sub-units led to reduced AMPA-
mediated currents induced by kainate application, a reduced frequency of 
spontaneous EPSCs in OPCs, and a reduced number of oligodendrocytes in 
the corpus callosum during early myelination (which recovers to normal levels 
by P21). Deleting GluA2, 3 and 4 from oligodendroglial cells induced a slightly 
more severe phenotype; this significantly reduced kainate-evoked AMPA 
currents in OPCs and slightly reduced the number of oligodendrocytes in the 
corpus callosum in adulthood. The reduction in oligodendrocyte number was 
due to oligodendrocyte apoptosis, suggesting that AMPA signalling promotes 
the survival of newly-generated oligodendrocytes. The number and length of 
myelin sheaths generated by surviving oligodendrocytes was unchanged in 
the triple knock-out animals (Kougioumtzidou et al., 2017). 
More recent work has shown that modification of AMPA current properties in 
OPCs can affect OPC proliferation and differentiation. Chen et al., 2018 virally 
over-expressed various mutated forms of AMPA receptor GluA2 sub-unit in 
OPCs to manipulate AMPA current properties, and observed the subsequent 
effects on oligodendroglial cell development. They found that increasing Ca2+ 
permeability (GluA2 Ca2+ permeable mutant) or reducing pore function of 
AMPA receptors (GluA2 pore-dead mutant) increases OPC proliferation. 
Additionally, over-expressing either of these mutated GluA2 sub-units or over-
expressing the GluA2 cytoplasmic tail (which should downregulate the 
trafficking of AMPA receptors to the plasma membrane) reduce the 
differentiation of transfected OPCs into oligodendrocytes (Chen et al., 2018). 
This indicates that impairing AMPA signalling in OPCs leads to reduced 
oligodendrocyte production and increased self-renewal. Why does 
overexpression of functionally-disrupting AMPA subunits affect OPC 
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proliferation and differentiation, but deletion of AMPA receptor subunits from 
OPCs does not? It may be that other signals controlling OPC population 
dynamics compensate when AMPA receptor signalling is completely lost. Such 
compensatory changes have been observed in experimentally-generated 
mutants, but do not occur when genes are simply knocked down (Rossi et al., 
2015). Checking for transcriptional changes in AMPA receptor-deficient OPCs 
could determine if loss of AMPA receptor signalling triggers compensatory 
upregulation of other signalling pathways to keep the OPC population stable. 
OPCs also express NMDA receptors; however, loss of NMDA receptors in 
OPCs also does not significantly alter oligodendroglial cell development. 
Conditional deletion of the NR1 sub-unit of NMDA receptors from OPCs has 
no effect on OPC proliferation or survival, differentiation, oligodendrocyte 
survival, or myelination as assessed by electron microscopy (De Biase et al., 
2011). Saab et al., 2016 did note that conditional deletion of NR1 subunit leads 
to a slight delay in the myelination of the optic nerve, which recovers by P70. 
Again, it is possible that deletion of NMDA signalling in oligodendrocytes is 
compensated by upregulation of other receptors or signalling pathways. NMDA 
signalling does appear to play a role in the metabolic support provided by 
oligodendrocytes to axons. Saab et al., 2016 found that conditional deletion of 
NR1 sub-unit from oligodendrocytes reduces expression of the glucose 
transporter GLUT1 in myelin sheaths and reduces recovery of axons after 
being challenged with high-frequency stimulation. These conditional knock-out 
animals also displayed signs of neurodegeneration later in adulthood (Saab et 
al., 2016). NMDA signalling may be required for oligodendrocytes to detect the 
activity levels (and therefore, the energetic demands) of the underlying axon 
and to subsequently supply metabolites to maintain neuronal health. Although 
NMDA receptor signalling is not required for initial myelination, it may be 
important for any de novo myelination or myelin remodelling which occurs in 
response to experience or circuit activity. Such myelin changes may not 
regulate conduction times in circuits, but instead may reflect the changing 
metabolic demands of circuits with learning. 
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Other neurotransmitters may also regulate the oligodendrocyte population. 
Hamilton et al., 2016 found that inhibiting GABA signalling in rodent brain slices 
(by applying the GABA receptor antagonist GABAzine) significantly increases 
the number of oligodendrocytes, the number of myelinated axons, and leads 
to shorter myelin sheaths. This suggests that endogenous GABA signalling 
can influence oligodendrogenesis and myelination. It is important to consider 
that Hamilton et al.'s results could be due to a global increase in neuronal 
activity; suppressing GABA signalling will reduce overall inhibition and 
subsequently increase neuronal activity, promoting the release of other 
activity-related signals which then influence myelination. Cell type-specific 
manipulation of GABA signalling in oligodendroglial cells is required to 
determine whether GABA directly or indirectly regulates oligodendrogenesis 
and myelination. 
1.6.3. BDNF Signalling to Oligodendroglial Lineage Cells 
It is important to consider that molecular signals other than neurotransmitters 
may also be released from active axons and influence oligodendroglial 
development. For example, neuronal activity can stimulate the production of 
brain-derived neurotrophic factor (BDNF). Reducing neuronal activity in the 
visual cortex of adult rats either by rearing in darkness or by intraocular 
injection of TTX reduces levels of both BDNF mRNA and TrkB (the BDNF 
receptor) mRNA in the cortex, without affecting transcription of other growth 
factors such as NGF (Castrén et al., 1992). The SNARE proteins VAMP2 and 
SNAP-25 which are required for neurotransmitter release are also required for 
release of BDNF (Shimojo et al., 2015). Subsequently, experiments 
demonstrating that neurotoxins (such as BoNT-B and TeNT) which 
proteolytically cleave VAMP2 or SNAP-25 reduces myelination actually inhibit 
both neurotransmitter and BDNF signalling. Hence, BDNF is another 
candidate molecule which could affect myelination in an activity-dependent 
manner.  
Furthermore, there is evidence that BDNF can influence oligodendroglial cell 
development. Oligodendrocytes express the BDNF receptor TrkB (Vondran et 
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al., 2010), and treating oligodendrocytes with BDNF in vitro activates TrkB, 
MAPK and Akt (Veer et al., 2009). Mice with global haploinsufficiency of BDNF 
have fewer OPCs and reduced myelin protein expression in the basal forebrain 
(Vondran et al., 2010). Oligodendrocyte-specific loss of BDNF signalling via 
deletion of TrkB significantly reduces myelination during early development; 
however, this phenotype recovers by adulthood (Wong et al., 2013), 
suggesting that BDNF signalling is not absolutely necessary for proper 
myelination.  
Recent research suggests that the stimulation of OPC proliferation seen in 
previous optogenetic experiments occurs via release of BDNF. Geraghty et al., 
2019 used the same optogenetic method as Gibson et al., 2014 to stimulate 
pyramidal neurons in the motor cortex, but tested this technique in mice with 
deficient BDNF signalling. They found that by either preventing activity-
mediated BDNF release, or deleting TrkB receptor expression from 
oligodendroglial cells, the enhancement of OPC proliferation and increased 
sheath thickness normally seen with optogenetic stimulation is also prevented. 
Thus, BDNF plays a critical role in activity-mediated regulation of the 
oligodendroglial population. It is possible that BDNF and neurotransmitter 
signalling work together to regulate myelination. Lundgaard et al., 2013 found 
that myelination in DRG-oligodendrocyte co-cultures is unaffected by NMDA 
receptor inhibition (via MK-801 treatment) in the absence of BDNF, but NMDA 
receptor inhibition in the presence of BDNF led to significant impairment of 
myelination. BDNF may therefore be required to initiate an activity-dependent 
programme of myelination in oligodendrocytes. It is important to note that 
these experiments relied solely on pharmacological manipulations, and so it is 
not clear whether the myelination phenotype is due to a direct effect on 
oligodendrocytes, or an indirect effect through neurons. Genetic manipulations 
are required to determine the specific cellular mechanisms by which BDNF 





1.6.4. Other Activity-related Signals 
Some evidence suggests that other signals from active axons may also play a 
role in regulating myelination. The growth of gliomas (brain tumours which are 
thought to derive from OPCs and neural precursor cells) is enhanced by 
optogenetic stimulation of neuronal activity (Venkatesh et al., 2015), similar to 
the proliferative effects of optogenetic stimulation on OPCs (Gibson et al., 
2014). Glioma growth is stimulated by neuroligin-3, which is secreted by active 
neurons. The effects of secreted neuroligin-3 on proliferation of non-cancerous 
OPCs remains to be investigated. 
Activity-mediated myelination may actually be regulated by complex 
interactions between multiple molecular signals. As previously discussed, 
there is conflicting evidence for axonal expression of Nrg1 regulating 
myelination in the CNS (see section ‘1.3.2 Axon Selection’). Socially isolated 
animals have reduced Nrg1 expression, hypomyelination and behavioural 
deficits; oligodendrocyte-specific deletion of the Nrg1 receptor ErbB3 
replicates both the myelin and behavioural phenotypes seen in isolated 
animals (Makinodan et al., 2012). Nrg1 may not be required for basal 
myelination, but may be important for regulating myelination in response to 
experience or neuronal activity. In support of this, Lundgaard et al., 2013 found 
that, like BDNF, adding Nrg1 to OPC-DRG neuron co-cultures appears to 
induce a switch to activity-mediated myelination. It is not clear whether certain 
neurons or circuits use BDNF versus Nrg1 to control their myelination in 
response to activity, or whether both signals are required for activity to shape 
myelination. More in-depth characterisation and manipulation of expression of 
these activity-related factors in different neuronal subtypes could clarify 
whether distinct circuits use different signals for activity-mediated myelination. 
1.6.5. How Does Neuronal Activity Affect Myelin Pattern Formation and 
Remodelling along Single Axons In Vivo? 
Research has shown that experience and learning can shape circuit 
myelination in the CNS, which may influence the function of these circuits. 
Changes to myelin are thought to occur in a neuronal activity-dependent 
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manner. Manipulating the activity of large populations of neurons, or global 
changes to activity-related molecular signals, can affect OPC proliferation, 
differentiation, and myelin sheath formation and growth. New evidence 
proposes that active axons are actually preferentially myelinated over 
neighbouring inactive axons (Mitew et al., 2018), suggesting that neuronal 
activity may control myelination in a local axon-specific manner. However, it is 
not known how the activity of an individual axon relates to its myelination. The 
activity of a single axon may locally regulate the formation and growth of its 
myelin sheaths to ultimately control formation of its own myelin pattern. In order 
to understand how neuronal activity and activity-related signals affect overall 
circuit myelination and function, there is a need to investigate the role of these 
signals at the level of individual axons. By manipulating and following a single 
axon, one can characterise how local neuronal activity affects myelin sheath 
growth and myelin pattern formation within a single circuit over time. 
Performing such longitudinal experiments in rodent models is technically 
challenging, whereas the larval zebrafish is an ideal model system for 
undertaking such investigations in a non-invasive manner. In Chapter 4, I will 
investigate how manipulating the activity of individual reticulospinal neurons in 
the zebrafish spinal cord affects the growth dynamics of individual myelin 
sheaths, and the formation of myelin patterns. 
1.7. Zebrafish as a Model to Investigate Myelinated Axon Biology 
1.7.1. Advantages of the Zebrafish Model 
The zebrafish initially gained popularity as a vertebrate model organism for its 
use in large-scale genetic screens to identify novel genes involved in 
developmental processes. Two seminal forward genetic screens collectively 
generated ~1800 different mutant lines in hundreds of different genes with 
many phenotypes affecting early development, CNS, heart, skin, fin, liver, and 
pigment pattering developmental processes (Driever et al., 1996; Haffter et al., 
1996). Larval zebrafish are an ideal vertebrate model organism for such large-
scale studies due to their rapid development (progressing from fertilisation to 
a motile larvae in a matter of days), and the ability to generate large numbers 
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of animals in a short space of time (an adult female can lay over 200 eggs in 
a single mating session). The zebrafish continues to be a useful model for 
genetic studies of vertebrate biology, particularly given that they have a highly 
conserved vertebrate genome in both sequence and function, with 
homologues for many human genes (Barbazuk et al., 2000; Postlethwait et al., 
2000). In fact, one such forward genetic screen identified 13 mutations in 10 
genes involved in the development of myelinated axons (Pogoda et al., 2006).  
Zebrafish are widely used beyond genetic screens, particularly for live imaging 
of cellular and subcellular biological processes. Larval zebrafish are ideal for 
such studies because they are optically transparent for the first few weeks of 
life. This transparency allows for live imaging of fluorescently-labelled cells or 
tissues of interest at cellular and subcellular resolution; several studies have 
employed zebrafish on this basis to define the dynamics of myelination 
(Almeida et al., 2018, 2011; Baraban et al., 2018; Czopka et al., 2013; 
Koudelka et al., 2016; Mensch et al., 2015). Mutant lines which disrupt pigment 
cell development can further increase the transparency of larvae, such as the 
nacre line, which lacks melanophores – this line carries a mutation in a 
transcription factor necessary for melanophore development (Lister et al., 
1999). Zebrafish are also highly amenable to transgenic manipulation. 
Transposon systems such as the Tol2kit (Kwan et al., 2007) facilitate simple 
and efficient generation of transgenic lines to express transcriptional activators 
(such as Gal4 or KalTA4), fluorescent proteins, or any other protein in cells or 
tissues of interest. There is currently a number of established transgenic lines 
expressing fluorescent reporters or transcriptional activators in various types 
of neurons and at numerous stages of oligodendroglial development. The lines 
used in this thesis are summarised in Table 1 in Chapter 2. 
1.7.2. Myelination in Zebrafish 
By 24 hours post-fertilisation (hpf), the zebrafish embryo has identifiable 
organs and tissues (for example, head, eyes, brain, tail, muscles) and exhibits 
rudimentary motor function (Kimmel, 1989). By 3 days post-fertilisation (dpf), 
the spinal cord contains axons of many different neuronal subtypes, including 
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the reticulospinal neurons of the hindbrain (Mendelson, 1986a, 1986b), and 
many well-characterised spinal neurons (Bernhardt et al., 1990). The axons of 
many of these identified neuron subtypes are myelinated at larval stages of 
development (Figure 6). OPCs are produced by progenitors of the pMN 
domain of the ventral spinal cord starting at 36 hpf, and migrate to colonise the 
CNS (Kirby et al., 2006; Park et al., 2004). These OPCs begin to differentiate 
into oligodendrocytes from 2-3 dpf, with a rapid increase in both 
oligodendrocyte number and extensive myelination of the CNS within the first 
two weeks (Brösamle and Halpern, 2002; Buckley et al., 2010; Czopka et al., 
2013). Both OPCs and oligodendrocytes express homologues of many 
proteins involved in oligodendroglial development and myelination in the 
mammalian CNS, such as Sox10, Olig2, Nkx2.2a, DM20, and MBP (Brösamle 
and Halpern, 2002; Kucenas et al., 2008; Park et al., 2002; Schweitzer et al., 
2006). 
 
Figure 6 – onset of myelination in the larval zebrafish. 
A summary of the first 5 days of development in the larval zebrafish, with key 
developmental stages during myelination highlighted. By 5 days post-fertilisation 
(dpf) many axons in the spinal cord are well myelinated. 
  
It is important to consider molecular differences which have arisen through 
evolution. One particular molecular difference between zebrafish and 
mammalian myelination is the expression of the adhesion immunoglobulin P0. 
In zebrafish and other teleosts, P0 is primarily expressed by oligodendrocytes 
and is a major CNS myelin component (Brösamle and Halpern, 2002; 
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Waehneldt et al., 1986). In mammals, P0 is expressed exclusively by Schwann 
cells in the PNS; instead mammals express PLP and its isoform DM20 in CNS 
myelin (Waehneldt et al., 1986). Zebrafish have numerous homologues of 
DM20 due to a genome duplication in the teleost lineage, and the closest 
homologue DMα2 is expressed by oligodendrocytes (Schweitzer et al., 2006). 
However, teleost DM20 homologues lack PLP-specific sequences found in 
mammals (Yoshida and Colman, 1996). It has been suggested that the 
evolution of PLP has replaced P0 in mammalian CNS myelin (Yoshida and 
Colman, 1996).  
Despite this biochemical difference between mammalian and zebrafish myelin, 
there are numerous examples of biological processes and signals regulating 
myelination which have been conserved between the two evolutionary 
branches. OPCs in both species exhibit similar highly explorative behaviours 
(Hughes et al., 2013; Kirby et al., 2006). Both zebrafish and rodent 
oligodendrocytes have a limited time period to initiate the formation of new 
myelin sheaths (Czopka et al., 2013; Watkins et al., 2008). Neuronal activity 
and synaptic vesicle release has been shown to affect myelination in both 
zebrafish and mammals (see section ‘1.6 Neuronal Activity can Influence 
Myelination’). Additionally, several genes identified in a zebrafish genetic 
screen to discover novel regulators of myelination also regulate mammalian 
myelination (Lyons et al., 2005; Monk et al., 2011; Monk and Talbot, 2009; 
Pogoda et al., 2006). Therefore any novel biological mechanisms uncovered 
from studies of zebrafish myelination are likely to be conserved in other 
vertebrates, and will be of both interest and relevance to mammalian myelin 
biology. 
Collectively, this makes the larval zebrafish an ideal model system to study the 
cellular and subcellular processes of myelination. In this thesis, I will use larval 
zebrafish to perform longitudinal analysis of individual myelinated axon 
development. The specific aims of my thesis are: 
1. To characterise the establishment of myelin patterns and myelin sheath 
remodelling along individual axons (Chapter 3). 
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2. To assess whether different subtypes of axon exhibit different myelin 
patterns, or different extents or types of myelin remodelling (Chapter 3). 
3. To manipulate neuronal activity of individual axons and observe how 
this affects myelin pattern establishment and specific dynamics of 
























2.1. Zebrafish Husbandry and Transgenic Lines Used 
All of the adult zebrafish used in this project were maintained in a 14-10 hour 
light-dark cycle, and housed according to UK Home Office regulations in the 
CBS zebrafish facility, Queen’s Medical Research Institute, University of 
Edinburgh. Zebrafish larvae were maintained in E3 embryo medium in a 28.5 
⁰ C incubator with a 14-10 hour light-dark cycle. Zebrafish were maintained 
under the project licence 70/8436. To obtain animals for experiments, one 
adult male and one or two adult female fish of appropriate transgenic lines 
were placed in a pair-mating tank with a divider the afternoon before mating. 
The divider was removed in the morning just prior to peak mating time, and the 
fertilised eggs were collected from the pair mating tank after one to three hours 
of mating. Table 1 lists the transgenic zebrafish lines which were used in this 
thesis (where ‘Tg’ = ‘transgenic’). 
Table 1 - transgenic lines used in this thesis. 
Line Origin Use 
Tg(RS:KalTA4) Dr. Isaac Bianco, 
UCL 
(unpublished) 
Express transgenes under Upstream 
Activator Sequences (UAS:transgenes) 
mainly in reticulospinal neurons (and 
occasionally additional neurons). 
Tg(HuC:Gal4) Mensch et al. 
2015 




Generated for this 
thesis 
Express the fusion protein of cation 
channel TRPV1 with tagRFPt in 
Gal4/KalTA4+ cells. Used to activate 
single neurons via the application of 
TRPV1 agonist capsaicin. 
Tg(UAS:GFP-
Contactin1a) 
Generated for this 
thesis 
Express the fusion protein of Contactin1a 
with eGFP, which labels unmyelinated 
axon space, in Gal4/KalTA4+ cells. Used 




Tg(mbp:eGFP) Almeida et al. 
2011 
Express eGFP in myelinating cells. Used 
to quantify the number of myelinating 




Karttunen et al., 
2017 
Express nucleus-localised eGFP in 
myelinating cells. Used to quantify the 
number of myelinating oligodendrocytes 
in the ventral spinal cord. 
Tg(mbp:eGFP-
CAAX) 
Almeida et al. 
2011 
Express a membrane-tethered eGFP in 
myelinating cells. Used to visualise 




Generated for this 
thesis 
Express TRPV1-tagRFPt in myelinating 
cells. Used to ablate myelinating cells via 
the application of TRPV1 agonist 
capsaicin. 
 
The recipe for E3 embryo medium is as follows: 
50x HEPES buffer stock (500 ml) 
95.58 g HEPES  
500 ml ddH2O  
50x E3 stock solution (1L) 
14.61 g NaCl (250 mM)  
0.63 g KCl (8.5 mM)  
1.83 g CaCl2 (16.5 mM)  
4.07 g MgSO4 (16.5 mM)  
Make up to 1 L with ddH2O  
10 mM HEPES buffered E3 Embryo medium (2L) 
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1920 ml ddH2O  
40 ml 50x HEPES  
40 ml 50x E2 medium  
Adjust to pH 7.2 with 5 M NaOH 
2.2. Plasmids Used and Generated 
The plasmid DNA constructs used in this thesis are summarised in Table 2. 
To generate UAS:tagRFPt-Contactin1a plasmid, the entry vectors p5E-
10xUAS, pME-tagRFPt-Contactin1a, p3E-polyA, and pdestTol2pA2 were 
recombined by an LR reaction (LR clonase II, Thermo Fisher Scientific) using 
the multisite Gateway system (Kwan et al. 2007). 
To generate UAS:TRPV1-tagRFPt plasmid, I first generated a pME-TRPV1-
tagRFPt entry vector plasmid. To do this, TRPV1-tagRFPt sequence was 
amplified by PCR from the (islet1:GAL4VP16,4xUAS:TRPV1-RFPT) plasmid 
used by Chen et al. 2016, using the following primers:  
attB1_TRPV1_fwd: 
5’GGGGACAAGTTTGTACAAAAAAGCAGGCTGCCACCATGGAACAACGG
GC 3’);  
attB2_TRPV1_rev: 
5’GGGGACCACTTTGTACAAGAAAGCTGGGTTTAATTGTACAGCTCGTCC
ATGC 3’).  
This PCR fragment was then inserted into the backbone pDONR221 by a BP 
reaction (BP Clonase II, Thermo Fisher Scientific). The entry vectors p5E-
10xUAS, pME-TRPV1-tagRFPt, p3E-polyA, and pdestTol2pA2 were 
recombined by an LR reaction to make the final plasmid. 
To generate mRNA from pCS2+ Tol2 Transposase: the plasmid was linearised 
by NotI restriction enzyme digestion (New England Biolabs); the linearised 
plasmid was purified using the Qiaquick gel extraction kit (Qiagen); mRNA was 
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transcribed from the linearised plasmid using the mMessage mMachine SP6 
transcription kit (Thermo Fisher Scientific); and transcribed mRNA was purified 
using the RNEasy mini kit (Qiagen).  
Table 2 – plasmid constructs used in this thesis. 
Plasmid Origin Use 
UAS:GFP Dr. Sigrid Koudelka, 
unpublished 
To label individual neurons in 
Gal4-expressing larvae. 
UAS:GFP-Contactin1a Koudelka et al. 2016 To follow the myelination 
status of single axons. 
mbp:eGFP-CAAX Almeida et al. 2011 To label individual myelinating 
oligodendrocytes and their 
myelin sheaths. 
pCS2+ Tol2 Transposase Kwan et al. 2007 To transcribe tol2 transposase 
mRNA in vitro. 
UAS:axon-GCaMP7 Dr. Rafael Almeida, 
unpublished 




Generated for this 
thesis 
To follow the myelination 
status of single axons. 
UAS:TRPV1-tagRFPt Generated for this 
thesis 
To activate or ablate single 
neurons via the application of 
TRPV1 agonist capsaicin. 
 
2.3. Generating Transgenic Lines 
Stable transgenic lines were generated by injecting 1-2 nl of 10-15 ng/μl 
plasmid DNA with 25 ng/μl tol2 transposase mRNA into wild-type eggs (see 
section ‘2.5 DNA Microinjection’). Where possible, the injected larvae were 
screened for mosaic transgene expression (expression in a few random cells), 
and transgene-positive larvae were raised to adulthood (F0 generation). Only 
some F0s will contain transgenic insertions within the germline; therefore, F0s 
were outcrossed and their progeny (F1 generation) screened for full 
expression of the transgene. Transgene-positive F1 larvae were raised to 
81 
 
adulthood, outcrossed, and their transgenic-positive progeny (F2 generation) 
raised to adulthood. Experiments were carried out using F2 and subsequent 
generations. 
2.4. Mounting Larvae on Glass Slides for Live Imaging 
For all live imaging experiments, except for calcium imaging (see section ‘2.8 
Calcium Imaging and Analysis’) and counting dorsal oligodendrocyte numbers, 
larvae were anaesthetised in 168 µg/mL MS222 tricaine (Sigma-Aldrich) in E3 
embryo medium. Each larvae was then gently positioned laterally on glass 
coverslips in 1.4% low melting-point agarose in E3 embryo medium using fine 
forceps (Williamson et al., 2019). A well of MS222 tricaine in E3 embryo 
medium was made on a glass slide using silicon grease, and the coverslip 
mounted onto the well with immobilised larva(e) facing down into the medium. 
2.5. DNA Microinjection 
Fertilised 1-4 cell-stage eggs were injected with 0.5-2 nl of DNA injection 
solution (plasmid DNA at 5-10 ng/μl, with 25 ng/μl tol2 transposase mRNA to 
facilitate transgenesis) (Williamson et al., 2019). Microinjections were 
performed using a glass microinjection needle fitted to a Pneumatic Picopump 
PV830 (World Precision Instruments Ltd, Hertfordshire, UK) and a 
Micromanipulator M3301R (World Precision Instruments Ltd, Hertfordshire, 
UK). For mosaic labelling of single cells, injected larvae were screened at 2-4 
dpf for expression in cells of interest (for example, single reticulospinal or 
CoPA neurons). This was done by first anaesthetising in 168 µg/mL MS222 
tricaine in E3 embryo medium, and then mounting larvae laterally on glass 
coverslips in 1.4% low melting-point agarose in E3 embryo medium as 
described in section 2.4 ‘Mounting Larvae on Glass Slides for Live Imaging’, 
finally, screening for fluorescence using an epifluorescence microscope. 
2.6. Image Acquisition 
Mounted larvae were imaged using a 20x dry lens on a Zeiss LSM880 Airyscan 
confocal microscope in super-resolution mode. Z-stack images were acquired 
at optimal z-depth, spanning the entire portion of spinal cord being analysed. 
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For time-course experiments, larvae were carefully removed from agarose 
after image acquisition using microknives, and placed in fresh E3 embryo 
medium to recover from anaesthetic (this was confirmed by return of locomotor 
activity).  
For live imaging axons in Chapter 3, three overlapping images were acquired 
at each time point covering a stretch of axon approximately 400-600 µm in 
length. For reticulospinal axons (which project caudally from the hindbrain 
down the spinal cord), the first image began at somite 1, and the subsequent 
images were acquired in a caudal direction along the axon (reaching 
approximately somite 4-5). For CoPA axons (which project rostrally from the 
spinal cord to the brain), the first image began at the cell body of the CoPA 
neuron, and the subsequent images were acquired in a rostral direction along 
the axon. For live imaging axons and ventral oligodendrocyte number in 
Chapter 4, a single image was acquired at each time point covering a stretch 
of axon approximately 150-250 µm in length at somite 7.  
For quantification of dorsal oligodendrocyte number, larvae were 
anaesthetised in MS222 tricaine and arrayed into a 96-well plate at a density 
of 1-3 larvae in 300 μl E3 embryo medium per well. This 96-well plate was 
placed in the Vertebrate Automated Screening Technology BioImager system 
(Union Biometrica), which automated the positioning of larvae and image 
acquisition using a Zeiss spinning disk confocal microscope (VAST-SDCM - 
Early et al. 2018).  
2.7. Capsaicin Treatment 
Capsaicin (Sigma-Aldrich) was prepared as a 5 mM primary stock in 100% 
DMSO and stored at -80 ⁰ C. Capsaicin treatments of 1-10 μM in 1% DMSO 
in E3 embryo medium were bath-applied to zebrafish larvae for either one or 
four hours per day depending on the experiment (specific durations stated in 
Chapter 4). For acute treatment experiments, capsaicin was applied once at 3 
dpf. For time-course experiments, capsaicin was applied daily from 3-7 dpf, 
and the media was replaced with fresh E3 embryo medium three times after 
each treatment.  
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2.8. Calcium Imaging and Analysis 
Larvae were paralysed in 1.5 mg/ml mivacurium chloride (Abcam) in E3 
embryo medium and positioned laterally on glass coverslips in 1.5% low 
melting-point agarose. A window of agarose, stretching from approximately 
somite 15-27, was then carefully removed using microknives. Immobilised 
larvae were mounted onto glass slides as described in section ‘2.4 Mounting 
Larvae on Glass Slides for Live Imaging’, with 1.5 mg/ml mivacurium chloride 
in E3 embryo medium in the silicon grease well.  
Mounted larvae were imaged using a 20x dry lens on a Zeiss LSM880 Airyscan 
confocal microscope. For each larva, a high-resolution image of TRPV1-
tagRFPt and axon-GCaMP7 in the expressing reticulospinal axon(s) of interest 
was acquired within the exposed region of the tail (somite 15-27). Then, a three 
to five minute timelapse movie (pre-treatment) of axon-GCaMP7 fluorescence 
only was acquired at approximately one frame per second. Next, the medium 
was removed from the silicon grease well and replaced with either vehicle (1% 
DMSO) or capsaicin (1 μM Csn, 1% DMSO) in 1.5 mg/ml mivacurium chloride 
in E3 embryo medium. A second timelapse movie was acquired (post-
treatment) 15 minutes after treatment application.  
Both the pre-treatment and post-treatment timelapse movies were then 
analysed using Fiji ImageJ software. For analysis, a background region of 
interest (ROI) was defined, and the average grey value of this region for each 
frame of the movie tabled. A clearly-defined collateral branching from the main 
reticulospinal axon was defined as an ROI, and the average grey value of this 
region for each frame of the movie was tabled. Background was subtracted 
from the collateral grey values to generate a FT value for each frame. The pre-
treatment movie was considered a measure of baseline neuronal activity, and 
so the average FT grey value of the pre-treatment movie was used as a 
baseline value (F0). The change in fluorescence was calculated for each frame 
of the post-treatment movie using the following equation: 
Change in fluorescence = 
(FT – F0) / F0 
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2.9. Preparation of Samples for Transmission Electron Microscopy 
– Chemical Fixation  
The following protocol for chemical fixation and preparation of zebrafish larvae 
for electron microscopy was established by Czopka & Lyons, 2011. 
Primary fixation:  Larvae were terminally anaesthetised in MS222 tricaine in 
E3 embryo medium, and transferred to 1.5 ml Eppendorf tubes (up to five 
larvae/tube). Primary fixative (2% glutaraldehyde + 4% paraformaldehyde, 0.1 
M sodium cacodylate buffer, pH 7.4) was applied to terminally anaesthetised 
larvae. Samples were microwaved to aid with fixation as follows:  one minute 
at 100 W, one minute off (x2); 20 seconds at 450 W, 20 seconds off (x5). 
Samples were kept in an ice bath during microwave steps to prevent 
overheating. Samples were left in primary fixative for at least a further two 
hours at room temperature, before rinsing in 0.1 M sodium cacodylate buffer 
(3x 10 minute washes at room temperature). 
Secondary fixation: Secondary fixative (2% Osmium tetroxide, 0.1 M sodium 
cacodylate, 0.1 M imidazole, pH 7.5) was applied to samples, which were then 
microwaved to aid with fixation as follows: one minute at 100 W, one minute 
off (x2); 20 seconds at 450 W, 20 seconds off (x5). Samples were kept in an 
ice bath during microwave steps to prevent overheating. Samples were left in 
secondary fixative for at least a further one hour at room temperature, before 
rinsing with distilled water (3x 10 minute washes at room temperature). Ideally, 
secondary fixative was left overnight, or until larvae were uniformly stained a 
dark brown colour. 
En bloc stain: Saturated uranyl acetate (~8% w/v in water) was applied to 
samples, which were then microwaved as follows: one minute at 450 W, one 
minute off, one minute at 450 W. 
Dehydration: 50% EM-grade ethanol in distilled water was applied to samples, 
which were then microwaved as follows: 45 seconds at 250 W, 10 minutes off 
at room temperature. This was repeated with 70% and 95% ethanol. 100% 
ethanol was added to samples and microwaved as follows: one minute at 250 
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W, one minute off, one minute at 250 W, 10 minutes off at room temperature. 
This 100% ethanol incubation step was repeated with fresh ethanol. 100% 
acetone was then applied to samples and microwaved as follows: one minute 
at 250 W, one minute off, one minute at 250 W, 10 minutes off at room 
temperature. This 100% acetone incubation step was repeated a further three 
times. 
Embedding in EMBED resin: EMBED resin was made using the Embed-812 
kit (Electron Microscopy Sciences). A 1:1 solution of EMBED:acetone was 
applied to samples and left overnight at room temperature. 100% EMBED was 
applied to samples and left for at least six hours at room temperature in the 
fume hood. Then, the larvae were transferred in 100% EMBED into wells of 
silicon embedding moulds, oriented appropriately using fine forceps so that 
each larva lay in the middle of the mould parallel to the surface. Moulds were 
baked in an oven at 65 ⁰ C for 48-72 hours, until resin had fully polymerised.  
Sectioning: EM blocks were carefully trimmed by hand using razor blades until 
approximately somite 14 (just anterior of the cloaca, located at the gap 
between the ventral fins). Semi-thin transverse sections through the larvae 
were cut using a glass knife on a Reichert Jung Ultracut microtome (Leica) 
until the cloaca was reached and the block face was uniformly smooth. Then, 
ultra-thin silver sections (thickness approximately 70-80 nm) were cut using a 
Diatome diamond knife. Sections were flattened using chloroform, and then 
carefully transferred from the diamond knife water boat to hexagonal copper 
electron microscopy grids (200 Mesh Grids, Agar Scientific) using a perfect 
loop. 
Section staining: Each copper grid was stained with 1:1 saturated uranyl 
acetate:EM-grade ethanol for five minutes, followed by a wash with 50% 
ethanol for one minute, and blotted dry on Whatman filter paper. Then, each 
grid was stained with Sato’s lead stain for five minutes, followed by a wash 




Sato’s lead stain recipe:  
0.2 g lead citrate 
0.15 g lead nitrate 
0.15 g lead acetate 
1 g sodium citrate 
48.2 ml boiled and cooled pure water (filtered through Millipore filter) 
1.8 ml 5M NaOH prepared from boiled and cooled pure water  
Lead citrate was heated on a hot plate in a fume hood until it changed colour 
from white to pale grey. The lead citrate was combined with all other 
ingredients in a beaker and stirred continuously until dissolved. Stain solution 
was aliquoted into syringes and stored at 4 ⁰ C until required. 
Imaging of stained sections: Stained grids were imaged at the King’s Buildings 
EM facility, University of Edinburgh, on a Jeol JEM-1400 Plus electron 
microscope at 12,000x magnification.  
2.10. Preparation of Samples for Transmission Electron 
Microscopy – High Pressure Freezing 
The following protocol was adapted from a previously published protocol for 
high-pressure freezing by Möbius et al. 2010. 
High-pressure freezing: Larvae were terminally anaesthetised with MS222 
tricaine in E3 embryo medium, and then transferred to cryoprotectant solution 
(20% BSA in E3 embryo medium). Using microknives, each larva was 
dissected to remove the head and tail tip, leaving a section of the larvae trunk 
from approximately somite 2-20. The dissected larva trunk was transferred to 
a HPM100 3 mm specimen carrier (Leica) with enough cryoprotectant to fill the 
specimen carrier. Another specimen carrier was ‘sandwiched’ on top, using 
plastic cassettes to hold the specimen carriers in place. This was, then, 
immediately frozen using the Leica EM HPM100 high-pressure freezer.  
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Freeze substitution: Specimen carriers were removed from the high-pressure 
freezer, but kept in liquid nitrogen to prevent defrosting of samples. Specimen 
carriers were transferred to a freeze-substitution solution (0.1% tannic acid, 
2% osmium tetroxide, 0.1% TAAB EM Stain 336) at liquid nitrogen 
temperature, and transferred to the Leica EM AFS2 freeze substitution system. 
Samples were incubated in freeze-substitution solution for 72 hours at -90 ⁰ C, 
warmed to -20 ⁰ C for one hour, and then warmed to 20 ⁰ C. Once at room 
temperature, samples were removed from specimen carriers and transferred 
to 100% acetone solution. 
After freeze-substitution, samples were embedded in EMBED resin and 
sectioned as per the chemical fixation protocol above. 
Section staining: Copper grids were stained using 25% TAAB EM stain 336 for 
45 minutes, followed by a wash with pure water, and blotted dry on Whatman 
filter paper.  
Stained sections were imaged as per the chemical fixation protocol above. 
2.11. Image Analysis 
Sheath and axon length measurements: Confocal fluorescence images were 
analysed using Fiji/ImageJ. The length of sheaths and axons were traced 
using the ‘segmented line’ tool, and their length measured using the ‘measure’ 
function.  
For axons labelled with FP-Cntn1a reporter, a myelin sheath was measured if 
there was a gap in FP-Cntn1a fluorescence which spanned the entire diameter 
of the axon. For Chapter 3, all sheaths along axons were measured twice, and 
the average of these two measurements was taken as the actual value. The 
duplicate measurements were always within 1 μm of each other, confirming 
the precision of these measurements. 
Oligodendrocyte number measurements: For total dorsal oligodendrocyte 
number, the images acquired by the VAST-SDCM system were processed 
using a concatenating and stitching script written by Dr. Jason Early, and 
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analysed using an automated counting macro for Fiji/ImageJ (with manual 
adjustments) also written by Dr. Jason Early (Early et al., 2018). For local 
ventral oligodendrocyte number, images were analysed using the Cell Counter 
plug-in for Fiji/ImageJ. 
Electron microscopy measurements: Electron microscopy images were 
analysed using Fiji/ImageJ. G-ratios were analysed by first tracing the outline 
of the axon using the ‘polygon’ tool, and its area measured using the ‘measure’ 
function. Then the outline of the myelin sheath was traced using the ‘polygon’ 
tool, and its area measured using the ‘measure’ function. The radii of the axon 
and the myelin sheath were calculated from the area measurements by solving 
the equation for circular area:  
Area = π.r2 
Then, sheath thickness was measured as a g-ratio as follows: 
  g-ratio = 
axon diameter / myelin sheath diameter 
2.12. Statistical Analysis 
Statistical analysis was performed using Microsoft Excel 2013 and GraphPad 
Prism software. Graphs were generated using GraphPad Prism software, and 
the n used represents the number of larvae, unless otherwise stated.  
D'Agostino & Pearson omnibus normality tests were performed where 
possible, to determine whether the data was distributed normally. For 
experiments where all data were normally distributed, the data averages are 
described in the text as means, and the error bars in associated graphs denote 
mean and standard deviation (SD) (as noted in figure legends). For 
experiments containing not normally distributed data, the data averages are 
described in the text as medians, and the error bars in associated graphs 
denote median and interquartile range (IQR) (as noted in figure legends). 
Statistical tests were chosen based on experimental design and the normality 
distribution of the data (parametric tests for normally distributed data, non-
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parametric tests for not normally distributed data where possible), and are 
described in appropriate figure legends. When testing for statistical 

















Chapter 3: Characterising the Remodelling of 










In Chapter 1, I discussed the evidence that changes to myelin occur in 
response to experience, and that such changes may, in turn, impact circuit 
function (see section ‘1.5 Myelin and the Regulation of Circuit Function’). I also 
discussed the fact that there is significant heterogeneity in the myelin patterns 
(the number, length, thickness, and distribution of sheaths) along individual 
axons throughout the CNS. Given that these myelination parameters can alter 
the underlying conduction properties of the axon, it is possible that specific 
myelin patterns are established to optimise circuit function. Moreover, axons 
belonging to particular circuits may develop particular myelin patterns based 
on circuit function. However, it is not clear how or when myelin patterns are 
established along individual axons, or whether these patterns are susceptible 
to remodelling over time.  
Characterisation of myelin pattern establishment along individual axons 
requires longitudinal analysis of single myelinated axons in vivo. Recent live 
imaging studies in rodents have demonstrated that longitudinal analysis of 
myelin is possible in the mammalian CNS. Combining cranial imaging windows 
with repeated two-photon microscopy allowed researchers to follow both de 
novo myelination and myelin remodelling over time (Hill et al., 2018; Hughes 
et al., 2018). However, these experiments limited analysis to a very specific 
region of the CNS, as only the upper 400 μm of the somatosensory cortex 
could be imaged. The authors did not identify specific subtypes of neurons to 
assess if, indeed, neuronal subtypes exhibit differences in myelination and 
myelin remodelling. These experiments are also technically very challenging 
to perform.  
The larval zebrafish is a powerful complementary model system for live 
imaging myelin patterns and myelin remodelling over time in vivo (see section 
‘1.7 Zebrafish as a Model to Investigate Myelinated Axon Biology’). Their small 
size and optical transparency, coupled with the suite of transgenic fluorescent 
reporters available, allows for individual axons and their myelin to be followed 
over prolonged periods of time. In a study by Auer et al., 2018, the myelin 
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patterns along various different axons in the spinal cord were imaged by live 
confocal microscopy, and showed that myelin sheath length can vary 
significantly both along and between axons. This variability may be a 
characteristic of particular neuron subtypes, or sheath length variability may 
change with time and therefore reflect the developmental stages of the axons 
analysed. The authors also followed individual fluorescently-labelled myelin 
sheaths in the larval zebrafish spinal cord by confocal microscopy for up to two 
weeks to measure their growth dynamics (Auer et al., 2018). It was determined 
that myelin sheaths grow in a stereotypical fashion, where sheaths undergo 
variable but rapid growth for the first three days after sheath formation, and 
then remain stable (thereafter growing only at the approximate rate of overall 
body elongation). However, it is not clear whether this phenomenon is 
consistent across axons of different neuronal subtypes, or, for example, if 
myelin is remodelled in certain circuits more than others.  
In order to understand myelin pattern establishment and remodelling in the 
context of circuit function, myelination must be assessed along axons of 
identified neuronal subtypes within characterised circuits over time. By 3 dpf 
(the approximate time of myelination onset in the zebrafish CNS), the larval 
zebrafish spinal cord contains axons of numerous neuron subtypes classified 
based on cellular morphology, position, and timing of axogenesis (Bernhardt 
et al., 1990; Hale et al., 2001; Mendelson, 1986b, 1986a). These subtypes 
include motor neurons, sensory neurons, reticulospinal neurons, and various 
interneurons. The axons of several of these known neuron subtypes are 
myelinated from 3 dpf onwards (such as reticulospinal neurons, commissural 
primary ascending (CoPA) interneurons, and circumferential descending (CiD) 
interneurons), whilst other axons are not myelinated (such as commissural 
bifurcating longitudinal (CoBL) interneurons, circumferential ascending (CiA) 
interneurons, and Rohon-Beard (RB) sensory neurons (Mensch, 2014)). 
Therefore, the larval zebrafish spinal cord contains several identified subtypes 
of myelinated axon which can be analysed to determine how myelin pattern 




Interestingly, different myelinated axon subtypes appear to use different 
mechanisms to regulate their initial myelination. Koudelka et al., 2016 
expressed tetanus neurotoxin (TeNT – to inhibit synaptic vesicle release) in 
individual reticulospinal and CoPA axons, and then followed the myelination of 
these axons over several days. They found that while synaptic vesicle release 
was successfully inhibited in both subtypes, only the myelination of 
reticulospinal axons was reduced by TeNT expression. Reticulospinal and 
CoPA neurons exhibit many similarities, including their time of birth and 
myelination, axon diameter, and neurotransmitter (Higashijima et al., 2004; 
Koudelka et al., 2016), yet seem to have different mechanisms by which they 
regulate their myelination. It is possible that this is due to differing requirements 
of the specific circuits in which these two neuron subtypes are found. For 
example, the myelination of reticulospinal neuron-containing circuits may be 
shaped by neuronal activity in order to optimise circuit function; whereas the 
myelination of CoPA interneuron-containing circuits may be shaped by some 
other developmental signal. Subsequently, these two axon subtypes may 
establish different myelin patterns and exhibit different types or extents of 
myelin remodelling during myelinated axon development. Here, I will discuss 
what is known about the circuitry of these two neuronal subtypes in the 
zebrafish CNS. 
3.1.1. Reticulospinal Neurons and their Circuitry 
Reticulospinal neurons are found in the mid- and hindbrain of the zebrafish, 
projecting their axons caudally along the spinal cord. In teleosts, these neurons 
are responsible for relaying locomotor control from the brain to the spinal cord 
by synapsing onto motor neurons and other spinal interneurons to give rise to 
locomotor behaviour. There are approximately 150 reticulospinal neurons 
which are arrange in bilaterally symmetrical pairs (Figure 7). The different 
subtypes of reticulospinal neurons are typically classified based on their time 
of birth and axogenesis, cell body position in the brain, dendritic and axon 
morphology, and known circuit function (Gahtan and O’Malley, 2003; Kimmel 
et al., 1982; Metcalfe et al., 1986). Most reticulospinal neurons are born within 
the first 24 hours of life (Mendelson, 1986a). This is then followed by two waves 
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of axogenesis; the first “primary wave” occurring between 20-24 hours post-
fertilisation (hpf), and the “secondary wave” occurring between 30-34 hpf 
(Mendelson, 1986b).  
 
Figure 7 – the different subtypes of reticulospinal neurons found in the 
zebrafish midbrain and hindbrain.  
Reticulospinal neurons can be identified based on the morphology and positioning 
of their cell bodies. The inset shows a schematic of the different subtypes of 
reticulospinal cells. The bold shapes represent clusters of cells rather than 
individual soma. RS subtypes known to regulate certain behaviours are coloured 
and named. Mauthner, MiD2cm (within the MiD2 cluster) and MiD3cm (within the 
MiD3 cluster) regulate escape responses. MeLr and MeLc in the nucleus of the 
medial longitudinal fasciculus (nucMLF) are involved in prey capture behaviour. 
RoV3, MiV1 and MiV2 are involved in direction changes during optomotor 





Among the first born reticulospinal neurons are the Mauthner cells (the largest 
diameter axons in the zebrafish) and their segmental homologue cells, 
MiD2cm and MiD3cm (collectively known as the M-series) (Mendelson, 
1986a), which mediate rapid escape response behaviours in fish. Escape 
responses can be evoked by visual, tactile, and auditory sensory stimuli, 
suggesting that these reticulospinal neurons receive inputs from multiple 
sensory systems (Eaton et al., 1977). Indeed, the Mauthner cell dendrites are 
known to receive inputs from auditory, lateral line, vestibular, visual, and 
somatosensory systems (Faber et al., 1989). Mauthner cells project axons to 
the contralateral spinal cord and grow small unbranched collaterals, which 
synapse onto motor neurons and other interneurons along the whole length of 
the spinal cord (Fetcho and Faber, 1988; Jontes et al., 2000). MiD2cm and 
MiD3cm also project their axons to the contralateral spinal cord, but have more 
complexly branching collaterals, which project bilaterally to the ventral spinal 
cord (MiD2cm) and ipsilaterally to the dorsal spinal cord (MiD3cm) (Gahtan 
and Malley, 2003). Although the post-synaptic targets of these collaterals are 
not fully known, it is hypothesised that MiD2/3cm also synapse onto motor 
neurons and interneurons to mediate the escape response (Gahtan and 
O’Malley, 2003). Activation of a Mauthner or homologue cell stimulates motor 
neurons contralateral to the stimulus, as well as inhibiting the contralateral M-
series – this causes contralateral muscle contraction and thus the fish turns 
away from the threatening stimulus (known as the “C-bend”). It is likely that 
having multiple cells capable of initiating escape responses serves to ensure 
that escape is still possible should one cell fail. However, the different cells 
also exhibit variances in their responses to sensory stimuli. Calcium imaging 
shows that all cells in the M-series can respond to tactile stimulus of the head, 
whereas only the Mauthner cell is activated by tactile stimulus of the tail 
(O’Malley et al., 1996). This was confirmed by ablation experiments, where 
ablation of all cells in the M-series eliminates both head- and tail-elicited 
escape responses; whereas ablation of just the Mauthner only eliminates tail-
elicited escape responses (Liu and Fetcho, 1999). Therefore, the segmental 
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homologues of the M-series may form overlapping but distinct circuits which 
converge on the same behavioural output. 
The Mauthner axon is the first to be myelinated in the zebrafish spinal cord 
with myelination beginning at 60 hpf (Almeida et al., 2011), closely followed by 
the larger diameter reticulospinal axons such as MiD2cm and MiD3cm. 
Myelination between 2 to 4 dpf significantly increases the conduction velocity 
along Mauthner axon (Dr. Daumantė Šuminaitė and Dr. Jenea Bin, 
unpublished). Interestingly, the latency of the escape response does not 
significantly change between 2-4 dpf, but other kinematics of the escape 
response (such as maximum velocity, duration of initial contraction, and 
displacement in the first 105 msec) do change (Eaton et al., 1977). 
Synaptogenesis and post-synaptic neuron development may underlie these 
changes. However, myelination may also influence emergence of circuit 
function in more complex ways than simply reducing response latency.  
The circuitry of other subtypes of reticulospinal neurons are less characterised. 
Gahtan et al., 2002 found that tactile stimulus of the head induces activity in 
the majority of identified reticulospinal neurons (not just the M-series), 
suggesting that other reticulospinal subtypes also receive sensory input and 
contribute to escape response behaviour. However, it has been noted that this 
result may be an artefact of the experimental set-up, where the larval zebrafish 
were completely immobilised in agar. Global activity of all reticulospinal 
neurons may, therefore, be due to physical struggling during attempts to 
perform normal swimming behaviour (Fetcho et al., 2008). This would indicate 
that many reticulospinal neuron subtypes are involved in normal swimming.  
A number of other reticulospinal subtypes have been shown to play a role in 
particular locomotor behaviours. The MeLr and MeLc neurons are required for 
prey capture behaviour; these cells reside within the nucleus of the medial 
longitudinal fasciculus (nucMLF), with dendrites projecting into the ventral 
tectum (a structure which is also required for prey capture) (Gahtan et al., 
2005). Bilateral ablation of MeLr and MeLc ameliorates prey capture behaviour 
but does not affect other motor behaviours, while ablation of other random 
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reticulospinal neurons does not affect prey capture (Gahtan et al., 2005). 
Meanwhile, calcium imaging of the entire reticulospinal population has 
identified cells involved in visually-guided swimming. Orger et al., 2008 
exposed fish to directional gratings which can induce forward swimming or 
change in swimming direction to match that of the gratings (known as the 
optomotor response). Various nucMLF cells are activated during forward 
swimming, whereas the ipsilateral RoV3, MiV1 and MiV2 cells are active 
during changes in direction, and laser ablation of the RoV3/MiV1/MiV2 group 
prevents corresponding changes in direction (Orger et al., 2008).  
Reticulospinal neurons are believed to be myelinated in an activity-dependent 
manner. Inhibiting synaptic vesicle release via expression of TeNT in individual 
reticulospinal neurons inhibits their myelination by reducing both the number 
and length of myelin sheaths formed along the axon (Koudelka et al., 2016). 
Given that reticulospinal neurons are specifically involved in locomotor circuits, 
and that the myelin patterns of circuits are hypothesised to be shaped by 
experience (and therefore influenced by signals relating to neuronal activity), 
it is possible that reticulospinal neurons establish a specific myelin pattern 
along their axons to optimise circuit function. Additionally, if myelin remodelling 
in response to neuronal activity is important for the establishment of myelin 
patterns, then sheaths along reticulospinal axons should exhibit remodelling. 
3.1.2. CoPA Interneurons and their Circuitry 
CoPA interneurons are born in the zebrafish spinal cord at approximately 17-
18 hpf (Bernhardt et al., 1990). Their cell bodies are located in the dorsal spinal 
cord and they typically extend two dendrites – one rostrally and one caudally 
along the dorsal tract of the spinal cord (Bernhardt et al., 1990; Hale et al., 
2001). Approximately one CoPA interneuron is found in each hemi-segment of 
the spinal cord, and each cell projects an axon to the ventral tract where it 
crosses to the contralateral side, and then projects back up to the dorsal tract 




Figure 8 – CoPA interneurons in the zebrafish spinal cord. 
CoPA interneurons are found along the entire spinal cord. Their cell bodies are 
located in the dorsal (D) tract, and project an axon to the ventral (V) tract which 
then ascends back up to the dorsal tract, proceeding rostrally towards the brain. 
 
CoPA interneurons receive excitatory input from RB sensory neurons (Pietri et 
al., 2009), which have extensive neurite arborisations that span the surface of 
the animal to detect sensory stimuli. Synapses between RB and CoPA cells 
have been observed as early as 25 hpf (coinciding with the emergence of 
touch-elicited behaviour). This suggest that CoPA interneurons are an 
important part of sensory relay circuitry mediating locomotor responses to 
sensory stimuli (Easley-Neal et al., 2013). However, RB sensory neurons are 
believed to be a transient population which undergo programmed cell death 
during the first few days of life (Svoboda et al., 2001; Williams et al., 2000). 
Therefore, CoPA interneurons may receive excitatory inputs from other cells 
as well. Branching collaterals emerge along the length of the CoPA axon 
(Mensch, 2014), but the post-synaptic targets of these collaterals are not yet 
fully known. One study suggests that CoPA interneurons send signals to the 
rostral spinal cord and synapse onto descending interneurons to mediate 
touch-elicited locomotor behaviour (Pietri et al., 2009).  
Depolarising glycinergic inputs to CoPA interneurons have been reported (at 
larval stages glycine depolarises due to the high intracellular levels of Cl- 
(Knogler and Drapeau, 2014; Pietri et al., 2009). Knogler and Drapeau, 2014 
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found that contralateral sensory stimulation elicited a rapid glutamatergic input 
in CoPA cells (inducing suprathreshold depolarisation and action potential 
firing), closely followed by a prolonged glycinergic input. It is hypothesised that 
this prolonged glycinergic signalling prevents CoPA cells from firing multiple 
action potentials in response to glutamatergic inputs. However, the source of 
this glycinergic input is not yet known. CoPA interneurons also receive 
inhibitory input. GABAergic cerebrospinal fluid contacting-neurons (CSF-cNs) 
synapse onto CoPA interneurons and motor neurons; this inhibition is required 
to maintain a balanced posture during swimming (Hubbard et al., 2016).  
Thus, it seems that CoPA interneurons play a crucial role in the transfer and 
processing of sensory information. CoPA neurons are believed to be in 
different circuits from reticulospinal neurons; if myelin patterns are tuned to the 
function of individual circuits, then CoPA axons should exhibit different myelin 
patterns to reticulospinal axons. Additionally, CoPA axon myelination seems 
to be independent of neuronal activity, as TeNT-expressing CoPA axons have 
a normal sheath number and sheath length (Koudelka et al., 2016). If CoPA 
neurons do not use activity to shape their myelination, then they may exhibit 
less myelin remodelling than the sheaths along reticulospinal axons. 
3.1.3. Aims for this Chapter 
Reticulospinal and CoPA neurons play key roles in motor and sensory circuits 
respectively. These two subtypes of axon are amongst the first to be 
myelinated in the zebrafish spinal cord, and research has shown that these 
two different subtypes use diverse signals to regulate their initial myelination. 
In this chapter, I aim to investigate: how myelin patterns form along individual 
reticulospinal and CoPA axons in the zebrafish spinal cord; how these 
myelinated axons are remodelled after initial myelin sheath formation; and 
whether these two subtypes of axon exhibit any differences in myelin patterns 
and sheath remodelling. I hypothesise that reticulospinal axons will exhibit 
different myelin patterns compared to CoPA axons, and that reticulospinal 
axons will exhibit a greater degree of myelin remodelling after initial myelin 
sheath formation. To test this hypothesis, I performed live imaging of single 
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reticulospinal and CoPA axons using fluorescent reporters to assess 
myelination at the single axon level. I live imaged single axons at multiple time 
points, and then characterised the myelin patterns for both subtypes, focusing 
on parameters of sheath number, sheath length, axon diameter, and 
unmyelinated gap length. I also assessed the remodelling of individual myelin 
sheaths, and how this correlates with various parameters of myelinated axon 
development. Finally, I performed a time-course analysis by electron 
microscopy in collaboration with Dr. Jenea Bin to assess how sheath thickness 
changes over the same time period. 
3.2. Results 
3.2.1. Live Imaging of Reticulospinal and CoPA Axons after Initial Myelination 
In order to visualise myelination along single axons, single-cell stage zebrafish 
eggs were injected with reporter-encoding plasmid DNA to facilitate mosaic 
transgenesis. Tg(HuC:Gal4) eggs were injected with 5 pg 10xUAS:eGFP and 
5 pg of 10xUAS:tagRFPt-Contactin1a plasmids. Gal4 is a yeast transcriptional 
activator which controls gene expression by binding to specific target 
sequences called Upstream Activator Sequences (UAS), thereby activating 
the expression of downstream genes (Scheer and Campos-Ortega, 1999). The 
transgenic line Tg(HuC:Gal4) expresses Gal4 under the control of the HuC 
promotor, and thus, in the majority of post-mitotic neurons (Mensch et al., 
2015). This means that some neurons where transgenesis of the injected 
plasmids occurs will express the genes of interest. Cytoplasmic expression of 
eGFP labelled the morphology of entire cells and visualised the axons and 
branching collaterals. The fusion protein tagRFPt-Contactin1a (hereafter 
denoted as RFP-Cntn1a) is a fluorescently-tagged version of one of the 
zebrafish homologs for Contactin1. This axonal membrane-bound protein is 
involved in axo-glial adhesion at paranodes and is also localised to nodes of 
Ranvier in the CNS (Rasband and Peles, 2016; Salzer, 2003). Zebrafish have 
two homologues for Contactin1, Contactin1a and Contactin1b. Both are 
expressed in the zebrafish CNS, with Contactin1b expression beginning later 
than Contactin1a (Gimnopoulos et al., 2002; Haenisch et al., 2005). It has been 
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shown that FP-Cntn1a fusion proteins can be used as a reporter of myelination 
along single axons; first FP-Cntn1a is expressed along the entire unmyelinated 
axon, but once an oligodendrocyte forms contacts with the axon, this extrudes 
the FP-Cntn1a reporter from these contact sites (Koudelka et al., 2016). The 
gaps in FP-Cntn1a along an axon indicate the location of myelin sheaths, while 
the regions of FP-Cntn1a expression denote unmyelinated axon or nodes of 
Ranvier. By expressing both eGFP and RFP-Cntn1a in single axons, both 
axon morphology and myelin patterns along reticulospinal and CoPA axons 
can be visualised. 
Injected larvae were screened to identify animals where isolated reticulospinal 
(RS) or CoPA axons were labelled, with the two subtypes identified based on 
the morphology of their axons in the spinal cord, as described in section ‘3.1 
Introduction’. Only one cell was imaged and analysed per animal. For RS 
axons, the Mauthner cells were excluded from imaging and analysis because 
these axons are myelinated in a non-traditional fashion. Along Mauthner 
axons, instead of distinct sheaths being separated by nodes of Ranvier, 
neighbouring sheaths overlap with one another and nodes are localised to the 
short collaterals.  
Myelination in the zebrafish spinal cord begins at approximately 2-3 days post-
fertilisation (dpf), and RS and CoPA axons are extensively myelinated within 
the first few days of myelination. Therefore, the axon of each identified cell was 
imaged by confocal microscopy at 5, 7, and 9 dpf, to assess how myelinated 
axons change after this initial period of sheath formation (Figure 9A). Note 
that, in experiments where all data are normally distributed, the data averages 
are described as means with standard deviation (SD) error bars; for 
experiments containing not normally distributed data, the data averages are 
described as medians with interquartile range (IQR) error bars. Almost all of 
the axons analysed had significant coverage of myelin along their axons from 
5 dpf onwards (the median % axon myelinated of RS axons was 93.4% at 5 
dpf, 97.4% at 7 dpf, and 97.2% at 9 dpf; the median % axon myelinated of 
CoPA axons was 89.3% at 5 dpf, 94.3% at 7 dpf, and 97.3% at 9 dpf; Figure 
9C-E). Approximately similar lengths of axon were analysed for the two 
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subtypes (median total length of RS axon analysed was 540.5 µm, median 
total length of CoPA axon analysed was 574.2 µm; Figure 9F).  
 
Figure 9 - live imaging myelinated axon development over time in the 
zebrafish spinal cord. 
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A) Experimental timeline; fertilised eggs were injected with plasmids to mosaically 
label single neurons in the spinal cord with fluorescent reporters of myelination. The 
axons of identified reticulospinal (RS) and CoPA neurons were imaged at 5, 7, and 
9 dpf. B)  Schematic highlighting the positions of RS and CoPA neurons and their 
axons. RS soma are located in the hindbrain and project axons caudally along the 
ventral spinal cord. CoPA soma are located at each somite of the spinal cord, and 
project ascending axons rostrally towards the brain. C) An example RS axon 
imaged at 5, 7, and 9 dpf, with myelin sheaths labelled. White arrows = 
unmyelinated axon labelled with RFP-Cntn1a. D) An example CoPA axon imaged 
at 5, 7, and 9 dpf, with myelin sheaths labelled. E) Quantification of the myelin 
coverage along RS and CoPA axons at 5, 7, and 9 dpf. The median % axon 
myelinated of RS axons was 93.4% (IQR = 89.6-96.5) at 5 dpf, 97.4% (IQR = 96.3-
98.1) at 7 dpf, and 97.2% (IQR = 96.6-98.4) at 9 dpf. The median % axon 
myelinated of CoPA axons was 89.3% (IQR = 77.5-95.8) at 5 dpf, 94.3% (IQR = 
87.3-97.7) at 7 dpf, and 97.3% (IQR = 92.7-98.3) at 9 dpf. F) Quantification of the 
length of axon analysed (total axon length from three overlapping confocal images). 
The median total length of RS axon analysed was 540.5 µm (IQR = 482.2-565.1), 
and the median total length of CoPA axon analysed was 574.2 µm (IQR = 536.7-
606.6). RS n = 14, CoPA n = 12. Scale bars = 10 µm. 
 
3.2.2. Changes in Sheath Number over Time 
First, the number of myelin sheaths along RS and CoPA axons between 5 and 
9 dpf was quantified to see if this significantly changed after the initial period 
of sheath formation. The mean number of sheaths along RS axons 
(normalised to axon length analysed) was 2.6 sheaths/100 µm axon at 5 dpf, 
2.5 sheaths/100 µm axon at 7 dpf, and 2.5 sheaths/100 µm axon at 9 dpf, with 
no statistically significant change in sheath number during this time period 
(Repeated Measures ANOVA, p = 0.572; Figure 10C). For CoPA axons, the 
median number of sheaths/100 µm axon was 2.5 at 5 dpf, 2.4 at 7 dpf, and 2.4 
at 9 dpf, and again there was no significant change in sheath number over time 
(Friedman test, p = 0.779, Figure 10F).  
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By imaging the same region of axon at each time point, individual myelin 
sheaths could be followed over time (Figure 10C-D). This allowed assessment 
of whether new sheaths were added or existing sheaths were retracted 
between 5 to 9 dpf (Figure 10A-B). While both phenomena occasionally 
occurred, the majority of axons showed no such changes in sheath number 
over time. Only five sheaths were added 5-7 dpf across the 26 axons analysed 
(an increase of total sheath number of 2.29%); 7-9 dpf, only one sheath was 
added (an increase of 0.29%). Sheath addition was limited to longer 
unmyelinated portions of the axon, as new sheaths were never added into the 
short nodal gaps between existing sheaths. Between 5 to 7 dpf, 12 sheaths 
were retracted (3.43% of total sheaths), while only two sheaths were retracted 
7-9 dpf (0.58% of total sheaths). All of the sheaths which were retracted were 
of short length; of the 14 sheaths which were retracted, 13 were under 10 µm 
in length; the final sheath was 10.6 µm in length. On both RS and CoPA axons, 
there was no significant change in the degree of sheath addition or retraction 
throughout the time period analysed (Figure 10D-E, G-H, Wilcoxon signed 
rank tests, see Figure 10 legend for statistics). 
Based on these results, I concluded that the vast majority of sheaths along RS 
and CoPA axons are made during early myelination (3-5 dpf), and that, 
thereafter, sheath number remains relatively stable. However, it is possible to 
remove sheaths as shown by the occasional incidence of sheath retractions. 
Sheath retractions have been described in numerous other studies, such as in 
timelapse imaging of single oligodendrocytes undergoing myelination in the 
zebrafish spinal cord (Hines et al., 2015; Mensch et al., 2015). Interestingly, 
Hines et al. 2015 noted that all of the sheath retractions they observed were of 
sheaths under 10 µm in length, similar to my findings along RS and CoPA 
axons. This raised the intriguing hypothesis that sheath fate can be predicted 
based on length. To investigate this, the sheaths were binned by length and 
the percentage which were either retracted or maintained was calculated. 
Between 5 to 7 dpf, 75% of sheaths under 5 µm long were retracted, while only 
20% of sheaths between 5-10 µm long and 5.3% of sheaths between 10-15 
µm long were retracted (Figure 10I). Between 7 to 9 dpf, 25% of sheaths under 
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5 µm long, 16.3% of sheaths between 5-10 µm long, and 0% of sheaths 
between 10-15 µm long were retracted (Figure 10J). This suggests that there 
is a correlation between sheath length and fate. 
 
Figure 10 – sheath number along RS and CoPA axons over time. 
A) An example of a new sheath being added to an axon; white arrows = 
unmyelinated axon labelled with tagRFPt-Cntn1a. B) An example of a sheath being 
retracted from an axon. C) The number of sheaths along RS axons over time.  The 
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mean number of sheaths/100 µm axon was 2.6 (SD = 0.7) at 5 dpf, 2.5 (SD = 0.5) 
at 7 dpf, and 2.5 (SD = 0.6) at 9 dpf. There was no statistically significant change 
in sheath number over time (Repeated Measures ANOVA, p = 0.572, n = 14). D) 
Quantification of sheath addition along RS axons over time. The median number of 
sheaths added/100 µm axon 5-7 dpf was 0 (IQR = 0-0.18); the median number of 
sheaths added/100 µm axon 7-9 dpf was 0 (IQR = 0-0). There was no statistically 
significant change in sheath addition with time (Wilcoxon signed rank test, p = 
0.125, n = 14). E) Quantification of sheath retraction along RS axons over time. The 
median number of sheaths retracted/100 µm axon 5-7 dpf was 0 (IQR = 0-0.19); 
the median number of sheaths retracted/100 µm axon 7-9 dpf was 0 (IQR = 0-0). 
There was no statistically significant change in sheath retraction with time (Wilcoxon 
signed rank test, p = 0.375, n = 14). F) The number of sheaths along CoPA axons 
over time.  The median number of sheaths/100 µm axon was 2.5 (IQR = 2.0-2.6) at 
5 dpf, 2.4 (IQR = 2.0-2.6) at 7 dpf, and 2.4 (IQR = 2.0-2.6) at 9 dpf. There was no 
statistically significant change in sheath number over time (Friedman test, p = 
0.779, n = 12). G) Quantification of sheath addition along CoPA axons over time. 
The median number of sheaths added/100 µm axon 5-7 dpf was 0 (IQR = 0-0.13); 
the median number of sheaths added/100 µm axon 7-9 dpf 0 (IQR = 0-0). There 
was no statistically significant change in sheath addition with time (Wilcoxon signed 
rank test, p = 0.250, n = 12). H) Quantification of sheath retraction along CoPA 
axons over time. The median number of sheaths retracted/100 µm axon 5-7 dpf 
was 0 (IQR = 0-0.16); the median number of sheaths retracted/100 µm axon 7-9 
dpf 0 (IQR = 0-0). There was no statistically significant reduction in sheath retraction 
with time (Wilcoxon signed rank test, p = 0.125, n = 12). I) The 5-7 dpf fate of myelin 
sheaths at different bins of sheath length. For sheaths < 5 µm in length at 5 dpf, 
75% of sheaths were retracted, 25% of sheaths were maintained 5-7 dpf (# sheaths 
= 12). For sheaths 5-10 µm in length at 5 dpf, 18.2% of sheaths were retracted, 
81.8% of sheaths were maintained 5-7 dpf (# sheaths = 11). For sheaths 10-15 µm 
in length at 5 dpf, 5.3% of sheaths were retracted, 94.7% of sheaths were 
maintained 5-7 dpf (# sheaths = 19). J) The 7-9 dpf fate of myelin sheaths at 
different bins of sheath length. For sheaths < 5 µm in length at 7 dpf, 25% of sheaths 
were retracted, 75% of sheaths were maintained 7-9 dpf (# sheaths = 4). For 
sheaths 5-10 µm in length at 7 dpf, 16.7% of sheaths were retracted, 83.3% of 
sheaths were maintained 7-9 dpf (# sheaths = 6). For sheaths 10-15 µm in length 
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at 7 dpf, 0% of sheaths were retracted, 100% of sheaths were maintained 7-9 dpf 
(# sheaths = 10). Scale bars = 10 µm. 
 
3.2.3. Sheath Length and Sheath Length Variability over Time 
Next, the length of myelin sheaths along RS and CoPA axons was quantified 
at 5, 7, and 9 dpf. The mean sheath length for each axon analysed was plotted 
over time (Figure 11A-B). The mean sheath length for RS axons significantly 
increased from 36.7 µm at 5 dpf to 39.8 µm at 7 dpf, but did not change 
significantly at 9 dpf when it was 39.9 µm (Repeated Measures ANOVA, p = 
0.0003, Tukey’s Multiple Comparisons test, Figure 11A). For CoPA axons, the 
mean sheath length also increased from 36.0 µm at 5 dpf to 39.9 µm at 7 dpf, 
and then did not change at 9 dpf when it was 40.5 µm (Repeated Measures 
ANOVA, p < 0.0001, Tukey’s Multiple Comparisons test, Figure 11B). 
Previous studies have shown that there can be significant variation in the 
length of sheaths along a given axon (Auer et al., 2018; Ibrahim et al., 1995; 
Murray and Blakemore, 1980); whether this variability is transient or 
maintained over time is not yet known. The sheaths along an axon may be 
remodelled in length over time, so that they all become a similar length to 
evenly space out the nodes of Ranvier. Both RS and CoPA axons exhibited 
significant variation in sheath length along axons at 5 dpf, with sheaths along 
a single axon often ranging from < 5 µm to > 60 µm (Figure 11E, G). At 9 dpf, 
these axons still have considerable variability in sheath length (Figure 11F, 
H). To quantify this variability, the standard deviation (SD) of sheath length 
measurements for each axon was taken at 5, 7, and 9 dpf (Figure 11C-D). 
The variability of sheath length along RS axons did not change between 5 and 
9 dpf (median sheath length variability was 15.2 at 5 dpf, 14.4 at 7 dpf, and 
13.5 at 9 dpf; Friedman test, p = 0.257). CoPA axons also showed no change 
in sheath length variability over time (mean sheath length variability was 17.1 




Based on these results, I concluded that sheath length variability along axons 
is maintained after initial sheath formation, and as with myelin sheath number, 
that very little myelin length remodelling takes place after axons are completely 
myelinated. 
 
Figure 11 – sheath lengths along RS and CoPA axons over time (continued 




Figure 11 (continued). 
A) The mean sheath length of each RS axon at 5, 7, and 9 dpf. The overall mean 
sheath length was 36.7 µm (SD = 9.8) at 5 dpf, 39.8 µm (SD = 10.0) at 7 dpf, and 
39.9 µm (SD = 9.4) at 9 dpf. There was a statistically significant change in mean 
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sheath length over time (Repeated Measures ANOVA, p = 0.0003; Tukey’s Multiple 
Comparisons test: 5 dpf vs 7 dpf p = **, 5 dpf vs 9 dpf p = ***, 7 dpf vs 9 dpf p = ns). 
RS n = 14. B) The mean sheath length of each CoPA axon at 5, 7, and 9 dpf. The 
overall mean sheath length was 36.0 µm (SD = 8.0) at 5 dpf, 39.9 µm (SD = 7.3) at 
7 dpf, and 40.5 µm (SD = 6.5) at 9 dpf. There was a statistically significant change 
in mean sheath length over time (Repeated Measures ANOVA, p < 0.0001; Tukey’s 
Multiple Comparisons test: 5 dpf vs 7 dpf p = ***, 5 dpf vs 9 dpf p = ***, 7 dpf vs 9 
dpf p = ns). CoPA n = 12. C) Quantification of sheath length variability along 
individual RS axons. Sheath length variability was assessed as the standard 
deviation of sheath lengths along each axon. The median sheath length variability 
was 15.2 (IQR = 13.3-18.4) at 5 dpf, 14.4 (IQR = 10.0-18.4) at 7 dpf, and 13.5 (IQR 
= 10.0-17.7) at 9 dpf. There was no statistically significant change in sheath length 
variability over time (Friedman test, p = 0.257). RS n = 14. D) Quantification of 
sheath length variability along individual CoPA axons. The mean sheath length 
variability was 17.1 (SD = 3.0) at 5 dpf, 17.0 (SD = 2.1) at 7 dpf, and 17.1 (SD = 
2.0) at 9 dpf. There was no statistically significant change in sheath length variability 
over time (Repeated Measures ANOVA, p = 0.951). CoPA n = 12. E) The 5 dpf 
lengths of individual sheaths along each RS axon analysed (each data point = a 
single myelin sheath; the black line = mean sheath length). F) The 9 dpf lengths of 
individual sheaths along each RS axon analysed. G) The 5 dpf lengths of individual 
sheaths along each CoPA axon analysed. H) The 9 dpf lengths of individual sheaths 
along each CoPA axon analysed. 
 
3.2.4. Changes in Axon Diameter over Time 
Myelin sheath length was variable between axons as well as along axons, with 
mean sheath length ranging from between 20-50 µm for both RS and CoPA 
axons (Figure 11A-B). It has been shown that, on average, sheath length 
correlates with the diameter of the underlying axon (Ibrahim et al., 1995; 
Murray and Blakemore, 1980). Therefore, the diameter of RS and CoPA axons 
was measured in order to assess whether sheath length correlates with axon 
diameter. Firstly, the area and length of a stretch of axon was measured, then 
the diameter was calculated by dividing area by length (Figure 12A). This was 
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measured for three different regions of each axon, and then the mean of these 
measurements was taken as the final axon diameter measurement. 
The mean RS axon diameter increased from 1.1 µm at 5 dpf to 1.2 µm at 7 
dpf, but showed no significant change thereafter, being 1.2 µm at 9 dpf 
(Repeated Measures ANOVA, p < 0.0001, Tukey’s Multiple Comparisons test, 
Figure 12B). CoPA axons showed no change in mean axon diameter during 
the period analysed, being 0.8 µm at 5 dpf, 0.8 µm at 7 dpf, and 0.8 µm at 9 
dpf (Repeated Measures ANOVA, p = 0.105, Figure 12F). This is concurrent 
with previous characterisation of axon diameter growth of these axon subtypes 
(Mensch, 2014).  
Next, the axon diameter was plotted against mean sheath length at each age 
to determine if the variability in mean sheath length can be explained by axon 
diameter. However, there was no significant correlation between axon 
diameter and mean sheath length at any age for both RS and CoPA axons 
(Figure 12C-E, G-I, Pearson’s correlation test; see Figure 12 legend for 
statistics). The variability in sheath length between axons is, thus, not due to 




Figure 12 - axon diameter of RS and CoPA axons over time. 
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A) Example images showing measurement of axon diameter over time. The area 
of a region of an axon was divided by the length to calculate diameter. B) 
Quantification of axon diameter of each RS axon at 5, 7, and 9 dpf. The mean axon 
diameter was 1.1 µm (SD = 0.2) at 5 dpf, 1.2 µm (SD = 0.2) at 7 dpf, and 1.2 µm 
(SD = 0.2) at 9 dpf. There was a statistically significant increase in axon diameter 
over time (Repeated Measures ANOVA, p < 0.0001; Tukey’s Multiple Comparison’s 
test: 5 dpf vs 7 dpf p = ***, 5 dpf vs 9 dpf p =***, 7 dpf vs 9 dpf p = ns). RS n = 13. 
C) Axon diameter plotted against mean sheath length for RS axons at 5 dpf. There 
was no statistically significant correlation between axon diameter and sheath length 
(Pearson’s correlation test, p = 0.917). D) Axon diameter plotted against mean 
sheath length for RS axons at 7 dpf. There was no statistically significant correlation 
between axon diameter and sheath length (Pearson’s correlation test, p = 0.689). 
E) Axon diameter plotted against mean sheath length for RS axons at 9 dpf. There 
was no statistically significant correlation between axon diameter and sheath length 
(Pearson’s correlation test, p = 0.544). F) Quantification of axon diameter of each 
CoPA axon at 5, 7, and 9 dpf. The mean axon diameter was 0.8 µm (SD = 0.08) at 
5 dpf, 0.8 µm (SD = 0.07) at 7 dpf, and 0.8 µm (SD = 0.08) at 9 dpf. There was no 
statistically significant change in axon diameter over time (Repeated Measures 
ANOVA, p = 0.105). CoPA n = 12. G) Axon diameter plotted against mean sheath 
length for CoPA axons at 5 dpf. There was no statistically significant correlation 
between axon diameter and sheath length (Pearson’s correlation test, p = 0.088). 
H) Axon diameter plotted against mean sheath length for CoPA axons at 7 dpf. 
There was no statistically significant correlation between axon diameter and sheath 
length (Pearson’s correlation test, p = 0.181). I) Axon diameter plotted against mean 
sheath length for CoPA axons at 9 dpf. There was no statistically significant 
correlation between axon diameter and sheath length (Pearson’s correlation test, p 
= 0.180). Scale bar = 5 µm. 
 
3.2.5. Unmyelinated Gap Length and Gap Length Variability over Time 
The next step in my investigation was to examine the length of unmyelinated 
gaps between sheaths along RS and CoPA axons between 5 and 9 dpf. These 
gaps included both long stretches of unmyelinated axon and the smaller gaps, 
which likely represent nodes of Ranvier. For seven RS axons (RS 1, 2, 5, 6, 9, 
11, and 14), not all unmyelinated gaps were included in this analysis as some 
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gaps could not be accurately measured at 9 dpf due to limitations in image 
resolution. Instead, only the gaps which could be accurately measured at all 
ages were analysed and plotted in Figure 13. 
The unmyelinated gap length decreased over time along both RS and CoPA 
axons. For RS axons, the median gap length was 2.3 µm at 5 dpf, 1.0 µm at 7 
dpf, and 1.0 at 9 dpf (Friedman test, p < 0.0001; Dunn’s Multiple Comparisons 
test, Figure 13A). For CoPA axons, the median gap length was 4.4 µm at 5 
dpf, 1.4 µm at 7 dpf, and 1.1 at 9 dpf (Friedman test, p < 0.0001; Dunn’s 
Multiple Comparisons test, Figure 13C). 
As with myelin sheath length, there was noteworthy variability in the length of 
unmyelinated gaps along RS and CoPA axons at 5 dpf (Figure 13E-F). 
Unmyelinated gap length variability was quantified as the standard deviation 
(SD) of unmyelinated gap length measurements for each axon at 5, 7, and 9 
dpf. Gap length variability significantly declines over time. For RS axons, the 
median gap length variability was 2.7 at 5 dpf, 0.3 at 7 dpf, and 0.2 at 9 dpf 
(Friedman test, p = 0.009; Dunn’s Multiple Comparisons test, Figure 13B). For 
CoPA axons, the median gap length variability was 5.0 at 5 dpf, 1.2 at 7 dpf, 
and 0.5 at 9 dpf (Friedman test, p < 0.0001; Dunn’s Multiple Comparisons test, 
Figure 13D). By 9 dpf, the majority of unmyelinated gaps were under 2 µm 
long and likely represented maturing nodes of Ranvier (Figure 13G-H). 
Therefore, the length of unmyelinated gaps between sheaths along both RS 
and CoPA axons becomes significantly less variable as they shorten into 
mature nodes of Ranvier with myelinated axon development. However, some 
axons still had large unmyelinated gaps at 9 dpf; for example, RS 11 was only 
70% myelinated and still had gaps up to 60 µm in length (Figure 13G). These 
axons may be sparsely myelinated, as have previously been described in the 
rodent cortex (Gao et al., 2019; Hill et al., 2018; Tomassy et al., 2014) and the 
zebrafish spinal cord (Auer et al., 2018). It is possible that these axons are 
simply myelinating at a slower rate than other axons; following these axons 
beyond 9 dpf may reveal that they eventually become fully myelinated with 




Figure 13 – unmyelinated gap lengths along RS and CoPA axons over time 





Figure 13 (continued). 
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A) The mean unmyelinated gap length of each RS axon at 5, 7, and 9 dpf. The 
overall median unmyelinated gap length was 2.3 µm (IQR = 1.3-5.9) at 5 dpf, 1.0 
µm (IQR = 1.0-1.1) at 7 dpf, and 1.0 (IQR = 0.9-1.1) at 9 dpf. There was a 
statistically significant reduction in unmyelinated gap length over time (Friedman 
test, p < 0.0001; Dunn’s Multiple Comparisons test: 5 dpf vs 7 dpf p = **, 5 dpf vs 9 
dpf p = ***, 7 dpf vs 9 dpf p = ns). RS n = 13. B) The mean unmyelinated gap length 
of each CoPA axon at 5, 7, and 9 dpf. The overall median unmyelinated gap length 
was 4.4 µm (IQR = 1.8-8.9) at 5 dpf, 1.4 µm (IQR = 1.0-3.9) at 7 dpf, and 1.1 µm 
(IQR = 0.9-2.8) at 9 dpf. There was a statistically significant reduction in 
unmyelinated gap length over time (Friedman test, p < 0.0001; Dunn’s Multiple 
Comparisons test: 5 dpf vs 7 dpf p = *, 5 dpf vs 9 dpf p = ***, 7 dpf vs 9 dpf p = ns). 
CoPA n = 12. C) Quantification of unmyelinated gap length variability along 
individual RS axons. Unmyelinated gap length variability was assessed as the 
standard deviation of unmyelinated gap lengths along each axon. The median 
unmyelinated gap length variability was 2.7 (IQR = 0.4-9.0) at 5 dpf, 0.3 (IQR = 0.2-
0.5) at 7 dpf, and 0.2 (IQR = 0.2-0.3) at 9 dpf. There was a statistically significant 
reduction in unmyelinated gap length variability over time (Friedman test, p = 0.009; 
Dunn’s Multiple Comparisons test: 5 dpf vs 7 dpf p = *, 5 dpf vs 9 dpf p = *, 7 dpf vs 
9 dpf p = ns). RS n = 13. D) Quantification of unmyelinated gap length variability 
along individual CoPA axons. The median unmyelinated gap length variability was 
4.9 (IQR = 2.1-13.8) at 5 dpf, 1.2 (IQR = 0.3-6.6) at 7 dpf, and 0.5 (IQR = 0.2-4.2) 
at 9 dpf. There was a statistically significant reduction in unmyelinated gap length 
variability over time (Friedman test, p < 0.0001; Dunn’s Multiple Comparisons test: 
5 dpf vs 7 dpf p = *, 5 dpf vs 9 dpf p = ***, 7 dpf vs 9 dpf p = ns). CoPA n = 12. E) 
The 5 dpf lengths of individual unmyelinated gaps along each RS axon analysed. 
Only the unmyelinated gaps which could be accurately measured at all time points 
are plotted. Each data point = a single unmyelinated gap between two sheaths. F) 
The 5 dpf lengths of individual unmyelinated gaps along each CoPA axon analysed. 
G) The 9 dpf lengths of individual unmyelinated gaps along each RS axon analysed. 







3.2.6. Comparison of the Myelin Patterns between RS and CoPA Axons 
I hypothesised that RS and CoPA axons would exhibit different myelination 
patterns. To test this, the various parameters described in sections ‘3.2.2’, 
‘3.2.3’, and ‘3.2.5’ were compared between the two axon subtypes. The 
comparisons (performed using Two-Way ANOVAs) are summarised in Table 
3. Overall, there were no differences in the myelin patterns between RS and 
CoPA axons. 
Table 3 – comparison of the myelin pattern parameters between RS and CoPA 
axons. 
Parameter tested Any significant differences between RS and CoPA?  
(Two-Way ANOVA p values) 
Myelin sheath 
number 
No significant differences  (p = 0.509) 
Sheath addition No significant differences (p  = 0.987) 
Sheath retraction No significant differences (p = 0.303) 
Myelin sheath length No significant differences (p = 0.619) 
Myelin sheath length 
variability 
No significant differences (p = 0.246) 
Unmyelinated gap 
length 
No significant differences (p = 0.896) 
Unmyelinated gap 
length variability 
No significant differences (p = 0.902) 
 
Based on these results, I concluded that, although RS and CoPA neurons use 
different signals to regulate their initial myelination, the myelin patterns 
established along their axons are very similar. 
3.2.7. Remodelling of Single Myelin Sheaths over Time 
After characterising the myelin patterns along RS and CoPA axons, I then 
investigated how individual myelin sheaths along these axons remodel during 
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the time period imaged. I have already characterised the retraction of individual 
sheaths along RS and CoPA axons (Figure 10). By following the same 
sheaths from 5 to 9 dpf, I was also able to assess how individual myelin 
sheaths change in length, either by growth or shrinkage (Figure 14A-B). 
 
Figure 14 – changes in sheath length along RS and CoPA axons over time 




Figure 14 (continued). 
A) An example of a single sheath growing in length 5-9 dpf. White arrows = 
unmyelinated adjacent to myelin sheath, blue text = length of myelin sheath at each 
age. B) An example of a single sheath shrinking in length 5-9 dpf. C) The change 
in length 5-7 dpf of individual sheaths along each RS axon analysed (each data 
point = a single myelin sheath). D) The change in length 7-9 dpf of individual 
sheaths along each RS axon analysed. E) The change in length 5-7 dpf of individual 
sheaths along each CoPA axon analysed. F) The change in length 7-9 dpf of 
individual sheaths along each CoPA axon analysed. Scale bars = 10 µm. 
 
For both RS and CoPA axons, individual axons had both growing and shrinking 
sheaths along their length (Figure 14C-F). However, the degree of change in 
sheath length seems to decline with time. Quantifying the total sheath growth 
per RS axon (normalised to length of axon analysed) showed that median 
sheath growth declines from 9.0 µm/100 µm axon 5-7 dpf, to 1.8 µm/100 µm 
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axon 7-9 dpf (Wilcoxon signed rank test, p = 0.0006, Figure 15A). Sheath 
shrinkage along RS axons does not significantly change (but trends towards a 
decrease over time), with mean shrinkage per axon being -3.0 µm/100 µm 
axon 5-7 dpf, and -2.1 µm/100 µm axon 7-9 dpf (paired t-test, p = 0.082, Figure 
15B). This means that the median overall change in sheath length per RS axon 
(summation of sheath growth and shrinkage values) is 7.0 µm/100 µm axon 5-
7 dpf, and significantly declines to -0.4 µm/100 µm axon 7-9 dpf (Wilcoxon 
signed rank test, p = 0.0004, Figure 15C). Similar changes occur along CoPA 
axons. Median sheath growth per CoPA axon declines over time from 8.0 
µm/100 µm axon 5-7 dpf to 2.8 µm/100 µm axon 7-9 dpf (Wilcoxon signed rank 
test, p = 0.0005, Figure 15D), while mean sheath shrinkage per axon remains 
unchanged from -1.2 µm/100 µm axon 5-7 dpf to -1.4 µm/100 µm axon 7-9 dpf 
(paired t-test, p = 0.457, Figure 15E). This means that the mean overall 
change in sheath length per CoPA axon reduces from 10.1 µm/100 µm axon 
5-7 dpf to 1.7 µm/100 µm axon 7-9 dpf (paired t-test, p = 0.0005, Figure 15F). 
I hypothesised that, given that RS and CoPA axons use different signals to 
regulate their myelination, the two axon subtypes would exhibit differences in 
the extent of myelin sheath remodelling that occurs. However, comparison of 
sheath growth, sheath shrinkage, and overall sheath length change between 
RS and CoPA axons by Two-Way ANOVAs showed few significant differences 




Figure 15 – total changes in sheath length along RS and CoPA axons over 
time. 
A) Quantification of the total sheath growth along RS axons 5-9 dpf, normalised to 
length of axon analysed. The median total sheath growth was 9.0 µm/100 µm axon 
(IQR = 6.6-14.8) 5-7 dpf, and 1.8 µm/100 µm axon (IQR = 1.2-2.2) 7-9 dpf. There 
was a statistically significant reduction in sheath growth over time (Wilcoxon signed 
rank test, p = 0.0006, n = 14). B) Quantification of the total sheath shrinkage along 
RS axons 5-9 dpf, normalised to length of axon analysed. The mean total sheath 
shrinkage was -3.0 µm/100 µm axon (SD = 1.7) 5-7 dpf, and -2.1 µm/100 µm axon 
(SD = 0.9) 7-9 dpf. There was no statistically significant change in sheath shrinkage 
over time (paired t-test, p = 0.082, n = 14). C) Quantification of the overall change 
in sheath length along RS axons from 5-9 dpf, normalised to length of axon 
analysed. The median overall change in sheath length was 7.0 µm/100 µm axon 
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(IQR = 3.2-10.7) 5-7 dpf, and -0.4 µm/100 µm axon (IQR = -1.2-0.2) 7-9 dpf. There 
was a statistically significant reduction in overall change in sheath length over time 
(Wilcoxon signed rank test, p = 0.0004, n = 14). D) Quantification of the total sheath 
growth along CoPA axons 5-9 dpf, normalised to length of axon analysed. The 
median total sheath growth was 8.0 µm/100 µm axon (IQR = 5.8-16.0) 5-7 dpf, and 
2.8 µm/100 µm axon (IQR = 1.3-4.2) 7-9 dpf. There was a statistically significant 
reduction in sheath growth over time (Wilcoxon signed rank test, p = 0.0005, n = 
12). E) Quantification of the total sheath shrinkage along CoPA axons 5-9 dpf, 
normalised to length of axon analysed. The mean total sheath shrinkage was -1.2 
µm/100 µm axon (SD = 0.8) 5-7 dpf, and -1.4 µm/100 µm axon (SD = 1.0) 7-9 dpf. 
There was no statistically significant change in sheath shrinkage over time (paired 
t-test, p = 0.457, n = 12). F) Quantification of the overall change in sheath length 
along CoPA axons from 5-9 dpf, normalised to length of axon analysed. The mean 
overall change in sheath length was 10.1 µm/100 µm axon (SD = 8.1) 5-7 dpf, and 
1.7 µm/100 µm axon (SD = 3.1) 7-9 dpf. There was a statistically significant 
reduction in overall change in sheath length over time (paired t-test, p = 0.0005, n 
= 12). 
 
Table 4 – comparison of the myelin remodelling parameters between RS and 
CoPA axons. 
Parameter tested Any significant differences between RS and CoPA?  
(Two-Way ANOVA p values) 
Sheath growth No significant differences  (p = 0.497) 
Sheath shrinkage Significant difference between subtypes (p = 0.003). 
Sidak’s Multiple Comparisons test identifies 
significant difference (p = ***) between RS 5-7 dpf 
and CoPA 5-7 dpf. 
Overall change in 
sheath length 
No significant differences (p = 0.303) 
 
Based on these results, I concluded that myelin sheath remodelling can occur 
in the form of growth and shrinkage, and that both RS and CoPA axons exhibit 
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remarkably similar degrees of sheath remodelling (with the exception of sheath 
shrinkage 5-7 dpf). Additionally, sheath growth remodelling significantly 
decreases on both RS and CoPA axons after 7 dpf, whereas sheath shrinkage 
does not significantly change over time. 
3.2.8. Correlation of Myelin Remodelling with Stage of Myelination 
The degree of myelin sheath growth significantly declines after 7 dpf on both 
RS and CoPA axons. This suggests that sheath growth is regulated by some 
factor which also changes over this time period. It is possible that such myelin 
remodelling only occurs at certain stages of myelination. To investigate this, I 
plotted the sheath remodelling values (growth and shrinkage) against the 
percentage of axon myelinated (as a read-out of stage of myelination – Figure 
16). There was an inverse correlation between sheath growth and percentage 
of axon myelinated both between 5 to 7 dpf and 7 to 9 dpf, and this was the 
case for both RS and CoPA axons (Spearman’s correlation tests, see Figure 
16 legend for statistics). However, there was no significant correlation between 
sheath shrinkage and percentage of axon myelinated at any stage on either 
RS or CoPA axons (Spearman’s correlation tests, see Figure 16 legend for 
statistics).  
Based on these results, I concluded that both RS and CoPA axons which are 
more myelinated will, in turn, exhibit less myelin sheath growth, suggesting 
that myelin sheath growth can only occur when there is empty space in which 
to grow. Additionally, myelin sheath growth and shrinkage may be 
independently regulated, as the sheath shrinkage observed at these stages is 




Figure 16 - correlations between changes in sheath length and myelin 
coverage along RS and CoPA axons. 
A) The RS axon 5-7 dpf sheath growth (green data points) and sheath shrinkage 
(magenta data points) measurements plotted against % of axon myelinated at 5 
dpf. There was a significant inverse correlation between sheath growth and % axon 
myelinated (Spearman’s correlation test, p = 0.0001, r = -0.851, n = 14). There was 
no statistically significant correlation between sheath shrinkage and % axon 
myelinated (Spearman’s correlation test, p = 0.982, n = 14). B) The RS axon 7-9 
dpf sheath growth and sheath shrinkage measurements plotted against % of axon 
myelinated at 7 dpf. There was a significant inverse correlation between sheath 
growth and % axon myelinated (Spearman’s correlation test, p = 0.019, r = -0.618, 
n = 14). There was no statistically significant correlation between sheath shrinkage 
and % axon myelinated (Spearman’s correlation test, p = 0.409, n = 14). C) The 
CoPA axon 5-7 dpf sheath growth and sheath shrinkage measurements plotted 
against % of axon myelinated at 5 dpf. There was a significant inverse correlation 
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between sheath growth and % axon myelinated (Spearman’s correlation test, p = 
0.006, r = -0.741, n = 12). There was no statistically significant correlation between 
sheath shrinkage and % axon myelinated (Spearman’s correlation test, p = 0.812, 
n = 12). D) The CoPA axon 7-9 dpf sheath growth and sheath shrinkage 
measurements plotted against % of axon myelinated at 7 dpf. There was a 
significant inverse correlation between sheath growth and % of axon myelinated 
(Spearman’s correlation test, p = 0.003, r = -0.783, n = 12). There was no 
statistically significant correlation between sheath shrinkage and % axon 
myelinated (Spearman’s correlation test, p = 0.265, n = 12). 
 
3.2.9. Correlation of Myelin Remodelling with Axon Growth 
Recent research has shown that individual myelin sheaths continue to grow 
after initial myelination at the rate of overall body growth (Auer et al., 2018). It 
is hypothesised that this is to ensure that the myelin coverage along axons in 
functioning circuits remains consistent as the animal, and in turn the axons, 
grow in size. For example, the RS axons involved in escape response 
behaviour are myelinated very early in development, but escape response 
behaviour must be maintained through to adulthood (when the animal has 
grown in size many-fold). If these myelin sheaths did not respond to growth in 
axon length then the relative myelin pattern along the axon would change. 
Altering the relative myelin pattern could adjust the conduction speed along 
the axon, which might affect circuit function and behaviour. 
To investigate how axon growth affects myelin remodelling along RS and 
CoPA axons, I plotted the overall change in myelin sheath length, myelin 
growth, and shrinkage values against change in axon length (Figure 17). To 
calculate the change in axon length over time, I measured the distance 
between the first and last collateral branch along the region of axon imaged. 
Assuming that the position of these branching collaterals on the axon is fixed, 
any change in the distance between these collaterals over time should reflect 
change in the length of this region of axon. For CoPA axons, change in axon 
length could only be calculated for seven out of the twelve cells; this was 
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because the branching location of collaterals could not be determined for five 
CoPA axons (CoPA 3, 4, 5, 9, and 11). 
The overall change in sheath length correlated with changes in axon length 
along RS axons both between 5 to 7 dpf and between 7 to 9 dpf (Figure 17A-
B, Pearson’s and Spearman’s correlation tests, see Figure 17 legend for 
statistics). When broken down into sheath growth and sheath shrinkage, 
sheath growth significantly correlated with change in axon length 5-7 dpf but 
not 7-9 dpf (Figure 17C-D, Pearson’s correlation tests, see Figure 17 legend 
for statistics), while sheath shrinkage did not correlate with change in axon 
length at either time point (Figure 17C-D, Pearson’s and Spearman’s 
correlation tests, see Figure 17 legend for statistics). The lack of correlation 
between sheath growth or shrinkage and change in axon length 7-9 dpf 
(Figure 17D) appeared to be contradictory to the correlation between overall 
change in sheath length and change in axon length (Figure 17B). However, 
the correlation between sheath shrinkage and change in axon length may be 
underpowered (p = 0.074, suggesting that it may approach significant with 
increased sample size).  
For CoPA axons, the overall change in sheath length did not correlate with 
change in axon length between 5-7 dpf, but did become significant between 7 
to 9 dpf (Figure 17E-F, Pearson’s correlation tests, see Figure 17 legend for 
statistics). When broken down into sheath growth and sheath shrinkage, 
sheath growth did not significantly correlate with change in axon length 5-7 
dpf, but did significantly correlate 7-9 dpf (Figure 17G-H, Pearson’s and 
Spearman’s correlation tests, see Figure 17 legend for statistics). However, 
the lack of correlation in both overall change in sheath length and sheath 
growth with change in axon length may be underpowered due to the reduced 
sample size, as there appeared to be a trend in both cases. Sheath shrinkage 
did not correlate with change in axon length at either time point (Figure 17G-




Based on these results, I concluded that sheath growth can correlate with 
change in axon length for both RS and CoPA axons, but that sheath 
shrinkage does not correlate with change in axon length. This provides 
further evidence that sheath growth and sheath shrinkage are independently 
regulated types of myelin sheath remodelling. 
 
 
Figure 17 – correlations between changes in sheath length and changes in 




Figure 17 (continued). 
A) The total change in sheath length along RS axons 5-7 dpf plotted against the 
total change in axon length 5-7 dpf. There was a statistically significant correlation 
between the two measurements (Pearson’s correlation test, p = 0.012, r = 0.673, n 
= 14). B) The total change in sheath length along RS axons 7-9 dpf plotted against 
the total change in axon length 7-9 dpf. There was a statistically significant 
correlation between the two measurements (Spearman’s correlation test, p = 0.042, 
r = 0.594, n = 14). C) The sheath growth and shrinkage along RS axons 5-7 dpf 
plotted against the total change in axon length 5-7 dpf. There was a statistically 
significant correlation between sheath growth and change in axon length 
(Pearson’s correlation test, p = 0.031, r = 0.598, n = 14); there was no significant 
correlation between sheath shrinkage and change in axon length (Pearson’s 
correlation test, p = 0.497, n = 14). D) The sheath growth and shrinkage along RS 
axons 7-9 dpf plotted against the total change in axon length 7-9 dpf. There was no 
significant correlation between sheath growth and change in axon length 
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(Spearman’s correlation test, p = 0.697, n = 14); there was no significant correlation 
between sheath shrinkage and change in axon length (Pearson’s correlation test, 
p = 0.074, n = 14). E)  The total change in sheath length along CoPA axons 5-7 dpf 
plotted against the total change in axon length 5-7 dpf. There was no significant 
correlation between the two measurements (Pearson’s correlation test, p = 0.202, 
n = 12). F) The total change in sheath length along CoPA axons 7-9 dpf plotted 
against the total change in axon length 7-9 dpf. There was a statistically significant 
correlation between the two measurements (Pearson’s correlation test, p = 0.026, 
r = 0.815, n = 12). G) The sheath growth and shrinkage along CoPA axons 5-7 dpf 
plotted against the total change in axon length 5-7 dpf. There was no significant 
correlation between sheath growth and change in axon length (Spearman’s 
correlation test, p = 0.139, n = 12); there was no significant correlation between 
sheath shrinkage and change in axon length (Pearson’s correlation test, p = 0.318, 
n = 12). H) The sheath growth and shrinkage along CoPA axons 7-9 dpf plotted 
against the total change in axon length 7-9 dpf. There was a statistically significant 
correlation between sheath growth and change in axon length (Pearson’s 
correlation test, p = 0.040, r = 0.776, n = 12); there was no significant correlation 
between sheath shrinkage and change in axon length (Spearman’s correlation test, 
p = 0.383, n = 12). 
 
3.2.10. Remodelling of Nodal Gaps over Time 
The length of nodes of Ranvier is another parameter which can be adjusted to 
modify conduction properties of an axon. In the rodent cortex, nodes identified 
by Na+ channel and Caspr expression can vary in length by almost nine-fold, 
and computational modelling indicates that subtle changes to node length 
could have a significant impact on conduction speeds (Arancibia-Cárcamo et 
al., 2017). Changing node length could either adjust the density of Na+ 
channels, or allow for increased number of Na+ channels per node. However, 
whether node length changes over time remains unknown. 
Node length may be controlled by the length of the flanking myelin sheaths. 
Myelin sheaths along both RS and CoPA axons show limited changes in length 
after 7 dpf; however, even subtle changes in sheath length could have 
profound effects on node length. Hence, it is possible that node lengths also 
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change over time, and that these changes continue after the predominance of 
sheath length remodelling has ceased. 
The reporter RFP-Cntn1a does not specifically label mature nodes, but rather 
all of the unmyelinated gaps between sheaths. Thus, it is not possible to 
definitively analyse mature node lengths in this data set. However, the long 
unmyelinated gaps, which presumably do not reflect nodes of Ranvier, can be 
eliminated from the data set by analysing only the short unmyelinated gaps 
(Cntn1a-labelled gaps which were < 5 µm in length). These gaps were termed 
‘nodal gaps’ (Figure 18A). 
To determine if nodal gaps are adjusted along RS and CoPA axons, the mean 
change in nodal gap length was calculated per axon 5-7 dpf and 7-9 dpf. Only 
axons where all of the nodal gaps along the axon could be accurately 
measured were included in the analysis. For RS axons the overall mean 
change in nodal gap length was -0.39 µm 5-7 dpf, which significantly declined 
to -0.09 µm 7-9 dpf (paired t-test, p = 0.003, Figure 18B). For CoPA axons, 
the overall mean change in nodal gap length was -0.43 µm 5-7 dpf, and also 
significantly declined to -0.11 µm 7-9 dpf (paired t-test, p = 0.037, Figure 18C). 
Therefore, nodal gaps reduce in length during myelin pattern establishment, 
but the degree of node refinement significantly declines after 7 dpf along both 




Figure 18 – changes in nodal gap length along RS and CoPA axons. 
A) Images of a single nodal gap between two sheaths at 5 dpf, 7 dpf, and 9 dpf. 
White dotted line = the length of the nodal gap. Nodal gaps were defined as 
unmyelinated gaps < 5 µm in length. B) The mean change in nodal gap length per 
RS axon over time. Only axons where all nodal gaps along the axon could be 
confidently measured were included in the analysis. The overall mean change in 
nodal gap length was -0.39 µm (SD = 0.18) 5-7 dpf, and -0.09 µm (SD = 0.12) 7-9 
dpf. There was a statistically significant change in mean change in nodal gap length 
over time (paired t-test, p = 0.003, n = 7). C) The mean change in nodal gap length 
per CoPA axon over time. The overall mean change in nodal gap length was -0.43 
µm (SD = 0.42) 5-7 dpf, and -0.11 µm (SD = 0.19) 7-9 dpf. There was a statistically 
significant change in mean nodal gap length over time (paired t-test, p = 0.037, n = 
12). Scale bar = 1 µm. 
 
Although both RS and CoPA axons showed similar extents of myelin sheath 
remodelling, it is possible that they differ in the extent of refinement of nodes 
of Ranvier. To investigate this, the change in nodal gap length was compared 
between RS and CoPA axons by Two-Way ANOVA. There was no significant 
difference between the two cell types (Two-Way ANOVA, p = 0.710).  
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Based on these results, I concluded that nodal gap length refinement declines 
significantly after 7 dpf along both RS and CoPA axons, and that these two 
axon subtypes showed no differences in the extent of nodal gap refinement 
that occurs. 
3.2.11. Time-Course Measurement of Sheath Thickness by Electron 
Microscopy 
By live imaging myelinated RS and CoPA axons, I was able to assess the 
number and length of myelin sheaths along the axon. Sheath thickness is 
another important parameter which contributes to myelin patterns, and which 
could be remodelled over time. The current gold-standard method of 
measuring sheath thickness is by imaging cross-sections of myelinated axons 
via transmission electron microscopy, which provides nanometre scale 
resolution. Such resolution is required to detect differences in sheath 
thickness, which may only be a few layers of lipid membrane thick. The extent 
and timing of sheath thickness remodelling can be inferred performing by 
electron microscopy analysis at various ages. 
Electron microscopy was used to investigate how myelin sheath thickness 
changes during the same time period in which live imaging of myelinated axon 
development was performed (5-9 dpf). Dr. Jenea Bin performed the chemical 
fixation, dehydration, and embedding of 5, 7, and 9 dpf larval zebrafish, and 
then both myself and Dr. Bin performed sectioning, staining, and imaging of 
these prepared samples. When sectioning the embedded larvae, a distinct 
point of the spinal cord was selected to ensure that samples were comparable 
– this was the middle region of the trunk, where the ventral fins are divided by 
the cloaca (Figure 19A). In a cross section of the zebrafish spinal cord (Figure 
19A), the axonal tracts are located on the lateral sides with the cell bodies of 
neurons located in the centre. There are two tracts of large-diameter axons 
which are myelinated in each hemispinal cord. These are: the ventral tract, 
where the predominance of myelinated axons will be of reticulospinal neurons, 
including the very large-diameter Mauthner axon (Figure 19C); and the dorsal 
tract, which includes the dorsal portion of axons from CoPA cells originating 
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caudal to the site of sectioning (Figure 19B). The dorsal and ventral tracts are 
separated by much smaller-diameter axons and processes, the majority of 
which are not myelinated. The occasional myelinated axon can be found in 
between the dorsal and ventral tracts, which likely represents myelinated 




Figure 19 – assessing myelin sheath thickness in the zebrafish spinal cord 
over time by transmission electron microscopy. 
A) A schematic highlighting the location of sections cut for transmission electron 
microscopy. Transverse sections were cut at the cloaca (approximately somite 15 
– red line). Inset: a schematic of a transverse section of the larval zebrafish spinal 
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cord, with labels colour coded to match pseudo-colouring of features in images 
below. B) Example images of the dorsal spinal cord at 5 dpf, 7 dpf and 9 dpf; 
myelinated axons are highlighted in yellow, unmyelinated large diameter axons are 
highlighted in blue. C) Example images of the ventral spinal cord at 5 dpf, 7 dpf and 
9 dpf. The largest axon (Mauthner) is highlighted in purple. Scale bars = 1 µm. 
 
3.2.12. Sheath Thickness Change in the Dorsal and Ventral Tracts 
The number and g-ratios of all myelinated axons in the dorsal or ventral tract 
were measured at 5, 7, and 9 dpf. The mean number of myelinated axons in 
the dorsal tract did not significantly change between different ages, being 13.7 
at 5 dpf, 19.8 at 7 dpf, and 17.2 at 9 dpf (One-Way ANOVA, p = 0.110, Figure 
20A). However, it did significantly increase between 5-7 dpf in the ventral tract, 
being 16.0 at 5 dpf, 26.8 at 7 dpf, and 26.6 at 9 dpf (One-Way ANOVA, p = 
0.009, Tukey’s Multiple Comparisons test, Figure 20B).  
The g-ratio of a myelinated axon is the axon diameter divided by the myelin 
sheath diameter. However, the quality of larval zebrafish spinal cord tissue 
preservation is not as high as it is for standard rodent electron microscopy; 
axons in the zebrafish spinal cord rarely retain a circular shape which makes 
it difficult to decide which diameter to measure. Instead, the area of the axon 
and the area of the axon plus myelin sheath were measured and the diameters 
calculated assuming the axons should have a circular shape (where area = 
π.r2). Using these calculations, the g-ratios of all myelinated axons in the dorsal 
and ventral spinal cord were plotted against axon diameter (Figure 20C-D). It 
has already been well-established that myelin sheath thickness correlates with 
the diameter of the axon (Hildebrand and Hahn, 1978). In accordance with this, 
there was a highly-significant correlation between axon diameter and g-ratio at 
all ages for both dorsal and ventral tract myelinated axons (Figure 20C-D, 
Pearson’s correlation tests, see Figure 20 legend for statistics). 
To assess how sheath thickness changes over time, the same population of 
axons needs to be analysed at each age; for example, if sheaths on axons 
myelinated before 5 dpf increase in thickness between 5-7 dpf, but there are 
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also thin sheaths formed on previously unmyelinated axons between 5-7 dpf, 
then the average change in g-ratio of all myelinated axons will be negligible. 
Thus, to compare g-ratios between the different ages, only the g-ratios of the 
ten largest-diameter axons (excluding Mauthner) in each animal were 
selected, to ensure that the same population of axons was analysed at each 
age. The mean dorsal tract g-ratio per animal did not change between different 
ages, being 0.81 at 5 dpf, 0.82 at 7 dpf, and 0.82 at 9 dpf (One-Way ANOVA, 
p = 0.705, Figure 20E). The mean ventral tract g-ratio per animal also did not 
significantly change between different ages, being 0.82 at 5 dpf, 0.85 at 7 dpf, 
and 0.83 at 9 dpf (One-Way ANOVA, p = 0.121, Figure 20F). 
It is possible for a change in sheath thickness over time to be undetected by 
g-ratio analysis if the axon diameter also increased over time. To address this, 
the diameters of the ten largest-diameter axons in the dorsal and ventral tracts 
were analysed 5-9 dpf. However, there was no significant difference in the 
overall mean axon diameter between different ages in the dorsal tract, being 
636.0 nm at 5 dpf, 691.4 nm at 7 dpf, and 650.5 nm at 9 dpf (One-Way ANOVA, 
p = 0.626, Figure 20G); nor in the ventral tract, being 702.7 nm at 5 dpf, 868.1 
nm at 7 dpf, and 817.2 nm at 9 dpf (One-Way ANOVA, p = 0.138, Figure 20H). 
There may be small but significant changes in sheath thickness over the time 
period analysed, but this data set is too underpowered to detect them. For 
example, a power calculation shows that the comparison of g-ratio of ventral 
myelinated axons at 5 and 7 dpf (Figure 20F) has only 30% power with five 
samples per group. A sample size of 16 per group would be required to reach 
80% power.  
Based on this data, I concluded that there were no large changes in sheath 
thickness 5-9 dpf in the zebrafish spinal cord. However, it is not possible to 
conclude whether or not myelin sheaths exhibit smaller changes in sheath 








A) The number of myelinated axons in a dorsal hemispinal cord at 5 dpf, 7 dpf, and 
9 dpf. The mean number of myelinated axons was 13.7 (SD = 2.7) at 5 dpf, 19.8 
(SD = 6.9) at 7 dpf, and 17.2 (SD = 2.8) at 9 dpf. There was no statistically significant 
change in the number of myelinated axons with age (One-way ANOVA, p = 0.110, 
5 dpf n = 6, 7 dpf n = 4, 9 dpf n = 5).  B) The number of myelinated axons (excluding 
Mauthner) in a ventral hemispinal cord at 5 dpf, 7 dpf, and 9 dpf. The mean number 
of myelinated axons was 16.0 (SD = 1.6) at 5 dpf, 26.8 (SD = 5.9) at 7 dpf, and 26.6 
(SD = 6.5) at 9 dpf. There was a statistically significant increase in the number of 
myelinated axons with age (One-way ANOVA, p = 0.009; Tukey’s Multiple 
Comparisons test: 5 dpf vs 7 dpf p = *, 5 dpf vs 9 dpf p = *, 7 dpf vs 9 dpf p = ns. 5 
dpf n = 5, 7 dpf n = 5, 9 dpf n = 5). C) The g-ratios of all dorsal myelinated axons 
plotted against axon diameter. There was a statistically significant correlation 
between g-ratio and axon diameter at all ages (Pearson’s correlation test; 5 dpf p < 
0.0001, r = 0.681, n = 82 axons; 7 dpf p < 0.0001, r = 0.552, n = 79 axons; 9 dpf p 
< 0.0001, r = 0.418, n = 86 axons). D) The g-ratios of all ventral myelinated axons 
plotted against axon diameter. There was a statistically significant correlation 
between g-ratio and axon diameter at all ages (Pearson’s correlation test; 5 dpf p = 
0.006, r = 0.303, n = 80 axons; 7 dpf p < 0.0001, r = 0.576, n = 132 axons; 9 dpf p 
< 0.0001, r = 0.409, n = 128 axons). E) The mean g-ratio of the 10 largest dorsal 
myelinated axons per animal at 5 dpf, 7 dpf, and 9 dpf. The overall mean g-ratio 
was 0.81 (SD = 0.02) at 5 dpf, 0.82 (SD = 0.03) at 7 dpf, and 0.82 (SD = 0.02) at 9 
dpf. There was no statistically significant change in g-ratio with age (One-way 
ANOVA, p = 0.705, 5 dpf n = 5, 7 dpf n = 5, 9d pf n = 5). F) The mean g-ratio of the 
10 largest ventral myelinated axons per animal at 5 dpf, 7 dpf, and 9 dpf. The overall 
mean g-ratio was 0.82 (SD = 0.03) at 5 dpf, 0.85 (SD = 0.02) at 7 dpf, and 0.83 (SD 
= 0.03) at 9 dpf. There was no statistically significant change in g-ratio with age 
(One-way ANOVA, p = 0.121, 5 dpf n = 5, 7 dpf n = 5, 9 dpf n = 5). G) The mean 
diameter of the 10 largest dorsal myelinated axons per animal at 5 dpf, 7 dpf, and 
9 dpf. The overall mean myelinated axon diameter was 636.0 nm (SD = 91.8) at 5 
dpf, 691.4 nm (SD = 88.2) at 7 dpf, and 650.5 nm (SD = 83.2) at 9 dpf. There was 
no statistically significant change in myelinated axon diameter with age (One-way 
ANOVA, p = 0.626, 5 pf n = 5, 7 dpf n = 5, 9 dpf n = 5). H) The mean diameter of 
the 10 largest ventral myelinated axons per animal at 5 dpf, 7 dpf, and 9 dpf. The 
overall mean myelinated axon diameter was 702.7 nm (SD = 125.4) at 5 dpf, 868.1 
nm (SD = 144.8) at 7 dpf, and 817.2 nm (SD = 95.7) at 9 dpf. There was no 
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statistically significant change in myelinated axon diameter with age (One-way 
ANOVA, p = 0.138, 5 dpf n = 5, 7 dpf n = 5, 9 dpf n = 5). 
 
3.2.13. Improving the Quality of Zebrafish Electron Microscopy Using 
High-Pressure Freezing Techniques 
As discussed in section ‘3.2.11 Time-Course Measurement of Sheath 
Thickness by Electron Microscopy’, the quality of zebrafish larval tissue fixed 
using conventional chemical fixation techniques is generally much poorer than 
typically seen in rodent tissue. The shapes of axon and myelin sheath cross 
sections are often distorted, making any measurement of axon diameters and 
g-ratios challenging to perform. One method in which sheath thickness could 
be measured would be to count the number of myelin wraps contained within 
a sheath. However, the quality of chemically fixed larval zebrafish spinal cord 
tissue is rarely good enough to distinguish the individual wraps in myelin 
sheaths. There is a need to improve the quality of zebrafish electron 
microscopy to facilitate more accurate and reliable quantification of myelin 
sheath ultrastructure. 
High-pressure freezing fixation has been described to vastly improve the 
quality of tissue ultrastructural preservation, in both rodents and zebrafish, for 
electron microscopy (Möbius et al., 2016, 2010). This technique relies on the 
extremely rapid freezing of tissue to liquid nitrogen temperature under high 
pressure, followed by osmium fixation and dehydration whilst frozen, before 
warming up to room temperature for embedding and sectioning as per normal 
electron microscopy protocols (Möbius et al., 2010). I decided to test whether 
high-pressure freezing could improve the quality of zebrafish larvae spinal cord 
tissue preservation to allow for more accurate quantification of myelin sheath 
thickness. 
In collaboration with Dr. Joanna Brown, I performed preliminary tests of a high-
pressure freezing protocol using 5 dpf zebrafish larvae. The successfully 
processed larvae were imaged using the same transmission electron 
microscope, and are shown in comparison to equivalent chemically-fixed larva 
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tissue in Figure 21. The shapes of axonal structures were vastly different using 
high-pressure freezing, appearing to retain a more circular shape. Additionally, 
the contrast and clarity of membranes was significantly improved using high-
pressure freezing. For example, a high magnification image of the Mauthner 
axon showed that individual wraps of membrane could be seen in tissue 
preserved using high-pressure freezing (Figure 21E-F).  
There were, nevertheless, some drawbacks to this method. The throughput of 
the tissue processing protocol was low (possibly due to the complexity of the 
preparation and lack of expertise in this new technique); therefore, insufficient 
sample numbers were acquired to perform any formal quantification. 
Additionally, the tissue preservation quality was not perfect – freeze damage 
was observed in several samples, and even the best preserved samples had 
signs of tissue damage (Figure 21D). Furthermore, the preservation of some 
cellular structures was not improved. Some membranes had poorer fixation 
than others, while the distinctive ‘dotted’ microtubule structure within axons 
was often poorly preserved with high-pressure freezing (Figure 21F). 
The quality of zebrafish spinal cord tissue preservation for electron microscopy 
can thus be significantly improved by fixation using high-pressure freezing. 
Yet, this technique requires greater optimisation to further increase the quality 




Figure 21 – high-pressure freezing can improve the preservation quality of 
zebrafish spinal cord tissue for transmission electron microscopy. 
A, C and E) Transmission electron micrographs of various regions of the zebrafish 
spinal cord obtained using conventional chemical fixation techniques. B, D and F) 
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Transmission electron micrographs of the zebrafish spinal cord obtained using high-
pressure freezing techniques. Scale bars in A-D = 1 µm; scale bars in E-F = 200 nm. 
 
3.2.14. Conclusion 
Here, I have characterised the myelin patterns of two distinct subtypes of 
myelinated axon in the zebrafish spinal cord. I have found that, for both RS 
and CoPA axons, the majority of parameters affecting myelin patterns (such 
as sheath number, sheath length, and nodal gap length) are established within 
a critical period after the onset of myelination, after which they showed no 
significant change. Individual myelin sheaths can undergo remodelling (either 
by growing or shrinking longitudinally, or even being completely retracted from 
the axon), but the predominance of this remodelling occurs by 7 dpf.  Despite 
using distinct signals to regulate their initial myelination, RS and CoPA axons 
show remarkable similarities in both the myelin patterns established and the 
degree of myelin remodelling which occurs within this critical developmental 
period. 
3.3. Discussion 
3.3.1. Myelin Patterns are Established within a Defined Developmental 
Window 
Changing myelin sheath parameters such as number, length, and thickness is 
predicted to adjust conduction speeds within circuits (Waxman, 1980). 
Establishing a specific myelin pattern may be crucial for circuit function. How 
and when such myelination patterns are established are important questions 
concerning the emergence of circuit function. Here, I have found that the 
myelin patterns along individual axons in the zebrafish spinal cord are 
established within a defined time window after the onset of myelination. Both 
RS and CoPA axons begin to be myelinated at approximately 3 dpf (Koudelka 
et al., 2016; Mensch, 2014); the majority of their myelin sheaths are formed by 
5 dpf, and there is some adjustment to sheath number and length by 7 dpf. 
However, after 7 dpf the sheath number, length, and length variability exhibit 
very little change. These results confirm previously reported findings that 
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myelin sheaths become stable several days after initial formation (Auer et al., 
2018), and indicate that such stability is consistently established along different 
axonal subtypes.  
Why do these myelin patterns stabilise during this time period? One possibility 
is that stability reflects establishment of behaviours regulated by the circuits 
being myelinated. For example, hunting behaviour emerges in larval zebrafish 
at approximately 4-5 dpf (Muto and Kawakami, 2013), and the prey capture 
response continues to develop over the following 2-3 days (Budick and 
O’Malley, 2000). This behaviour is regulated by the MeLr and MeLc RS 
neurons (Gahtan et al., 2005). It is possible that adjustments to the myelin 
patterns (and, therefore, conduction properties) along these particular axons 
occur 5-7 dpf in response to experience as the larvae learns how to hunt. 
These patterns may subsequently become stable once an optimal hunting 
strategy has been learned. Alternatively, sheaths may stabilise regardless of 
experience or learning. Whether the myelin patterns along RS and CoPA 
axons can be altered by experience after 7 dpf is not clear. It would be 
fascinating to see whether inducing locomotor behaviours (using visual stimuli 
such as the optomotor response, or increasing exposure to paramecia prey) 
or increasing sensory stimulation (such as repeated tactile stimuli) could 
change the myelin patterns along RS and CoPA axons after 7 dpf. However, 
live imaging of sheaths in the adult rodent somatosensory cortex demonstrated 
that myelin sheaths remain highly stable even with increased sensory 
stimulation (Hughes et al., 2018), suggesting that experience does not 
significantly alter myelin patterns after their formation. 
How do myelin patterns change later in life with continued growth? I have 
shown that the overall change in sheath length along RS (5-9 dpf) and CoPA 
(7-9 dpf) axons significantly correlates with change in axon length. Similarly, 
Auer et al., 2018 demonstrated that stable myelin sheaths continue to grow at 
the rate of overall body growth for at least three weeks after initial sheath 
formation. This suggests that the myelin patterns established along axons are 
simply scaled up with body growth. Given that an organism can increase in 
size by several-fold throughout development, do myelin sheaths continue to 
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grow indefinitely with body size? Or is there a threshold after which new myelin 
sheaths must be added to maintain constant myelin coverage? Imaging 
individual RS and CoPA axons first at 7 dpf, and then at 1-2 months post-
fertilisation, could assess if and how myelin patterns change with significant 
body growth. However, as zebrafish develop they become progressively less 
transparent, which makes live imaging at subcellular resolution technically 
challenging. Pigment mutants, such as the nacre line, can increase optical 
transparency, and imaging techniques such as two-photon or three-photon 
microscopy (which allows for imaging of deeper tissues) could be used to 
address these questions. 
3.3.2. Individual Myelin Sheaths can be Retracted or Remodelled 
I found that, once formed, myelin sheaths along RS and CoPA axons can 
either be fully retracted or can be remodelled by growing or shrinking in length.  
Sheath Retractions 
Virtually all of the sheaths which retracted were under 10 µm in length (only 
one retracted sheath was longer than 10 µm; this sheath was 10.6 µm in 
length). These results are concurrent with previous observations in the 
zebrafish spinal cord that retracted sheaths never exceed 10 µm in length 
(Hines et al., 2015). Between 5 to 7 dpf, sheath length can somewhat predict 
a sheath’s fate – 75% of sheaths under 5 µm in length were retracted, while 
only 20% of sheaths 5-10 µm in length were retracted, and just one sheath 
(5.3%) 10-15 µm in length was retracted during the time period analysed. Only 
two sheaths were retracted after 7 dpf, and both were also under 10 µm in 
length. These findings suggest that short sheaths are unstable, that sheaths 
become progressively more stable with longitudinal growth, and are fully 
stabilised once over 10µm. 
What triggers sheath retraction? Bare, unmyelinated axon was never observed 
after sheath retraction, as the neighbouring sheaths always grew to fill the gap 
left behind. It is not clear whether sheath retraction occurs before growth of the 
neighbour sheaths, or whether sheath retraction and neighbouring sheath 
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growth occur simultaneously. One possibility is that the growth of neighbouring 
sheaths puts physical pressure on short unstable sheaths to trigger their 
retraction. Timelapse analysis of sheath dynamics along individual axons 
could determine whether retraction and neighbouring growth occur in 
sequence or in parallel. 
Alternatively, a signal from the axon itself may initiate sheath retraction. Ca2+ 
imaging in oligodendrocytes has shown that distinct Ca2+ events occur in 
individual myelin sheaths during early growth, and that some of these events 
are triggered by neuronal activity (Baraban et al., 2018; Krasnow et al., 2018). 
Interestingly, long-duration high-amplitude Ca2+ events seem to predict sheath 
retraction (Baraban et al., 2018). These sheath retractions are mediated by the 
Ca2+-dependent protease calpain. This suggests that certain patterns of Ca2+ 
signalling in myelin sheaths can trigger retractions. However, it is not clear if 
these long-duration high-amplitude Ca2+ events occur in response to neuronal 
activity. Further investigation of sheath retractions along individual axons 
where activity has been manipulated could elucidate whether activity plays a 
role in initiating sheath retractions. This will be investigated in Chapter 4. 
Sheath Growth and Shrinkage 
Individual myelin sheaths along RS and CoPA axons can either grow or shrink 
in length between 5 to 9 dpf. Sheath growth primarily occurs by 7 dpf, after 
which the extent of growth significantly declines. This is likely because sheath 
growth inversely correlates with the amount of myelin along the axon, and by 
7 dpf both RS and CoPA axons are well myelinated. However, sheath growth 
may not be limited to unmyelinated axonal space; sheaths can grow to fill the 
space left by shrinking or retracted sheaths. Again, it is not clear whether a 
sheath grows simultaneously or after its neighbouring sheath shrinks or 
retracts; timelapse analyses are required to address this question.  
There is still some sheath growth after 7 dpf, and sheath growth along CoPA 
axons correlates with change in axon length 7-9 dpf. Again, these findings 
match the results of Auer et al., 2018, who found that individual sheaths can 
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grow very rapidly for the first few days after initial formation, and then growth 
declines to a baseline matching that of overall body growth. 
What regulates sheath growth? Neuronal activity is one candidate – the rate 
of Ca2+ transients in myelin sheaths correlates with sheath growth, and global 
changes in neuronal activity in the zebrafish spinal cord induces a 
corresponding change in both the rate of Ca2+ transients and in sheath growth 
(Baraban et al., 2018; Krasnow et al., 2018). Whether the activity of an 
underlying axon directly promotes the growth of its myelin sheaths will be 
investigated in Chapter 4. However, there are likely to be other signals which 
also regulate sheath growth. For example, sheath growth may be intrinsically 
programmed into oligodendrocytes – cortically-derived oligodendrocytes 
generate shorter myelin sheaths than spinal cord-derived oligodendrocytes in 
an in vitro microfibre myelination system, reflective of the sheath lengths 
generated in vivo (Bechler et al., 2015). This suggests that the growth of 
cortical myelin sheaths is limited compared to spinal cord sheaths. 
Oligodendrocytes may have intrinsically programmed myelinating capacities 
which can also influence sheath growth. The number of myelin sheaths made 
per oligodendrocyte is largely set within the first few hours after differentiation 
(Czopka et al., 2013). Oligodendrocytes which form a large number of sheaths 
during this period may be limited in how much these sheaths can grow; while 
oligodendrocytes which only form a few myelin sheaths may promote their 
growth more to produce longer sheaths.  
Sheath shrinkage appears to be regulated independently from sheath growth. 
The extent of sheath shrinkage along RS or CoPA axons does not significantly 
change between 5 to 9 dpf, and sheath shrinkage does not correlate with the 
available unmyelinated axonal space nor with change in axon length. It is not 
clear what regulates sheath shrinkage. One possibility is that a sheath shrinks 
when it is overcome by the growth forces of its neighbouring sheaths. 
However, if this was the case then the degree of sheath shrinkage would 
decline with sheath growth after 7 dpf. Another possibility is that 
oligodendrocytes have a finite myelinating capacity, and so shrinkage of a 
sheath occurs when the oligodendrocyte needs to focus its resources on 
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growing other sheaths. For instance, if an oligodendrocyte myelinates some 
axons which strongly promote sheath growth, then its other sheaths may 
shrink as a result. It is not clear whether oligodendrocytes do, indeed, have a 
finite myelinating capacity. Increasing the axonal surface area causes 
oligodendrocytes to produce more myelin sheaths than normal, which 
suggests that an oligodendrocyte’s myelinating capacity is flexible (Almeida et 
al., 2011). The activity of the underlying axon may also regulate sheath 
shrinkage. As previously discussed, activity can influence the rate of Ca2+ 
transients in myelin sheaths which, in turn, correlates with sheath elongation 
(Baraban et al., 2018; Krasnow et al., 2018). Sheaths with Ca2+ transient rates 
below approximately 2/hour typically shrank in length; neuronal activity (or lack 
thereof) may induce such Ca2+ transient rates to regulate sheath shrinkage. 
Whether neuronal activity affects sheath shrinkage will be investigated in more 
detail in Chapter 4. 
3.3.3. Axon Diameter and Nodal Gaps 
Axonal parameters such as axon diameter and length of nodes of Ranvier can 
influence the conduction speed of an axon, and so changes in these 
parameters will also likely play an important role in regulating circuit function. 
I found that the diameter of RS axons increases 5-7 dpf, but remained stable 
thereafter, whereas CoPA axons do not change in diameter 5-9 dpf. These 
measurements were in accordance with previous data characterising axon 
diameters during larval development (Mensch, 2014).  
It was not possible to measure the length of definitive nodes of Ranvier in this 
data set, as the axonal marker RFP-Cntn1a does not distinguish between 
nodes and larger stretches of unmyelinated axon. However, the majority of 
these gaps shrank to under 2 µm in length by 9 dpf, suggesting that proper 
nodes form by this time point. Mathematical modelling has suggested that 
small changes in node length could profoundly affect conduction velocities 
(Arancibia-Cárcamo et al., 2017). ‘Nodal gaps’ (gaps between sheaths which 
were shorter than 5 µm in length) reduce in length 5-9 dpf, but the degree of 
nodal gap length change significantly declines after 7 dpf. This indicates that, 
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like myelin sheaths, nodes are refined within a defined time period after the 
onset of myelination. In order to properly characterise the remodelling of 
mature nodes of Ranvier, fluorescent reporters such as FP-Caspr and FP-
NF186 could be used to label the paranodes and nodes proper along individual 
axons. 
3.3.4. RS and CoPA Axons Show Remarkably Similar Myelin Patterns and 
Degrees of Myelin Remodelling 
RS and CoPA axons belong to locomotor and sensory circuits respectively, 
and research has shown that only RS axons use synaptic vesicle release to 
regulate their myelination (Koudelka et al., 2016). If myelin patterns are 
established based on circuit function, then axons from different circuits should 
establish their own myelin patterns. Additionally, if myelin can be remodelled 
by experience, then axons which use neuronal activity to mediate their 
myelination may exhibit more myelin remodelling than axons which do not. I 
hypothesised that RS and CoPA axons would establish different myelin 
patterns, and that RS axons would exhibit a greater degree of myelin sheath 
remodelling than CoPA axons. However, comparison of myelin patterns 
(sheath number, length, length variability, unmyelinated gap length, and length 
variability) and myelin remodelling (sheath retraction, sheath growth, and 
sheath shrinkage) showed that there were virtually no significant differences 
between RS and CoPA axons. The only identifiable difference was in sheath 
shrinkage between 5-7 dpf.  
Myelin Patterns 
Why do RS axons not exhibit different myelin patterns compared to CoPA 
axons? There are many different subtypes of RS neurons in the zebrafish mid- 
and hind-brain, with different RS subtypes involved in distinct locomotor 
circuits and behaviours. It is possible that more detailed investigation of 
specific RS subtype axons would identify myelin patterns specific to certain 
locomotor circuits. For example, MeLr and MeLc RS axons (responsible for 
prey capture behaviour) may exhibit slightly different myelin patterns 
compared to RoV3/MiV1/MiV2 RS axons (responsible for changes in 
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swimming direction). Moreover, each of these sub-groups of RS axons may 
exhibit subtle myelin pattern differences when individually compared with 
CoPA axons. The identities of the specific RS subtypes in this chapter’s data 
set are not known; obtaining a sufficient sample size of one particular RS 
subtype would be difficult to achieve. The RS axons in this chapter were 
labelled by microinjecting reporter plasmid DNA into Tg(HuC:Gal4) eggs, 
which then led to random mosaic labelling of neurons with fluorescent 
reporters. On average, several hundred eggs would have to be injected to 
obtain between 1 to 5 larvae with isolated fluorescently-labelled RS neurons, 
and often several of these cells could not be followed through to 9 dpf 
(insufficient fluorescence signal to image at all time points was the most 
common problem). Labelling and imaging enough cells of a specific RS 
subtype using this method is not feasible. An alternative driver line could be 
used to increase the success rate of mosaic transgenesis; the line 
Tg(RS:KalTA4) expresses KalTA4 mainly in RS neurons, and so injecting a 
higher concentration of plasmid DNA into Tg(RS:KalTA4) eggs may be a more 
efficient method of labelling specific RS neuron subtypes. 
RS and CoPA neurons have many similarities; they are born at approximately 
the same time during development, they have axons of similar diameters, and 
they are both glutamatergic. CoPA neurons do not use synaptic vesicle release 
to regulate their initial myelination (Koudelka et al., 2016). However, 
neurotransmitter signalling may be involved in later remodelling of myelin 
sheaths after their initial formation, and so may still influence establishment of 
myelin patterns along CoPA axons. This might explain why RS and CoPA 
axons have similar myelin patterns. Oligodendrocytes have been shown to 
detect and respond to neurotransmitters other than glutamate, such as GABA 
(Berger et al., 1992; von Blankenfeld et al., 1990). GABAergic neurons may 
signal to oligodendrocytes and myelin sheaths in a different way to glutamate, 
and so may lead to the formation of different myelin patterns. Many inhibitory 
axons are myelinated; in the mammalian CNS, myelinated GABAergic axons 
have been reported in all cortical layers and in underlying white matter, making 
up almost half of the myelinated axons in layers II/III of the rodent cortex 
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(Micheva et al., 2016). Tracing single myelinated axons using array 
tomography revealed that GABAergic axons have shorter nodal gaps and 
myelin sheaths than non-GABAergic axons – specific myelin patterns may be 
regulated by specific neurotransmitters (Micheva et al., 2016). Kolmer-Agduhr 
neurons, dorsal longitudinal ascending (DoLA) neurons, commissural 
secondary ascending neurons (CoSA), and ventral longitudinal neurons 
(VeLD) are all present in the zebrafish spinal cord at the same time frame as 
RS and CoPA axons, and have been shown to express GABA (Bernhardt et 
al., 1992; Higashijima et al., 2004). It would be interesting to investigate 
whether these axons are myelinated, and whether they exhibit distinct myelin 
patterns compared to the glutamatergic RS and CoPA axons. The myelination 
of these axons could be assessed by microinjecting eGFP and RFP-Cntn1a 
plasmids into pan-neuronal driver eggs (such as Tg(HuC:Gal4) or 
Tg(NBT:KalTA4)) and then screening for single cell expression based on 
previously described morphology and location (Bernhardt et al., 1992, 1990).  
Myelin Remodelling 
Myelin remodelling along RS axons was generally the same as CoPA axons; 
the only difference between the two axon subtypes was that RS axons exhibit 
slightly more sheath shrinkage 5-7 dpf. These findings contradict my 
hypothesis that axons which use activity-related signals to regulate myelination 
would exhibit more myelin remodelling. Why do RS axons exhibit a similar 
degree of myelin remodelling as CoPA axons? Silencing the release of 
neurotransmitters via expression of TeNT in individual RS axons leads to fewer 
and shorter myelin sheaths up until 7 dpf (Koudelka et al., 2016). It may be 
that neurotransmitter signalling plays a role in the formation and very early 
growth of myelin sheaths, but does not significantly affect the later growth or 
remodelling of myelin sheaths. In support of this, oligodendrocytes have 
reduced density of AMPA and NMDA receptors, and exhibit smaller responses 
than OPCs to glutamate signalling, suggesting a downregulation of 
neurotransmitter signalling as myelination progresses (De Biase et al., 2010). 
Restricting the modulation of myelination by activity to a critical developmental 
period would mean that activity does not constantly change myelin patterns. 
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Such a result would ensure that circuit function is maintained throughout life. 
Precisely how and when activity affects the dynamics of myelin sheaths during 
myelination is in need of investigation. How the activity of an individual neuron 
affects the early growth, and later growth of myelin sheaths will be investigated 
in Chapter 4. 
3.3.5. Remodelling of Sheath Thickness over Time 
One caveat of the live imaging experiments conducted in this chapter is that 
they do not assess sheath thickness over time. Although sheath number and 
length are stable after 7 dpf, it is possible that sheaths continue to grow 
radially. There is a need to accurately measure the thickness of myelin sheaths 
at multiple time points in vivo in order to quantify sheath thickness remodelling. 
Label-free imaging techniques based on the reflective properties of myelin 
sheaths have previously been used to measure g-ratios. Lim et al., 2014 used 
third harmonic generation microscopy to measure the thickness of sheaths 
made by Schwann cells in co-culture, in teased fibre preparations, and in the 
sciatic nerve in vivo. Alternatively, Kwon et al., 2017 used spectral 
reflectometry to measure axon diameter changes in vivo after traumatic brain 
injury, and states that this technique can also detect ultrastructural changes to 
myelin sheaths. Whether these techniques can detect subtle physiological 
changes in sheath thickness over time needs to be tested. Otherwise, super-
resolution microscopy could be used to measure the thickness of fluorescently-
labelled myelin sheaths over time. The live imaging data in this chapter were 
acquired using the super-resolution mode on a Zeiss LSM880 Airyscan 
confocal microscope. Airyscan microscopy uses an array of 32 detectors and 
deconvolution processing, which increases lateral resolution to 140 nm (Huff, 
2015) (beyond the diffraction limit for conventional fluorescence microscopy of 
~200 nm). RS axons are, on average, 1.2 µm in diameter from 7 dpf onwards 
(Figure 12A). Using Airyscan microscopy, the smallest change in g-ratio which 
could theoretically be detected along an average RS axon with starting g-ratio 
of 0.8 would be to 0.73. Techniques such as stimulated emission depletion 
(STED) microscopy could also be used to measure changes in sheath 
thickness over time. Chéreau et al., 2017 used STED microscopy to measure 
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changes in the diameter of GFP-labelled axons in brain slices at 50 nm 
resolution. At this resolution, the smallest change in sheath thickness that 
STED microscopy could detect along the same RS axon as above would be to 
g-ratio 0.77. Both of these super-resolution techniques are compatible with live 
imaging, and so could be used to measure changes in sheath thickness along 
the same axon over time. 
To date, sheath thickness is typically measured by transmission electron 
microscopy, where ultra-thin sections of fixed tissue are cut, stained, and 
imaged using an electron microscope. While this technique limits analysis to a 
single time point, it also provides nanoscale-resolution detail of sheath 
ultrastructure. Although sheath thickness along the same axon cannot be 
followed over time, profiling the average sheath thickness of RS or CoPA 
axons at 5, 7, and 9 dpf could indicate whether sheath thickness is remodelled 
during these developmental stages. I attempted to address whether sheath 
thickness changes with age by measuring the g-ratios of myelinated axons in 
the dorsal and ventral tracts of the zebrafish spinal cord at 5, 7, and 9 dpf. I 
found that there was no statistically significant difference in sheath thickness 
between the ages in my dataset.  
However, there are several limitations with this experimental approach. Firstly, 
the current sample size may not be sufficient to identify subtle differences in 
sheath thickness between groups. For example, the comparison of ventral 
myelinated axon g-ratios at 5 versus 7 dpf has only 30% power, requiring an n 
of 16 per group to achieve 80% power. Therefore, this experiment should be 
repeated to increase the sample size for statistical comparison. 
Secondly, the quality of larval zebrafish spinal cord fixation makes measuring 
sheath thickness difficult. Axons are often distorted in shape and the individual 
wraps of membrane in myelin sheaths are rarely visible. The poor fixation 
quality appears to be a stage-specific effect, as the quality of adult zebrafish 
CNS tissue prepared for transmission electron microscopy is comparable to 
mammalian tissue. As a result, the sheath thickness measurements made in 
5-9 dpf larvae in this chapter may not be accurate. I attempted to improve the 
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quality of larval spinal cord tissue preservation by testing high-pressure 
freezing techniques in conjunction with Dr. Joanna Brown (Möbius et al., 
2016). Although this technique did improve myelin ultrastructure preservation, 
the tissue still exhibited fixation issues and freeze damage. Additionally, the 
protocol was not high-throughput enough to fix and image several samples for 
formal quantification. High-pressure freezing of zebrafish larvae will need to be 
further optimised to improve the quality of overall tissue preservation and 
increase throughput for official analysis of sheath thickness at different ages. 
For example, tissue preservation could be improved by testing different 
cryoprotectants. When performing the freezing step, the sample must be 
enclosed in a cryoprotectant in the specimen carrier. The cryoprotectant 
prevents air pockets from forming around the sample, transfers heat properly 
during freezing, and protects the sample from freeze damage. Here, we used 
20% BSA in E3 embryo medium as a cryoprotectant, but various others can 
be used, such as 1-hexadecene, yeast paste, and polyvinylpyrrolidone (PVP) 
(Möbius et al., 2010). Optimising the cryoprotectant could not only improve the 
quality of tissue preservation, but could also increase the success rate to 
improve sample throughput. 
Thirdly, it was not possible to identify specific axonal subtypes in spinal cord 
cross-sections. Combining electron microscopy with cell-specific labelling 
techniques could help identify and measure g-ratios of RS or CoPA axons. Cell 
subtype-specific measurements could be undertaken using immunogold 
staining for cell subtype-driven expression of fluorescent proteins 
(Viswanathan et al., 2015), or other labels (Lam et al., 2015; Shu et al., 2011). 
These correlative techniques would be challenging to perform as there are 
currently no known subtype-specific drivers for RS or CoPA neurons. RS and 
CoPA neurons are currently labelled using either a pan-neuronal driver (such 
as the HuC promoter) or partially-specific neuronal drivers (such as the 
Tg(RS:KalTA4) line, which drives KalTA4 expression mainly in RS neurons but 
also, occasionally, in other neurons such as CoPA neurons, Rohon-Beard 
neurons, and neurons in the PNS). A single labelled RS or CoPA neuron would 
have to be identified by light microscopy with no other cells labelled, to be sure 
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that any labelled axon(s) identified by electron microscopy were the correct 
subtype. Ideally a single axon that had been imaged in living animals would 
then be followed in fixed preparations to correlate live imaging and 
ultrastructural analyses. 
Finally, measuring axonal g-ratios in a single cross-section only tells us the 
thickness of one myelin sheath along an axon. Serial section electron 
microscopy and 3D reconstruction of single cells (as performed by Tomassy 
et al., 2014) could be used to analyse the thickness of several sheaths along 
an axon at nanoscale resolution. 
Alternatively, expansion microscopy can be used to perform nanoscale 
resolution measurements of structures not normally detectable by light 
microscopy. The technique involves anchoring chemically fixed tissue to a 
swellable polymer gel, so that when water is added to the tissue, it uniformly 
increases in size in all dimensions (Tillberg et al., 2016). This technique can 
be used in tissue with preserved endogenous fluorescence, or combined with 
conventional immunostaining, to identify specific proteins or structures of 
interest. Gao et al., 2019 combined expansion microscopy with lattice light-
sheet microscopy to measure myelin sheath thickness along entire 
fluorescently-labelled axons in the rodent cortex. A similar approach could be 
used to measure sheath thickness along entire RS or CoPA axons at 5, 7, and 
9 dpf in order to assess how sheath thickness changes with age. In preliminary 
experiments, I have found that expansion microscopy can be used to expand 
zebrafish larvae and image immunostained axons in the spinal cord (data not 
shown), indicating that this technique exhibits promise for imaging sheath 
thickness along individual RS and CoPA axons. 
3.3.6. How Do Myelin Patterns Affect Overall Circuit Function? 
The data in this chapter show that both RS and CoPA axons have similar 
myelin patterns (in terms of sheath number, length, length variability, and nodal 
gap length), which are established within the same time period after onset of 
myelination. How does establishment of these myelin patterns affect the 
function of the circuits to which RS and CoPA axons belong? One way to 
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assess circuit function is by studying behavioural output(s). As discussed in 
section ‘3.3.4 RS and CoPA Axons Show Remarkably Similar Myelin Patterns 
and Degrees of Myelin Remodelling’, the myelin patterns for different subsets 
of RS axons should be further characterised to correlate with specific 
locomotor behaviours. For instance, the 5-9 dpf myelin pattern parameters 
along MiD2/3cm RS axons could be correlated with the kinematics of escape 
responses (such as escape bend angles or escape swim velocity) (Dunn et al., 
2016). MeLr and MeLc RS axon myelin patterns could be correlated with 
hunting efficiency, or with the kinematics of the prey capture response (such 
as tail angles during orienting swims) (Bianco et al., 2011; Gahtan et al., 2005).   
Circuit function can also be assessed by directly measuring the activity of 
neurons during circuit activity. Electrophysiological recordings could correlate 
the establishment of myelin patterns with conduction timing and synaptic 
communication. Electrophysiology is typically done using electrodes to directly 
record voltage or current in neurons; however, genetically-encoded voltage 
indicators (GEVIs) are now available to perform entirely optic 
electrophysiology in single cells in vivo (Gong et al., 2015). Indicators such as 
Ace2N-4AA-mNeon have fast enough kinetics to detect single action potentials 
when combined with high speed imaging (Bando et al., 2019; Gong et al., 
2015). These techniques could be used to record activity in RS neurons and 
downstream motor and interneurons at 5, 7, and 9 dpf to see how conduction 
velocity, post-synaptic recruitment and activity changes with myelin pattern 
establishment. For CoPA neurons, the post-synaptic targets first need to be 
verified. Combining GEVIs or genetically-encoded Ca2+ indicators (GECIs) 
with optogenetic stimulation of individual CoPA neurons could reveal 
candidate post-synaptic targets which respond to CoPA stimulation. Once the 
post-synaptic targets are verified, electrophysiological analysis, as above, 
could reveal whether myelin pattern establishment between 5-9 dpf affects 
conduction velocities, or the recruitment or activity of the post-synaptic targets. 
It may be that changes in behaviours and electrophysiological properties of 
circuits do, indeed, correlate with the establishment of myelin patterns along 
axons in vivo. However, this does not mean that myelin pattern establishment 
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drives changes in circuit function. To determine if there is a causative 
relationship between myelin patterns and circuit function would require altering 
the myelin patterns established along RS and CoPA axons and then 
measuring the circuit’s functional output. Manipulating signals known to 
regulate myelin sheath formation and growth in single neurons might be one 
way of changing myelin patterns along individual axons. If experience-driven 
activity does alter myelination patterns, then behavioural paradigms could be 
used to change the myelin patterns formed along specific axons. Raising 
larvae with and without live paramecia (to modify hunting behaviour) may alter 
the patterns specifically along MeLr and MeLc RS axons. Larvae given regular 
sensory stimulation may have different myelin patterns along CoPA axons 
compared to larvae without stimulation. Alternatively, the activity of individual 
neurons could be directly manipulated. There are several transgenic tools 
which can be used to manipulate synaptic vesicle release or electrical 
excitability of individual neurons in vivo (these will be discussed in more detail 
in section ‘4.1 Introduction’). Whether the activity of an individual neuron can 
permanently alter its myelin pattern will be investigated in Chapter 4. Once the 
myelin pattern along an axon has been altered, circuit function could be 
measured using the behavioural and electrophysiological tests described 
above. 
Myelin patterns could be more broadly changed throughout the entire CNS by 
increasing the number of myelinating oligodendrocytes – research has shown 
that, when myelinating supply is increased relative to axonal demand, axons 
have increased sheath number but decreased sheath length (Almeida et al., 
2018). Treating larvae with compounds which increase the production of 
myelinating oligodendrocytes could change the myelin pattern established 
along all axons rather than a specific axon of interest. Behavioural tests and 
electrophysiological characterisation described above could then determine 
whether global changes to myelin patterns affect overall nervous system 
function. However, it is important to remember that compound treatments may 
have side effects on cell types other than myelinating oligodendrocytes. 
Additionally, significant increases in myelinating oligodendrocyte number can 
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lead to mistargeting of myelin to non-axonal targets such as neuronal cell 
bodies, the effects of which on circuit function are not currently known (Almeida 
et al., 2018). Treatments should be carefully selected to ensure that 
oligodendrocyte number is increased without any adverse effects. 
Altering myelin patterns along axons may not significantly affect conduction 
properties or circuit function. The nervous system can be remarkably plastic; 
other features such as synapses or axon diameter may be modified to 
compensate for altered myelin patterns in order to achieve optimal circuit 
function. It is likely that many different parameters work synergistically to 
regulate circuit activity. A holistic approach is required to understand if and 
how the formation and maintenance of myelination patterns influences overall 
circuit development and function over time. 
3.3.7. Disruption to Myelin Patterns 
If establishing particular myelin patterns along axons is important for circuit 
function, then what happens when these myelin patterns are disrupted? Myelin 
can be lost in response to injury or disease. Spinal cord injury is typically 
followed by demyelination of nearby spared axons (Kakulas, 1999; Totoiu and 
Keirstead, 2005). In Multiple Sclerosis (MS), demyelinating lesions can be 
found throughout grey and white matter of the CNS (Albert et al., 2007; 
Newcombe et al., 1991). Myelin may also be lost with age. A study of human 
individuals ranging from 44-77 years old suggests that the microstructure of 
numerous white matter tracts declines with age (Cox et al., 2016). In rodents, 
both the number of myelinating oligodendrocytes and myelin coverage in the 
somatosensory cortex decline at older ages (Hill et al., 2018). 
Loss of myelin along axons with age, injury, or disease will disrupt conduction 
within circuits. For example, toxin-induced demyelination in the cat spinal cord 
leads to conduction block (Smith et al., 1981). And yet, denuded axons can be 
remyelinated. In animal models of spinal cord contusion, spared demyelinated 
axons are remyelinated, with sheaths made during remyelination identified as 
thinner and shorter than normal healthy sheaths (Lasiene et al., 2008; Totoiu 
and Keirstead, 2005). Remyelinated axons have also been reported post-
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mortem in humans after spinal cord injury (Kakulas, 1999). In MS post-mortem 
tissue, lesions termed ‘shadow plaques’ have been identified, believed to be 
sites of previous demyelination that have been repopulated by 
oligodendrocytes and subsequently remyelinated (Lucchinetti et al., 1999; 
Prineas et al., 1993; Prineas and Connell, 1979). Like with spinal cord injury, 
remyelination is not perfect. Studies of both post-mortem MS tissue and 
demyelinating animal models suggest that sheaths on remyelinated axons are 
generally shorter and thinner than unaffected healthy myelin sheaths, even 
several months after the demyelinating episode (Blakemore, 1974; Blakemore 
and Murray, 1981; Prineas et al., 1993; Prineas and Connell, 1979). 
Remyelination in injury and disease is believed to restore conduction to 
demyelinated axons, and has been shown to do so in animal models (Smith et 
al., 1981). However, remyelination is likely to change the myelin pattern along 
axons, given that remyelinated sheaths tend to be thinner and shorter than 
normal. How this disruption to myelin patterns affects circuit function is not 
clear. Lasiene et al., 2008 performed mathematical modelling based on their 
measurements of remyelination after spinal cord injury, and found that the 
shorter sheaths observed after remyelination are predicted to reduce 
conduction velocities by 21%. How myelin patterns change through de- and 
remyelination along single axons, and how this affects circuit activity and 
behaviour warrants further investigation. It would be interesting to see if the 
myelin patterns along individual axons in the zebrafish spinal cord are changed 
after demyelination. In a cell-ablation model of demyelination in larval zebrafish 
(where myelinating cells express the enzyme nitroreductase and can be 
ablated by treatment with the pro-drug metronidazole), demyelination is 
followed by robust regeneration of sheaths with normal thickness and length 
(Karttunen et al., 2017). Further demyelination models could be tested to 
confirm that robust remyelination is a general feature of demyelination in larval 
zebrafish. I have generated a novel zebrafish model of demyelination where 
all myelinating cells express the fusion protein TRPV1-tagRFPt and can be 
ablated by treatment with high doses of capsaicin (see Appendix 1: A Novel 
Zebrafish Model of Demyelination – Tg(mbp:TRPV1-RFP)). This model 
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requires more extensive characterisation to profile the extent of de- and 
remyelination which occurs. Following characterisation, this model could be 
compared with other demyelination models to assess how myelination patterns 
along individual RS and CoPA axons change with de- and remyelination. 
Not all myelin sheaths are lost in injury, disease, or old age. Is it possible for 
surviving myelin sheaths to remodel to compensate for myelin loss in order to 
maintain conduction speeds? Recent research in zebrafish indicates that 
myelin sheaths can be induced to remodel when the myelin pattern is 
disrupted. Auer et al., 2018 ablated individual oligodendrocytes to sparsely 
remove myelin sheaths along surrounding axons. When a single myelin sheath 
is lost from a myelinated axon, the adjacent myelin sheaths can reinitiate the 
rapid growth seen during early sheath formation to cover the exposed portion 
of the axon. Occasionally, a new myelin sheath is made in this gap and can 
grow back to restore the original pattern of myelin, even if this requires pushing 
back against the neighbouring sheaths. This suggests that, although myelin 
sheaths become stable after initial myelination, they retain the capacity for 
remodelling. It is not currently known whether mammalian myelin sheaths also 
retain this remodelling capacity, nor how surviving sheaths along axons 
remodel in response to more extensive demyelination. It would be intriguing to 
assess whether surviving myelin sheaths along an axon remodel to maintain 
conduction properties in response to demyelination and imperfect 
remyelination. Myelin sheath remodelling should also be characterised in older 
animals to see if age-associated myelin loss triggers changes in sheath length 
or thickness, particularly as the declining number of oligodendrocytes suggests 
that remyelination fails at these stages (Hill et al., 2018). 
3.3.8. Summary 
In this chapter, I characterised the formation of myelin patterns and 
remodelling of myelin sheaths along two different subtypes of glutamatergic 
axon in the zebrafish spinal cord. I found that both RS and CoPA axons exhibit 
a similar extent of myelin remodelling, and form similar myelin patterns within 
a defined time period after the onset of myelination. Future work should further 
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characterise the remodelling of myelin sheath thickness over time; assess 
which signals contribute to the formation of myelin patterns and myelin 
remodelling; and investigate the effects of myelin patterns on circuit activity 
and function in the context of health and disease. 
In the next chapter, I will investigate how the activity of individual axons affects 

















Chapter 4: Investigating How Neuronal Activity Affects 










There is a growing body of evidence suggesting that experience can shape 
the myelination in the CNS (see section ‘1.5.3 Experience Affects 
Myelination’). The primary hypothesis underlying this phenomenon is that the 
neuronal activity of active circuits can signal to oligodendroglial cells to 
promote the myelination of these circuits. Much research has shown that 
neuronal activity can influence OPC proliferation, differentiation, target 
selection, and myelin sheath formation (as discussed in Chapter 1, section ‘1.6 
Neuronal Activity can Influence Myelination’). However, it is not clear how 
neuronal activity affects the dynamics of myelination along single axons over 
time, or of existing individual myelin sheaths within a circuit.  
One possibility is that existing myelin sheaths continue to detect and respond 
to neuronal activity after initial formation, and, therefore, can be constantly 
shaped by circuit activity. Neuronal activity could induce changes to sheath 
length or thickness to adjust the pattern of myelin along an axon. It is 
hypothesised that such a mechanism would allow neuronal activity to fine-tune 
conduction properties within a circuit as and when required to modify the 
functional output. However, evidence suggests that life-long remodelling of 
myelin sheaths is limited. To determine whether sheaths are remodelled, Hill 
et al., 2018 used label-free SCoRe microscopy to live image individual myelin 
sheaths in the upper layers of the somatosensory cortex of P60 mice. They 
found that only 19% of sheaths were dynamic in length over an imaging period 
of 30 days. Hughes et al. 2018 live imaged eGFP-labelled myelin sheaths in 
the somatosensory cortex of P365 mice for up to 50 days, and found that only 
0.97% of sheaths were dynamic over this time period. They also investigated 
whether circuit activity could influence the remodelling capacity of these stable 
sheaths by exposing the mice to sensory stimulation for three weeks. This 
exposure activates sensory circuits and, presumably, increases the activity of 
the somatosensory cortex. There was no change in the degree of myelin 
sheath remodelling observed in these stimulated animals. However, there was 
increased production of oligodendrocytes in the somatosensory cortex of 
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stimulated animals. It is important to note that this study did not measure the 
activity of the underlying axons to confirm that sheaths on active axons did not 
remodel. It, nevertheless, does suggest that, at least in sensory circuits, 
activity can promote the production of new myelinating oligodendrocytes 
throughout life, but does not necessarily remodel existing myelin sheaths. 
It is, in fact, entirely plausible that remodelling sheaths throughout life would 
not be beneficial for overall nervous system function. If the myelin patterns of 
active circuits were always changing, this could lead to constantly fluctuating 
conduction properties in circuits. Therefore, another possibility is that neuronal 
activity can remodel myelin sheaths to shape myelin patterns along axons, but 
only within a critical developmental window. There is some evidence that 
neuronal activity may influence early sheath growth. Ca2+ transients in myelin 
sheaths have been shown to correlate with early sheath growth (Baraban et 
al., 2018). Electrical stimulation of the hindbrain increases the frequency of 
sheath Ca2+ transients and sheath growth, while silencing neuronal activity 
with TTX inhibits the same (Krasnow et al., 2018). It is not clear whether myelin 
sheaths continue to exhibit these activity-dependent Ca2+ transients beyond 
early stages of growth. Battefeld et al., 2019 found that actively growing myelin 
sheaths have a high rate of Ca2+ transients, which declines with sheath 
maturation. Electrophysiological recordings of neuro-glial communication 
show that oligodendrocytes exhibit much smaller responses to 
neurotransmitter signalling as they differentiate (De Biase et al., 2010; Kukley 
et al., 2010). This suggests that oligodendrocytes become less responsive to 
neuronal activity as myelination progresses. Live imaging of myelin sheaths in 
the zebrafish spinal cord revealed that sheaths exhibit variable rates of sheath 
growth in the first few days after formation, and then become stable thereafter 
(Auer et al., 2018). This is concurrent with my findings from Chapter 3 – the 
growth of myelin sheaths along both reticulospinal and CoPA axons is 
generally limited to a defined period after the onset of myelination (until 7 dpf). 
Reticulospinal axons are myelinated in a synaptic vesicular release-dependent 
manner, which indicates that these neurons are capable of activity-dependent 
myelination (Koudelka et al., 2016). It is possible that neuronal activity can 
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regulate the early growth of myelin sheaths to establish a particular myelin 
pattern, but that, after a critical window of plasticity, these myelin sheaths no 
longer respond to neuronal activity and remain stable.  
Further investigation is required to determine if, how, and when neuronal 
activity affects the dynamics of myelin sheaths and myelin pattern 
establishment. Numerous techniques have been employed to study the role of 
neuronal activity in regulating various aspects of myelination, as summarised 
in Table 5. These techniques include pharmacological treatments to 
manipulate all neurons or oligodendrocytes, and transgenic tools to manipulate 
activity in a neuronal subset of choice. If the activity of a single neuron (rather 
than a whole population of neurons) can locally regulate the myelination of its 
axon has not been determined. Koudelka et al., 2016 inhibited vesicular 
release in individual reticulospinal cells in the zebrafish spinal cord and found 
that this inhibits their myelination. However, they did not assess how local 
vesicular release affects the dynamics of individual sheaths, or how increasing 
neuronal activity might affect myelin remodelling. Larval zebrafish are ideally 
suited for investigating the role of neuronal activity in regulating sheath 
dynamics and myelin pattern formation due to their optical transparency for 
live imaging (as shown in Chapter 3). 
Investigating how neuronal activity regulates myelination at the single axon 
level requires a technique to activate or inhibit the activity of individual neurons. 
Ideally this should be an inducible tool to prevent changes to neuronal activity 
affecting neuronal development prior to the onset of myelination. Such 
experiments could be done using optogenetics, where light-gated 
channelrhodopsins are expressed in a single neuron, and activity can be 
induced using the relevant wavelength of light (Boyden et al., 2005; Gradinaru 
et al., 2010). Alternatively, chemogenetics could be used, where ligand-gated 
ion channels or receptors are expressed in a single neuron, and activity can 
be induced by application of the appropriate ligand. Chemogenetic techniques 
are particularly useful in the larval zebrafish given that activating ligands can 
be easily administered by bath application. Mammalian TRP channels have 
previously been used in zebrafish to robustly increase neuronal activity (Chen 
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et al., 2016). TRPV1-tagRFPt (TRPV1-RFP) is a fusion protein between the 
rat TRPV1 cation channel and tagRFPt. TRPV1 is a non-selective cation 
channel (although it has a preference for Ca2+ over Na+ and K+ (Munns et al., 
2015)), which is expressed in nociceptive sensory neurons. In mammals, the 
TRPV1 channel is activated by noxious heat, acidity, and capsaicin (a 
compound found in ‘hot’ chili peppers) (Caterina et al., 1997); however, due to 
evolution, the zebrafish orthologue is activated by heat and acidity, but not 
capsaicin (Gau et al., 2013). Chen et al., 2016 capitalised on this evolutionary 
difference to generate a chemogenetic tool for stimulating neurons in zebrafish 
– the rat TRPV1 channel can be expressed in neurons of interest, and then 
applying the agonist capsaicin will activate these neurons (without affecting 
endogenous zebrafish TRP channels). They demonstrated that treatment with 
low-concentrations of capsaicin successfully increases activity of specific 
neurons, while high-concentration treatments of capsaicin ablates cells (Chen 
et al., 2016). This is an easy, non-invasive, temporally-regulated system for 
controlling neuronal activity of single neurons within freely behaving animals. I 
decided to use this chemogenetic system to investigate the role of neuronal 
activity in myelin sheath dynamics and myelin pattern establishment. 
4.1.1. Aims for this Chapter 
In this chapter, I aim to investigate how local neuronal activity affects the 
dynamics of individual sheaths and the formation of myelin patterns along 
individual axons in the zebrafish spinal cord. Reticulospinal axons have been 
shown to be myelinated in a synaptic-vesicle dependent manner. Based on 
this, I hypothesised that increasing the activity of individual reticulospinal 
axons would significantly alter sheath dynamics and the myelin patterns 
established. To test these hypotheses, I stimulated individual reticulospinal 
axons using the TRPV1-RFP chemogenetic system, coupled with live imaging, 
during the peak time of myelination (3-7 dpf). I then measured the dynamics of 
individual sheaths on both stimulated and unstimulated axons during this time 
period. I also assessed the myelin patterns of stimulated versus unstimulated 
axons by measuring sheath length, sheath number, and also how nodal gap 
length and axon diameter were affected by increased neuronal activity.
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Table 5 – summary of previous techniques used to investigate role of neuronal activity in myelination.  
Technique Description Critique Studies using technique 
Tetrodotoxin (TTX) Voltage-gated Na+ channel blocker, 
inhibits action potential propagation. 
Can be bath applied to cells or 
animals, or injected to tract or region 
of interest. 
Pharmacological treatments can affect non-
neuronal cells as well. Global treatment cannot 
inhibit just specific neurons of interest, if used in 
vivo. 
(Barres and Raff, 1993; Bergles 
et al., 2000; Demerens et al., 
1996; Hines et al., 2015; 
Káradóttir et al., 2008, 2005; 
Kukley et al., 2010, 2007; 




GABA receptor antagonist which 
prevents inhibitory effects of GABA 
signalling, leading to increased 
overall excitation. 
An indirect method for increasing neuronal activity. 
May induce seizures (non-physiological levels of 
activity). Pharmacological treatments can affect 
non-neuronal cells as well. Global treatment cannot 
inhibit just specific neurons of interest. 
(Mensch et al., 2015). 
Electrode 
stimulation 
Electrodes used to directly apply 
electrical stimulation to region of 
interest. Can be implanted in vivo. 
Provides control of firing frequencies in populations 
of neurons. Cannot stimulate just specific neurons 
in interest within a region. 
(Krasnow et al., 2018; Li et al., 
2010; Malone et al., 2013; Nagy 
et al., 2017; Wake et al., 2011). 
Kir2.1 Inward-rectifying K+ channel causing 
sustained hyperpolarisation and 
reduced excitability. 
Can be expressed in specific neurons of interest. 
No temporal control of activity. 




Opsins Optogenetic system. Light-gated 
cation channels originally derived 
from algae. Variety of excitatory and 
inhibitory opsins available, activated 
by various wavelengths of light 
(Boyden et al., 2005; Gradinaru et 
al., 2010). 
Can be expressed in specific neurons of interest. 
Provides temporal control of activity. May require 
invasive implantation of optical fibres. 
(Geraghty et al., 2019; Gibson 






Chemogenetic system. Modified 
muscarinic acetylcholine receptors 
activated by inert ligand clozapine-N-
oxide (Alexander et al., 2009; 
Armbruster et al., 2007). 
Can be expressed in specific neurons of interest. 
Provides temporal control of activity. DREADDs are 
actually activated by clozapine, which has 
endogenous binding targets and could cause side 
effects (Gomez et al., 2017). 
(Mitew et al., 2018). 
TeNT Clostridial neurotoxin which inhibits 
synaptic vesicle release via cleavage 
of SNARE protein VAMP-2 (Binz et 
al., 2010). 
Can be expressed globally or in specific neurons of 
interest. Inhibits specific aspect of neuronal activity 
(neurotransmitter/BDNF release, not electrical 
impulses). No temporal control of activity. 
(Hines et al., 2015; Mensch et 
al., 2015; Wake et al., 2015, 
2011). 
BoNTs Clostridial neurotoxins which inhibit 
synaptic vesicle release via cleavage 
of SNARE proteins (Binz et al., 
2010). There are 7 isoforms (A-G). 
Can be expressed globally or in specific neurons of 
interest. Inhibits specific aspect of neuronal activity 
(neurotransmitter/BDNF release, not electrical 
impulses). No temporal control of activity. 
(Wake et al., 2015, 2011). 
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Ruthenium Red Stimulates synaptic vesicle release in 
Ca2+ independent manner (Trudeau 
et al., 1996). 
Increases specific aspect of neuronal activity 
(neurotransmitter release, not electrical impulses). 
No temporal control of activity. Has other known 
targets. 
(Kukley et al., 2007; Ziskin et 
al., 2007). 
α-latrotoxin Stimulates synaptic vesicle release 
by forming Ca2+-permeable pores to 
increase Ca2+ influx (Henkel and 
Sankaranarayanan, 1999). 
Increases specific aspect of neuronal activity 
(neurotransmitter release, not electrical impulses). 
No temporal control of activity. 
(Gautier et al., 2015; Kukley et 
al., 2007; Mangin et al., 2008). 
Glutamate receptor 
antagonists 
Antagonists which block 
glutamatergic receptors. Examples 
include: CNQX, NBQX, GYKI 
(AMPA/kainate receptors); AP5, MK-
801 (NMDA receptors); DHPG (mGlu 
receptors). 
Inhibits specific aspect of neuronal activity 
(glutamate signalling to oligodendroglia). Will likely 
affect cell types other than oligodendroglia. 
(Barres et al., 1990; Bergles et 
al., 2000; De Biase et al., 2010; 
Káradóttir et al., 2008, 2005; 
Kukley et al., 2010, 2007; 
Lundgaard et al., 2013; Luyt et 
al., 2003; Wang et al., 1996; 
Wyllie et al., 1991; Žiak et al., 
1998; Ziskin et al., 2007) 
Glutamate receptor 
agonists 
Agonists which activate 
glutamatergic receptors. Examples 
include: glutamate, AMPA, kainate, 
NMDA, quisqualate (AMPA, kainate 
and mGlu receptors). 
Stimulates specific aspect of neuronal activity 
(glutamate signalling to oligodendroglia). Will likely 
affect cell types other than oligodendroglia. 
(Barres et al., 1990; Berger et 
al., 1992; Káradóttir et al., 2005; 
Spitzer et al., 2019; Wang et al., 





4.2.1. TRPV1-tagRFPt as a Tool to Increase Neuronal Activity without 
Adversely Affecting Neurodevelopment 
To test the suitability of the TRPV1-tagRFPt (TRPV1-RFP) tool for increasing 
activity during myelination, a transgenic line was generated where TRPV1-
RFP is expressed under the UAS promoter sequence (Figure 22A). The 
transgene can then be expressed in neurons of interest by crossing 
Tg(UAS:TRPV1-RFP) fish with Gal4 or KalTA4 driver fish. Crossing 
Tg(UAS:TRPV1-RFP) with Tg(Rs:KalTA4) generated progeny where TRPV1-
RFP was expressed mosaically in reticulospinal (RS) neurons (Figure 22B).  
 
Figure 22 - the TRPV1-tagRFPt tool for chemogenetic stimulation of RS 
axons. 
A) A simplified plasmid map of the 10xUAS:TRPV1-tagRFPt plasmid used to 
generate the transgenic line Tg(UAS:TRPV1-tagRFPt) (TRPV1-RFP). TRPV1-RFP 
is under the control of the 10xUAS promoter sequence, so that expression of 
TRPV1-RFP occurs only in cells where the transcriptional activator Gal4 or KalTA4 
is present. B) The animal cross used to express TRPV1-RFP specifically in RS 
axons. Tg(UAS:TRPV1-tagRFPt) is crossed to Tg(RS:KalTA4), a transgenic line 
where the transcriptional activator KalTA4 is expressed in RS axons. Progeny 
which are positive for both transgenes will mosaically express TRPV1-RFP in RS 
axons (example image of RS axons expressing TRPV1-tagRFP is shown in the 




Chen et al., 2016 found that different types of neurons had different 
sensitivities to capsaicin-induced TRPV1-RFP activity. While Rohon-Beard 
sensory neurons were activated by one hour of 10 µM capsaicin, hypothalamic 
neurons were ablated by the same treatment. Therefore, several doses of 
capsaicin were tested to determine which were tolerable for RS axons 
expressing TRPV1-RFP. Animals aged 3 dpf, containing TRPV1-RFP-
expressng RS axons, were treated with either vehicle, 1 µM, or 10 µM 
capsaicin for one hour. Axons were imaged immediately after this treatment to 
determine if capsaicin-induced cell ablation occurred (shown by degenerating 
axons), and found that there was no cell ablation at low capsaicin doses (1 




Figure 23 – The effects of acute treatment with low and high doses of 
capsaicin on RS axon health. 
A) Example images of TRPV1-RFP+ RS axons at 3 dpf treated with vehicle, 1 µM 
capsaicin or 10 µM capsaicin for 1 hour, as well as TRPV1-RFP- axons treated with 
10 µM capsaicin. TRPV1-RFP-expressing axons treated with 10 µM capsaicin 
completely degenerate, as shown by axonal blebbing. B) Quantification of % 
animals with degenerating RS axons in each treatment group. The % of animals 
with degenerating axons with acute treatment was 10% for vehicle treated TRPV1-
RFP+ animals (n = 10), 0% for 1 µM capsaicin treated TRPV1-RFP+ animals (n = 
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12), 100% for 10 µM capsaicin treated TRPV1-RFP+ animals (n = 9), and 0% for 
10 µM capsaicin treated TRPV1-RFP- animals (n = 6). Scale bar = 10 µm. 
 
Next, Ca2+ imaging was performed to test that 1 µM capsaicin treatment was 
sufficient to increase the activity of TRPV1-RFP-expressing RS axons. RS 
axons were labelled with TRPV1-RFP and an axon-localised form of GCaMP7 
cloned by Dr. Rafael Almeida (axon-GCaMP7). GCaMP is a genetically-
encoded Ca2+ indicator, where an increase in intracellular Ca2+ causes a 
conformational change of the GCaMP protein, and leads to emission of 
fluorescence (Nakai et al., 2001). When neurons fire action potentials, Ca2+ 
influx occurs and therefore the electrical activity of GCaMP-expressing 
neurons can be visualised as changes in fluorescence. Short timelapse movies 
(three to five minutes long) were taken of axon-GCaMP7 fluorescence at 
distinct regions of RS axons both immediately before and 15 minutes after the 
application of either vehicle or 1 µM capsaicin (Figure 24A-C). The change in 
activity (calculated as the change in fluorescence, or ΔF/F0) from baseline with 
treatment was quantified. There was a rapid and significant increase in 
neuronal activity in TRPV1-RFP-expressing neurons when treated with 
capsaicin at 3 dpf, with the mean ΔF/F0 for vehicle-treated animals -0.10, and 
for capsaicin-treated animals 0.42 (unpaired t-test with Welch’s Correction for 
Variance, p = 0.001, Figure 24C, D). TRPV1-RFP-expressing cells continued 
to respond to capsaicin as the larva develops; Ca2+ imaging in 5 dpf larvae 
demonstrated that capsaicin treatment increased the activity of TRPV1-RFP-
expressing axons (the mean ΔF/F0 was -0.05 for vehicle treated animals, and 
0.18 for 1 µM capsaicin treated animals; unpaired t-test with Welch’s 
Correction for Variance, p = 0.046, Figure 24E). These animals had previously 
received capsaicin or vehicle treatments at both 3 and 4 dpf, showing that cells 
which received repeated treatments could still respond to capsaicin. Treating 
with capsaicin had no statistically significant effect on the activity of axons 
which do not express TRPV1-RFP (the mean ΔF/F0 was -0.07 for vehicle 
treated animals, and -0.06 for 1 µM capsaicin treated animals; unpaired t-test, 








A) Example still images showing RS axons expressing TRPV1-RFP and axon-
GCaMP7. B) Single timestamped frames from a timelapse movie of GCaMP7 
fluorescence in the axons shown in A). C) The GCaMP7 fluorescence intensity 
(plotted as ΔF/F0) trace of the axons shown in A) and B) for a 3 minute timelapse 
movie. The time points denoted by the grey arrows and dotted lines correspond to 
the fluorescence values of the frames shown in B). D) Quantification of the Ca2+ 
activity of TRPV1-RFP+ RS axons treated with vehicle or 1 µM capsaicin at 3 dpf. 
The mean ΔF/F0 was -0.10 (SD = 0.11) for vehicle treated animals, and 0.42 (SD 
= 0.40) for 1 µM capsaicin treated animals. There was a significant increase in the 
activity of TRPV1-RFP axons with capsaicin treatment (unpaired t-test with Welch’s 
correction for variance, p = 0.001, vehicle n = 8, 1 µM capsaicin n = 11). E) 
Quantification of the Ca2+ activity of TRPV1-RFP+ RS axons treated with vehicle or 
1 µM capsaicin at 5 dpf. The mean ΔF/F0 was -0.05 (SD = 0.03) for vehicle treated 
animals, and 0.18 (SD = 0.18) for 1 µM capsaicin treated animals. There was a 
significant increase in the activity of TRPV1-RFP axons with capsaicin treatment 
(unpaired t-test with Welch’s correction for variance, p = 0.046, vehicle n = 5, 1 µM 
capsaicin n = 5). F) Quantification of the Ca2+ activity of TRPV1-RFP- RS axons 
treated with vehicle or 1 µM capsaicin at 3 dpf. The mean ΔF/F0 was -0.07 (SD = 
0.10) for vehicle treated animals, and -0.06 (SD = 0.07) for 1 µM capsaicin treated 
animals. There is no statistically significant difference between the two groups 
(unpaired t-test, p = 0.878, vehicle n = 4, 1 µM capsaicin n = 4). Scale bar = 10 µm. 
 
The longer-term effects of repeated capsaicin treatments were then 
investigated. To do this, animals with TRPV1-RFP-expressing RS axons were 
treated with either vehicle, or 1 µM capsaicin, daily from 3-7 dpf. Axons were 
imaged at 3 and 7 dpf to quantify any changes in the number of expressing 
axons (Figure 25A). The treatment time was increased from one hour daily 
(as tested in previous experiments) to four hours daily to see how more 
prolonged increases in activity affect axonal health. Capsaicin treatment had 
no statistically significant effect on long-term survival of TRPV1-RFP-
expressing RS axons (the mean % of axons at 7 dpf was 94.1% for vehicle 
treated animals, and 98.5% for 1 µM capsaicin treated animals; unpaired t-




Figure 25 – the effects of long-term treatment with low doses of capsaicin on 
RS axon health. 
A) Example images of RS axons at 3 dpf and 7 dpf, treated with either vehicle or 1 
µM capsaicin for 4 hours daily 3-7 dpf. B) Quantification of the number of axons at 
7 dpf after treatment with vehicle or 1 µM capsaicin daily 3-7 dpf (as % of the 
number of axons at 3 dpf prior to treatment). The mean % of axons at 7 dpf was 
94.1% (SD = 11.0) for vehicle treated animals, and 98.5% (SD = 11.6) for 1 µM 
capsaicin treated animals. There was no statistically significant difference between 
the two treatment groups (unpaired t-test, p = 0.488, vehicle n = 7, 1 µM capsaicin 
n = 7). Scale bar = 10 µm. 
 
Based on these results, I concluded that low doses (1 µM) of capsaicin could 
selectively increase the activity of TRPV1-RFP-expressing RS axons, and that 
repeated stimulation of these axons during the time period of myelination (3-7 
dpf) had no obvious adverse effects on RS axon development. I decided to 
use four hour daily treatments of 1 µM capsaicin to stimulate RS neurons and 




4.2.2. Single Axon Activity Does Not Affect Oligodendrogenesis 
Research has shown that increased neuronal activity promotes the 
proliferation of OPCs and their subsequent differentiation into 
oligodendrocytes (Gibson et al., 2014; Mitew et al., 2018). In both of these 
studies, a significant population of pyramidal neurons in the rodent cortex was 
stimulated; it is not clear if the activity of individual axons can affect local 
oligodendrogenesis. To investigate this, relevant crosses between 
Tg(UAS:TRPV1-RFP), Tg(RS:KalTA4), and Tg(mbp:nls-eGFP) were 
performed to obtain larvae that had expression of TRPV1-RFP in RS axons 
and nuclear-localised eGFP expression in all myelinating cells. In these larvae, 
single RS axons could be stimulated by treating with capsaicin for four hours 
daily from 3-7 dpf, and the number of myelinating oligodendrocytes in the 
surrounding axonal tract could be counted at each age (Figure 26). Animals 
with very sparse expression of TRPV1-RFP were selected for this experiment; 
between one to five axons expressed TRPV1-RFP per animal, with mean axon 
number being 1.8 (SD = 1.4) for unstimulated controls and 2.4 (SD = 1.0) for 
stimulated animals. 
The mean number of oligodendrocytes in a 3-somite area of the ventral tract 
(where RS axons are located) at 3 dpf (prior to any stimulation) was 29.6 for 
vehicle, and 26.3 for capsaicin (Figure 26B). There was no significant 
difference in oligodendrocyte number between unstimulated and stimulated 
axons at either 5 or 7 dpf (at 5 dpf the mean oligodendrocyte number was 43.4 
for vehicle, and 39.7 for capsaicin; and at 7 dpf it was 49.1 for vehicle, and 
47.8 for capsaicin; unpaired t-tests, 5 dpf p = 0.170, 7 dpf p = 0.661, Figure 
26B). 
The same treatment protocol (four hours daily from 3-7 dpf) was tested in 
larvae that did not express TRPV1-RFP in order to confirm that long-term 
capsaicin treatment has no effect on overall oligodendrocyte production 
independent of neuronal activity. This was done using Tg(mbp:eGFP) larvae, 
where myelinating cells express cytoplasmic eGFP. Counting the total number 
of oligodendrocytes at 7 dpf, with either vehicle or capsaicin treatment, showed 
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that there was no significant effect on oligodendrogenesis (Figure 27; number 
of oligodendrocytes in the dorsal tract was 155.7 for vehicle, and 164.3 for 1 
µM capsaicin; unpaired t-test with Welch’s Correction for Variance, p = 0.395). 
Based on these results, I concluded that neither the activity of individual axons 
nor treatment with capsaicin has a significant effect on oligodendrogenesis 
during this initial myelination period. This means that any effects of stimulation 
on axon myelination are due to activity regulating the formation or growth of 
the myelin sheaths themselves, rather than sheath formation or growth effects 
being a by-product of an enlarged oligodendrocyte population. 
 
Figure 26 – ventral oligodendrocyte number with chemogenetic stimulation 
of individual RS axons. 
A) Example images of GFP-expressing oligodendrocytes in the ventral spinal cord 
of animals with individual TRPV1-RFP+ RS axons at 3, 5, and 7 dpf treated with 
vehicle or 1 µM capsaicin. B) Quantification of the number of oligodendrocytes in 
the ventral spinal cord at 3, 5, and 7 dpf in animals with individual TRPV1-RFP+ RS 
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axons treated with vehicle or 1 µM capsaicin. The mean number of ventral 
oligodendrocytes at 3 dpf was 29.6 (SD = 6.0) for vehicle, and 26.3 (SD = 4.2) for 
capsaicin; at 5 dpf was 43.4 (SD = 5.3) for vehicle, and 39.7 (SD = 5.8) for capsaicin; 
and at 7 dpf was 49.1 (SD = 4.4) for vehicle, and 47.8 (SD = 7.4) for capsaicin. 
There was no statistically significant difference between the two groups at any age 
(unpaired t-tests; 3 dpf p = 0.172, vehicle n = 10, capsaicin n = 10; 5 dpf p = 0.170, 
vehicle n = 9, capsaicin n = 9; 7 dpf p = 0.661, vehicle n = 8, capsaicin n = 9). Scale 
bar = 10 µm. 
 
 
Figure 27 – the effects of capsaicin alone on oligodendrocyte number in the 
spinal cord. 
A) Example images of oligodendrocytes in the spinal cord of 7 dpf larvae, treated 
with either vehicle or 1 µM capsaicin for 4 hours daily from 3-7 dpf. B) Quantification 
of the number of oligodendrocytes in the dorsal spinal cord at 7 dpf following either 
vehicle or 1 µM capsaicin treatment. The mean number of oligodendrocytes was 
155.7 (SD = 40.9) for vehicle treated animals, and 164.3 (SD = 26.8) for 1 µM 
capsaicin treated animals. There was no statistically significant difference between 
the two treatment groups (unpaired t-test with Welch’s correction for variance, p = 
0.395, vehicle n = 24, 1 µM capsaicin n = 24. Scale bar = 10 µm. 
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4.2.3. Activity Promotes Early (3-5 dpf) Myelin Sheath Dynamics 
FP-Cntn1a fusion proteins act as a marker of myelination along axons by 
labelling only the unmyelinated regions (Koudelka et al., 2016). A stable 
transgenic line was generated where GFP-Cntn1a was expressed under the 
UAS promoter sequence (Tg(UAS:GFP-Cntn1a)), and appropriate crosses 
were performed with Tg(RS:KalTA4) and Tg(UAS:TRPV1-RFP) fish to 
generate larvae expressing both TRPV1-RFP and GFP-Cntn1a in single RS 
axons (Figure 28). RS axons were treated with vehicle (unstimulated) or 
capsaicin (stimulated) for four hours daily 3-7 dpf, and imaged at 3, 5, and 7 
dpf to assess how increased activity affected the dynamics of individual myelin 
sheaths during this period (Figure 28A). Only animals with sparse expression 




Figure 28 – following the myelination of individual RS axons through 
chemogenetic stimulation. 
A) Experimental timeline; larvae with TRPV1-RFP+ RS axons were imaged at 3, 5, 
and 7 dpf using reporters for myelination, and treated with either vehicle or 1 µM 
capsaicin for 4 hours daily from 3-7 dpf. B) Example RS axons which were imaged 
at 3, 5, and 7 dpf with either vehicle or 1 µM capsaicin treatment. Myelination along 
the axon was assessed using the GFP-Cntn1a reporter (where GFP fluorescence 
denotes unmyelinated regions, white arrows, and gaps in the GFP fluorescence 




Many axons had not begun myelination by the 3 dpf imaging session; however, 
some axons did have small myelin sheaths at this time point. To assess early 
myelin sheath dynamics, analysis was performed on cells where the same 
area of axon could be followed from 3-5 dpf, measuring the sheaths which 
were present at both 3 and 5 dpf. The lengths of ‘early born’ myelin sheaths 
(sheaths which were present at 3 dpf) were measured at 3 and 5 dpf to see 
how stimulating axonal activity affected their early growth (Figure 29A). Some 
axons had only one early born sheath, whereas other axons had several. For 
analysis, the length of early born sheath(s) along an axon were quantified and 
the mean of these was taken where appropriate to obtain one measurement 
per axon. At 3 dpf, prior to any stimulation, the mean length of early born 
sheaths per axon was 8.2 µm for vehicle, and 7.3 µm for capsaicin (Figure 
29B). By 5 dpf, the mean sheath length of these early born sheaths was 
significantly longer on stimulated versus unstimulated axons (36.4 µm for 
vehicle, and 45.4 µm for capsaicin; unpaired t-test, p = 0.024, Figure 29B). 
This could also be measured as the change in sheath length, where the 
difference in length 3-5 dpf was measured for each sheath and the mean value 
per axon taken where appropriate (Figure 29C, mean change in sheath length 
3-5 dpf per axon was 27.3 µm for vehicle, and 38.5 µm for capsaicin; unpaired 




Figure 29 – early sheath dynamics along chemogenetically stimulated 
individual RS axons. 
A) Example images of myelin sheath growth 3-5 dpf on TRPV1-RFP+ RS axons. 
White arrows = the edges of the myelin sheath. B) The mean sheath length of 
‘earliest born sheaths’ on TRPV1-RFP+ RS axons at 3 and 5 dpf treated with either 
vehicle or 1 µM capsaicin. ‘Earliest born sheaths’ are defined as sheaths which 
were formed prior to imaging at 3 dpf. The mean sheath length per axon at 3 dpf 
was 8.2 µm (SD = 4.5) for vehicle, and 7.3 µm (SD = 3.3) for capsaicin; and at 5 
dpf was 36.4 µm (SD = 4.9) for vehicle, and 45.4 µm (SD = 6.1) for capsaicin. There 
was no statistically significant difference between the two groups at 3 dpf, but there 
was a significant increase in sheath length with capsaicin treatment at 5 dpf 
(unpaired t-tests; 3 dpf p = 0.720, vehicle n = 6, capsaicin n = 5; 5 dpf p = 0.024, 
vehicle n = 6, capsaicin n = 5). C) The mean change in sheath length 3-5 dpf of 
earliest born sheaths along TRPV1-RFP+ RS axons treated with either vehicle or 1 
µM capsaicin. The mean change in sheath length 3-5 dpf per axon was 27.3 µm 
(SD = 7.1) for vehicle, and 38.5 µm (SD = 9.2) for capsaicin. There was a significant 
increase in the mean change in sheath length with capsaicin treatment (unpaired t-
test, p = 0.049, vehicle n = 6, capsaicin n = 5). D) The mean sheath length of ‘later 
born sheaths’ on TRPV1-RFP+ axons at 5 dpf treated with either vehicle or 1 µM 
capsaicin. ‘Later born sheaths’ were defined as sheaths born between the 3 and 5 
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dpf imaging sessions. The mean sheath length per axon was 30.0 µm (SD = 11.3) 
for vehicle, and 32.4 µm (SD = 8.9) for capsaicin. There was no statistically 
significant difference between the two groups (unpaired t-test, p = 0.595, vehicle n 
= 14, capsaicin n = 10). Scale bar = 10 µm. 
 
Crucially, this effect is specific to stimulated axons and not just a general effect 
of capsaicin treatment on myelin sheath growth. As a control, the same 
experiment was performed on larvae with axons which did not express TRPV1-
RFP (Figure 30A). Analysis showed that capsaicin alone did not significantly 
affect the early growth of early born myelin sheaths (Figure 30B, C; the mean 
sheath length of early born sheaths per axon at 5 dpf was 34.0 µm for vehicle, 
and 35.1 µm for capsaicin (unpaired t-test, p = 0.911); the mean change in 
sheath length 3-5 dpf per axon was 25.3 µm for vehicle, and 24.4 µm for 
capsaicin (unpaired t-test, p = 0.867)). 
Many sheaths were formed along RS axons between 3 to 5 dpf. The mean 
length of these ‘later born’ myelin sheaths at 5 dpf was calculated for each 
axon (Figure 29D). There was no significant difference in the length of these 
later born sheaths between unstimulated and stimulated axons at 5 dpf (mean 
sheath length of later born sheaths per axon was 30.0 µm for vehicle, and 32.4 
µm for capsaicin; unpaired t-test, p = 0.595). However, these sheaths could 
have been formed at any point between imaging at 3 dpf and imaging at 5 dpf. 
It is not known how long each of these later born sheaths had been exposed 
to the unstimulated or stimulated conditions, and, therefore, it was impossible 
to determine whether or not stimulation might have enhanced the initial growth 
of these later born myelin sheaths. 
Based on these results, I concluded that neuronal activity promotes the growth 




Figure 30 – early sheath dynamics along TRPV1-RFP-negative RS axons 
treated with capsaicin. 
A) Example images of sheath growth 3-5 dpf along TRPV1-RFP-negative RS axons 
treated with either vehicle or 1 µM capsaicin. Unmyelinated axon is labelled with 
tagRFPt-Cntn1a. White arrows = the edges of the myelin sheath. B) The mean 
sheath length of “earliest born sheaths” on TRPV1-RFP-negative RS axons at 3 
and 5 dpf treated with either vehicle or 1 µM capsaicin. “Earliest born sheaths” are 
defined as sheaths which were formed prior to imaging at 3 dpf. The mean sheath 
length per axon at 3 dpf was 8.7 µm (SD = 7.7) for vehicle, and 10.7 µm (SD = 10.5) 
for capsaicin; and at 5 dpf was 34.0 µm (SD = 13.3) for vehicle, and 35.1 µm (SD = 
18.6) for capsaicin. There was no statistically significant difference between the two 
groups at any age (unpaired t-tests; 3 dpf p = 0.721, vehicle n = 6, capsaicin n = 5; 
5 dpf p = 0.911, vehicle n = 6, capsaicin n = 5). C) The mean change in sheath 
length 3-5 dpf of earliest born sheaths along TRPV1-RFP-negative RS axons 
treated with either vehicle or 1 µM capsaicin. The mean change in sheath length 3-
5 dpf per axon was 25.3 µm (SD = 7.9) for vehicle, and 24.4 µm (SD = 9.6) for 
capsaicin. There was no significant difference between the two groups (unpaired t-





4.2.4. Activity Does Not Affect Later (5-7 dpf) Myelin Sheath Dynamics 
The early born myelin sheaths were then followed 5-7 dpf to see if increased 
neuronal activity continued to promote their growth (Figure 31A). This analysis 
was performed on cells where the same area of axon could be followed from 
3-7 dpf. The mean change in sheath length of early born sheaths 5-7 dpf was 
calculated per axon. Despite the fact that sheaths on unstimulated axons 
continued to grow, those on stimulated axons exhibited almost no growth 5-7 
dpf (the mean change in sheath length 5-7 dpf per axon was 5.8 µm for vehicle, 
and 0.1 µm for capsaicin; unpaired t-test, p = 0.056, Figure 31B). Although 
this difference was not statistically significant, a power calculation states that 
this comparison has only 54% power, and that an n of 12 samples per group 
would be required to reach 80% power. However, the throughput of the 
experiment meant that increasing the sample size was not feasible (an n of 5-
6 per group was obtained after screening several thousand larvae and imaging 
more than 50 cells over time). It is plausible that the sheaths on stimulated 
axons ran out of space sooner than the sheaths on unstimulated axons, due 
to an early stimulation of sheath growth, leading to a reduced change in sheath 
length compared to unstimulated axons. 
The dynamics of later born myelin sheaths were also followed 5-7 dpf. This 
analysis was performed on cells where the same area of axon could be 
followed from 3-7 dpf. Unlike the early born sheaths (which exhibited negligible 
change in length), the later born sheaths along both unstimulated and 
stimulated axons exhibited significant change in length. However, there was 
no statistically significant difference in the change in sheath length of later born 
sheaths between unstimulated and stimulated axons from 5-7 dpf (the mean 
change in sheath length 5-7 dpf per axon was 11.1 µm for vehicle, and 9.7 µm 
for capsaicin; unpaired t-test, p = 0.548, Figure 31C). This further indicates 
that the dynamics of later born myelin sheaths are not regulated by neuronal 
activity. 
There are two possibilities for a lack of effect of activity on sheath growth 
between 5 to 7 dpf. One possibility is that sheaths have a finite amount of 
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space in which to grow by 5-7 dpf; therefore, even if activity were capable of 
accelerating the growth of sheaths on stimulated axons, they might simply run 
out of space early on, and so the sheaths on unstimulated axons can catch up 
by 7 dpf. The other possibility is that myelin sheaths no longer detect or 
respond to neuronal activity between 5 to 7 dpf, and so sheaths on both 
unstimulated and stimulated axons would grow at the same rate between 5 to 
7 dpf, assuming they had to space to do so. To differentiate between these 
possibilities, I restricted my analysis to myelin sheaths which still had at least 
a total of 20 µm adjacent unmyelinated axonal space at 7 dpf, because these 
sheaths should still have had ample space into which to grow and should, in 
principle, have had the capacity to respond to activity at the later 5-7 dpf stage. 
And yet, I found that there was no significant difference in the change in length 
of these sheaths between unstimulated and stimulated axons (the mean 
change in sheath length 5-7 dpf per axon was 8.9 µm for vehicle, and 10.8 µm 
for capsaicin; unpaired t-test, p = 0.861, Figure 31D). Nevertheless, the 
sample size was smaller for this analysis (n = 3-4 per group), and this 
calculation may thus be underpowered. A power calculation suggests that, with 
the variability observed in Figure 31D, a sample size of 876 per group would 
be required to reach 80% power. Therefore, any effect of neuronal activity on 
sheath dynamics 5-7 dpf is likely to be negligible, even on sheaths with space 
in which to grow, reflecting the limited remodelling of myelin along these axons 




Figure 31 – later sheath dynamics along chemogenetically stimulated 
individual RS axons. 
A) Example images of myelin sheath growth 5-7 dpf on TRPV1-RFP+ RS axons. 
White arrows = the edges of the myelin sheath. B) The mean change in sheath 
length 5-7 dpf of earliest born sheaths along individual TRPV1-RFP+ RS axons 
treated with either vehicle or 1 µM capsaicin. ‘Earliest born sheaths’ were defined 
as sheaths which were formed prior to imaging at 3 dpf. The mean change in sheath 
length 5-7 dpf per axon was 5.8 µm (SD = 4.8) for vehicle, and 0.1 µm (SD = 3.5) 
for capsaicin. There was no statistically significant difference between the two 
groups (unpaired t-test, p = 0.056, vehicle n = 6, capsaicin n = 5). C) The mean 
change in sheath length 5-7 dpf of later born sheaths along individual TRPV1-RFP+ 
RS axons treated with either vehicle or 1 µM capsaicin. ‘Later born sheaths’ were 
defined as sheaths born between the 3 and 5 dpf imaging sessions. Only sheaths 
which still had room to grow at 5 dpf were included in this analysis. The mean 
change in sheath length 5-7 dpf per axon was 11.1 µm (SD = 4.2) for vehicle, and 
9.7 µm (SD = 4.0) for capsaicin. There was no statistically significant difference 
between the two groups (unpaired t-test, p = 0.548; vehicle n = 10, capsaicin n = 
5). D) The mean change in sheath length 5-7 dpf of sheaths with room still to grow 
at 7 dpf along individual TRPV1-RFP+ RS axons treated with either vehicle or 1 µM 
capsaicin. ‘Sheaths with room still to grow at 7 dpf’ were defined as sheaths which 
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had at least a total of 20 µm of unmyelinated adjacent axonal space at 7 dpf. The 
mean change in sheath length 5-7 dpf per axon was 8.9 µm (SD = 14.2) for vehicle, 
and 10.8 µm (SD = 11.4) for capsaicin. There was no statistically significant 
difference between the two groups (unpaired t-test, p = 0.861, vehicle n = 4, 
capsaicin n = 3). Scale bar = 10 µm. 
 
4.2.5. Sheath Growth and Shrinkage 
Thus far, I have calculated the mean change in sheath length per axon of early- 
and later-formed myelin sheaths 3-7 dpf, without discriminating between the 
growth and shrinkage of the distinct sheaths along those axons. It is possible 
that neuronal activity may specifically change either the growth or shrinkage of 
individual sheaths along axons, which would not necessarily be detected by 
assessing the mean changes in sheath length. However, none of the sheaths 
which were followed 3-5 dpf shrank in length; therefore, neuronal activity must 
promote sheath growth between 3 to 5 dpf, rather than inhibit sheath 
shrinkage. 
In Chapter 3, I showed that both sheath growth and shrinkage occur along 
individual RS axons between 5 to 7 dpf, albeit to a limited extent. I proceeded 
to quantify sheath growth and shrinkage along unstimulated and stimulated 
RS axons 5-7 dpf in order to test if neuronal activity affects myelin remodelling 
at these stages (Figure 32). This analysis was performed on cells where the 
same individual sheaths could be followed between 5 to 7 dpf. I found that, 
although there was a 46% reduction in the median amount of 5-7 dpf sheath 
growth along stimulated axons compared to unstimulated (Mann-Whitney 
effect size r = 0.26), this was not a statistically significant difference (the 
median sheath growth along vehicle-treated axons was 19.8 µm/100 µm axon, 
and for capsaicin-treated axons was 10.7 µm/100 µm axon; Mann-Whitney 
test, p = 0.171, Figure 32A). A power calculation confirms that this test has 
only 18% power, with an n of 86 required to reach 80% power. As noted above 
in section ‘4.2.4 Activity Does Not Affect Later (5-7 dpf) Myelin Sheath 
Dynamics’, it is possible that the sheaths along stimulated axons do, indeed, 
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exhibit less growth than unstimulated axons 5-7 dpf. This could be a result of 
the transient enhancement of sheath growth between 3 to 5 dpf, which leaves 
sheaths with less available space into which to grow, or because these sheaths 
downregulate growth 5-7 dpf to eventually reach the same length as sheaths 
along unstimulated axons. 
Next, I assessed the rates of sheath shrinkage along axons with normal or 
increased activity. I found that there was no significant effect of neuronal 
stimulation on sheath shrinkage 5-7 dpf (the median sheath shrinkage along 
vehicle-treated axons was -3.3 µm/100 µm axon, and for capsaicin-treated 
axons was -2.8 µm/100 µm axon; Mann-Whitney test, p = 0.835. Vehicle n = 
16, capsaicin n = 12; Figure 32B).  
 
Figure 32 – sheath growth and shrinkage 5-7 dpf along unstimulated and 
stimulated RS axons. 
A) The sheath growth along RS axons 5-7 dpf vehicle or 1 µM capsaicin. The 
median sheath growth along TRPV1-RFP axons treated with vehicle was 19.8 
µm/100 µm axon (IQR = 9.2-28.3), and for capsaicin-treated axons was 10.7 
µm/100 µm axon (IQR = 4.4-19.8). There was no statistically significant difference 
between the two groups (Mann-Whitney test, p = 0.171; vehicle n = 16, capsaicin n 
= 12).  B) The sheath shrinkage along RS axons 5-7 dpf vehicle or 1 µM capsaicin. 
The median sheath shrinkage along TRPV1-RFP axons treated with vehicle was -
3.3 µm/100 µm axon (IQR = (-5.2)-(0)), and for capsaicin-treated axons was -2.8 
µm/100 µm axon (IQR = (-4.2)-(0)). There was no statistically significant difference 
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between the two groups (Mann-Whitney test, p = 0.835; vehicle n = 16, capsaicin n 
= 12). 
 
Based on these results, I concluded that neuronal activity does not affect the 
dynamics of myelin sheaths 5-7 dpf (although increased n is likely to reveal 
that growth of myelin sheaths after 5 dpf is downregulated along stimulated 
axons). 
4.2.6. Effects of Single Axon Stimulation on Sheath Retraction 
Timelapse and time course analyses of single oligodendrocytes has shown 
that myelin sheaths can be retracted, typically within a short period after their 
formation (Baraban et al., 2018; Hines et al., 2015; Mensch et al., 2015). Ca2+ 
imaging in oligodendrocytes identified large-amplitude long-duration Ca2+ 
events in sheaths immediately prior to their retraction, which suggests that 
sheaths can receive local signals that can induce retraction (Baraban et al., 
2018). There is also evidence that inhibiting synaptic vesicle release in axons 
increases the retraction of short myelin sheaths (Hines et al., 2015).  
I have demonstrated that sheath retractions can occur along RS axons after 
the initial period of myelin sheath formation (see section ‘3.2.2 Changes in 
Sheath Number over Time’); however, it is not known how neuronal activity 
affects sheath retractions. To investigate this, I followed individual myelin 
sheaths along unstimulated and stimulated axons, and quantified the number 
of sheath retractions which occurred. Only one out of the 17 sheaths formed 
before imaging at 3 dpf was retracted by 5 dpf, suggesting that very few sheath 
retractions occur during early stages of myelination. However, it is likely that a 
significant amount of sheath dynamics are missed between the imaging 
sessions on 3 and 5 dpf, and that many small sheaths or contacts form and 
retract within this time period. 
Sheath retractions were also observed between 5 to 7 dpf (Figure 33A). I have 
previously shown that virtually all of the sheaths which are retracted during this 
time period are under 10 µm long, and that the fate of myelin sheaths appears 
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to correlate with their length (section ‘3.2.2 Changes in Sheath Number over 
Time’). Therefore, I restricted the analysis to axons which had sheaths which 
were of a size capable of being retracted (that is, axons which had sheaths < 
10 µm in length at 5 dpf). There was a 57% reduction in the number of sheaths 
retracted along stimulated axons compared to controls 5-7 dpf (Cohen’s d 
effect size = 1.13). However, this difference was not statistically significant (the 
mean number of sheath retractions/100 µm axon 5-7 dpf was 0.7 for vehicle, 
and 0.3 for capsaicin; unpaired t-test, p = 0.112, Figure 33B). A power 
calculation indicates that this analysis has only 41% power, and that increasing 
the sample size from six to 16 per group is required to reach 80% power. 
These results suggest that activity can likely reduce the rate of sheath 
retractions along an axon, but further analysis is required to determine whether 
this phenotype would reach statistical significance. 
 




A) Example images of sheath retraction occurring 5-7 dpf on TRPV1-RFP+ RS 
axons treated with either vehicle or 1 µM capsaicin. White arrows = unmyelinated 
gaps between myelin sheaths, blue arrow heads = myelin sheaths. In each example 
one myelin sheath is retracted 5-7 dpf. B) Quantification of sheath retractions along 
vehicle or 1 µM capsaicin treated RS axons. Only axons which had any retractable 
sheaths (sheaths < 10 µm in length) were analysed. The mean number of sheath 
retractions/100 µm axon 5-7 dpf was 0.7 (SD = 0.4) for vehicle, and 0.3 (SD = 0.3) 
for capsaicin. There was no statistically significant difference between the two 
groups (unpaired t-test, p = 0.112, vehicle n = 6, capsaicin n = 6). Scale bar = 10 
µm. 
 
4.2.7. Neuronal Activity Affects the Formation of Myelin Patterns along 
Individual Axons 
Analysis of sheath dynamics along unstimulated and stimulated axons 
indicates that activity promotes the growth of myelin sheaths during a critical 
developmental period, after which sheaths no longer respond to neuronal 
activity. In Chapter 3, I demonstrated that the myelin pattern (the number and 
length of myelin sheaths) along RS axons is established by 7 dpf. It is not clear 
whether promoting sheath growth 3-5 dpf permanently alters the myelin 
patterns established on RS axons by 7 dpf. To investigate this, I characterised 
the myelin patterns of unstimulated and stimulated axons by measuring the 
number and length of their myelin sheaths at 3, 5, and 7 dpf. 
Myelin Patterns along all RS Axons Imaged 
Prior to any manipulation, all of the RS axons imaged were predominantly 
unmyelinated at 3 dpf (median % axon myelinated at 3 dpf was 3.2% for 
vehicle, and 3.6% for capsaicin; Mann-Whitney test, p = 0.677, Figure 34A). 
Daily stimulation of neuronal activity did not significantly change the proportion 
of the axon which was myelinated from a statistical point of view (median % 
axon myelinated at 5 dpf being 74.3% for vehicle and 81.2% for capsaicin; and 
at 7 dpf being 91.5% for vehicle and 96.0% for capsaicin (Mann-Whitney tests; 
5 dpf p = 0.304, 7 dpf p = 0.531, Figure 34A)). It is, nevertheless, interesting 
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to note the slight increase in % axon myelinated in stimulated axons at both 
ages. 
I have shown that neuronal activity promotes the growth of myelin sheaths 3-
5 dpf (Figure 29). However, whether this results in permanently longer myelin 
sheaths along stimulated versus unstimulated RS axons was not clear. The 
mean sheath length for each axon was calculated at each age; prior to 
stimulation, the mean sheath length per axon at 3 dpf was 5.7 µm for vehicle, 
and 4.7 µm for capsaicin. Intriguingly, I found that there was no statistically 
significant effect of daily activity stimulation on overall mean sheath length at 
either 5 or 7 dpf (mean sheath length per axon at 5 dpf was 28.9 µm for vehicle, 
and 31.7 µm for capsaicin; and at 7 dpf was 37.6 µm for vehicle, and 37.2 µm 
for capsaicin; unpaired t-tests, 5 dpf p = 0.431, 7 dpf p = 0.927, Figure 34B). 
Similarly, sheath number (normalised to length of axon analysed) was not 
significantly changed by daily stimulation at any age (the mean sheath number 
/100 µm axon at 3 dpf was 0.7 for vehicle, and 0.6 for capsaicin; at 5 dpf was 
2.7 for vehicle, and 2.6 for capsaicin; and at 7 dpf was 2.5 for vehicle, and 2.5 
for capsaicin; unpaired t-tests, 3 dpf p = 0.641, 5 dpf p = 0.880, 7 dpf p = 0.884, 
Figure 34C). 
This data suggests that, although neuronal activity can accelerate the growth 
of myelin sheaths during a critical period, it does not change the final myelin 




Figure 34 – the myelin pattern of individual chemogenetically stimulated RS 
axons. 
A) The amount of myelin along RS axons at 3, 5, and 7 dpf treated with either 
vehicle or 1 µM capsaicin. The median % axon myelinated at 3 dpf was 3.2% (IQR 
= 0.9-8.4) for vehicle, and 3.6% (IQR = 0-6.2) for capsaicin; at 5 dpf was 74.3% 
(IQR = 50.6-93.9) for vehicle and 81.2% (IQR = 69.5-95.1) for capsaicin; and at 7 
dpf was 91.5% (IQR = 76.9-97.3) for vehicle and 96.0% (IQR = 89.4-97.2) for 
capsaicin. There was no statistically significant difference between the two groups 
at any age (Mann-Whitney tests; 3 dpf p = 0.677, vehicle n = 21, capsaicin n = 17; 
5 dpf p = 0.304, vehicle n = 21, capsaicin n = 17; 7 dpf p = 0.531, vehicle n = 16, 
capsaicin n = 12). B) The average sheath length along RS axons at 3, 5, and 7 dpf 
treated with either vehicle or 1 µM capsaicin. The mean sheath length per axon at 
3 dpf was 5.7 µm (SD = 4.6) for vehicle, and 4.7 µm (SD = 4.3) for capsaicin; at 5 
dpf was 28.9 µm (SD = 11.1) for vehicle, and 31.7 µm (SD = 10.6) for capsaicin; 
and at 7 dpf was 37.6 µm (SD = 10.3) for vehicle, and 37.2 µm (SD = 9.4) for 
capsaicin. There was no statistically significant difference between the two groups 
at any age (unpaired t-tests; 3 dpf p = 0.489, vehicle n = 21, capsaicin n =17; 5 dpf 
p = 0.431, vehicle n = 21, capsaicin n =17; 7 dpf p = 0.927, vehicle n = 16, capsaicin 
n = 12). C) The number of sheaths along RS axons at 3, 5 and 7 dpf treated with 
either vehicle or 1 µM capsaicin. The mean sheath number at 3 dpf was 0.7 /100 
µm axon (SD = 0.6) for vehicle, and 0.6 /100 µm axon (SD = 0.6) for capsaicin; at 
5 dpf was 2.7 /100 µm axon (SD = 0.6) for vehicle, and 2.6 /100 µm axon (SD = 
0.4) for capsaicin; and at 7 dpf was 2.5 /100 µm axon (SD = 0.6) for vehicle, and 
2.5 /100 µm axon (SD = 0.4) for capsaicin. There was no statistically significant 
difference between the two groups at any age (unpaired t-tests; 3 dpf p = 0.641, 
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vehicle n = 21, capsaicin n = 17; 5 dpf p = 0.880, vehicle n = 21, capsaicin n = 17; 
7 dpf p = 0.884, vehicle n = 16, capsaicin n = 12). 
 
Myelin Patterns of Axons with and without Early born Sheaths 
Overall, there was no significant long-lasting change to the myelin patterns of 
RS axons upon chemogenetic stimulation. However, there was variation in the 
timescale of myelination within the population of RS axons analysed. As noted 
above in section ‘4.2.3 Activity Promotes Early (3-5 dpf) Myelin Sheath 
Dynamics’, on some RS axons myelination began before imaging at 3 dpf, 
whereas, on other RS axons myelination did not start until between 3 and 5 
dpf. My data indicate that neuronal activity only increases the growth of the 
earliest born sheaths on axons (sheaths formed before 3 dpf) between 3 to 5 
dpf, and that activity does not significantly affect the dynamics of any myelin 
sheaths after 5 dpf (Figure 29, Figure 31, Figure 32). Consequently, neuronal 
activity might, in principle, selectively affect the myelin patterns of axons where 
myelination begins before 3 dpf (along axons with early born sheaths) more 
than axons where myelination begins between 3 and 5 dpf (axons without early 
born sheaths). I investigated whether activity differentially affected the myelin 
patterns of RS axons with and without early born sheaths. The myelin patterns 
were assessed along cells where the same portion of axon could be followed 
3-7 dpf. 
For axons with early born sheaths, chemogenetic stimulation did not 
significantly change the proportion of axon which was myelinated (the median 
% axon myelinated at 3 dpf was 8.4% for vehicle-treated axons, 6.2% for 
capsaicin-treated axons; at 5 dpf was 85.9% for vehicle, 96.4% for capsaicin; 
and at 7 dpf was 96.7% for vehicle, and 96.7% for capsaicin; Mann-Whitney 
tests; 3 dpf p = 0.931; 5 dpf p = 0.429; 7 dpf p = 0.662; Figure 35A).  Neither 
the number nor the length of myelin sheaths along early myelinated axons 
were significantly different between unstimulated and stimulated groups at 3 
dpf (the mean sheath length per axon at 3 dpf was 9.9 µm for vehicle, 7.6 µm 
for capsaicin, unpaired t-test p = 0.384; mean sheath number (normalised to 
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length of axon analysed) at 3 dpf was 1.0 /100 µm axon for vehicle, 1.3 /100 
µm axon for capsaicin, unpaired t-test p = 0.362, Figure 35B, C). By 5 dpf, the 
mean sheath length of stimulated axons was 42% longer than controls, in line 
with the observed increase in growth rate over this period (albeit not quite 
statistically significant; mean sheath length at 5 dpf was 28.4 µm for vehicle, 
40.3 µm for capsaicin, unpaired t-test p = 0.071). There was also a 12% 
reduction in sheath number along stimulated axons compared to controls 
(again, not quite statistically significant; mean sheath number at 5 dpf was 2.6 
/100 µm axon for vehicle, 2.3 /100 µm axon for capsaicin, unpaired t-test p = 
0.098, Figure 35B, C). By 7 dpf, there was a statistically significant difference 
in both sheath length and sheath number between unstimulated and 
stimulated groups (mean sheath length at 7 dpf was 34.1 µm for vehicle, and 
43.7 µm for capsaicin, unpaired t-test p = 0.045; mean sheath number at 7 dpf 
was 2.7 /100 axon µm for vehicle, and 2.1 /100 µm axon for capsaicin, 
unpaired t-test p = 0.037, Figure 35B, C).  
In summary, despite the fact that both stimulated and unstimulated axons were 
myelinated to the same extent, neuronal activity induced subtle changes in the 
myelin pattern formed along axons with early born myelin sheaths. These 
axons had longer myelin sheaths because chemogenetic stimulation promoted 
the growth of early born myelin sheaths 3-5 dpf. This increase in sheath length 
likely reduced the available axonal space for new sheaths to form, and so 
fewer later born myelin sheaths were made along these axons.  
Axons without early born myelin sheaths also exhibited no significant 
differences in the proportion of axon which was myelinated upon 
chemogenetic stimulation (median % axon myelinated at 5 dpf was 75.7% for 
vehicle, 82.6% for capsaicin; and at 7 dpf was 91.9% for vehicle, and 95.6% 
for capsaicin; Mann-Whitney tests, 5 dpf p = 0.886; 7 dpf p = 1.000; Figure 
35D). Unlike the axons which did have early born sheaths, chemogenetic 
stimulation did not increase sheath length along axons without early born 
sheaths (mean sheath length at 5 dpf was 32.1 µm for vehicle, and 26.5 µm 
for capsaicin; and at 7 dpf was 42.0 µm for vehicle, and 33.4 µm for capsaicin; 
unpaired t-tests, 5 dpf p = 0.603; 7 dpf p = 0.288; Figure 35E). There may be 
202 
 
a trend towards a decrease in sheath length, with mean sheath length at 7 dpf 
being 20% shorter along stimulated axons than controls. There was also no 
significant change in sheath number (mean sheath number at 5 dpf was 2.6 
/100 µm axon for vehicle, 3.0 /100 µm axon for capsaicin; and at 7 dpf was 2.3 
/100 µm for vehicle, and 2.8 /100 µm for capsaicin; unpaired t-tests 5 dpf p = 
0.445; 7 dpf p = 0.262; Figure 35F). Again, there may be a trend towards an 
increase in sheath number, with mean sheath number being 22% increased 
along stimulated axons compared to controls. 
In summary, neuronal activity does not significantly alter the extent of 
myelination along axons without early born sheaths. It is possible that neuronal 
activity subtly changes the myelin pattern along these axons, where stimulated 
axons may have more, but shorter, sheaths than controls; however, this is not 
statistically significant, and requires further investigation to confirm. This 
potential reduction in sheath length may appear counterintuitive given my 
previous findings that activity promotes sheath growth during a critical period 
between 3 to 5 dpf. Nevertheless, a reduction in sheath length and increase in 
sheath number could be explained by changes to the rate of sheath retraction. 
Neuronal activity may prevent sheath retractions (as indicated by my data in 
Figure 33). With more sheaths competing for the same amount of axonal 
space, the mean sheath length may be shorter along stimulated axons than 
controls. An increased n number is required to determine if changes to sheath 




Figure 35 – the myelin patterns of RS axons with and axons without early born 
sheaths after chemogenetic stimulation. 
A) The myelin coverage along RS axons with early born sheaths at 3, 5, and 7 dpf 
treated with vehicle or 1 µM capsaicin. The median % axon myelinated at 3 dpf was 
8.4% (IQR = 5.3-12.7) for vehicle, 6.2% (IQR = 5.9-17.2) for capsaicin; at 5 dpf was 
85.9% (IQR = 44.8-96.6) for vehicle, 96.4% (IQR = 81.0-96.9) for capsaicin; and at 
7 dpf was 96.7% (IQR = 77.8-97.3) for vehicle, and 96.7 (IQR = 86.0-98.1) for 
capsaicin. There was no statistically significant difference between the two groups 
at any age (Mann-Whitney tests; 3 dpf p = 0.931; 5 dpf p = 0.429; 7 dpf p = 0.662; 
vehicle n = 6, capsaicin n = 5). B) The mean sheath length along RS axons with 
early born sheaths at 3, 5, and 7 dpf treated with vehicle or 1 µM capsaicin. The 
mean sheath length at 3 dpf was 9.9 µm (SD = 4.6) for vehicle, 7.6 µm (SD = 3.2) 
for capsaicin; at 5 dpf was 28.4 µm (SD = 11.2) for vehicle, 40.3 µm (SD = 7.0) for 
capsaicin; and at 7 dpf was 34.1 µm (SD = 8.4) for vehicle, and 43.7 µm (SD = 4.0) 
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for capsaicin. There was a statistically significant difference between vehicle and 
capsaicin at 7 dpf (unpaired t-tests; 3 dpf p = 0.384; 5 dpf p = 0.071; 7 dpf p = 0.045; 
vehicle n = 6, capsaicin n = 5). C) The number of sheaths (normalised to length of 
axon analysed) along RS axons with early born sheaths at 3, 5, and 7 dpf treated 
with vehicle or 1 µM capsaicin. The mean sheath number at 3 dpf was 1.0 /100 µm 
axon (SD = 0.4) for vehicle, 1.3 /100 µm axon (SD = 0.5) for capsaicin; at 5 dpf was 
2.6 /100 µm axon (SD = 0.4) for vehicle, 2.3 /100 µm axon (SD = 0.2) for capsaicin; 
and at 7 dpf was 2.7 /100 axon µm (SD = 0.5) for vehicle, and 2.1 /100 µm axon 
(SD = 0.2) for capsaicin. There was a statistically significant difference between 
vehicle and capsaicin at 7 dpf (unpaired t-tests; 3 dpf p = 0.362; 5 dpf p = 0.098; 7 
dpf p = 0.037; vehicle n = 6, capsaicin n = 5). D) The myelin coverage along RS 
axons without early born sheaths at 5 and 7 dpf treated with vehicle or 1 µM 
capsaicin. The median % axon myelinated at 5 dpf was 75.7% (IQR = 55.4-85.3) 
for vehicle, 82.6% (IQR = 53.6-86.5) for capsaicin; and at 7 dpf was 91.9% (IQR = 
77.6-97.4) for vehicle, and 95.6% (IQR = 89.4-96.5) for capsaicin. There was no 
statistically significant difference between the two groups at any age (Mann-
Whitney tests; 5 dpf p = 0.886; 7 dpf p = 1.000; vehicle n = 4, capsaicin n = 4). E) 
The mean sheath length along RS axons without early born sheaths at 5 and 7 dpf 
treated with either vehicle or 1 µM capsaicin. The mean sheath length per axon at 
5 dpf was 32.1 µm (SD = 17.5) for vehicle, and 26.5 µm (SD = 10.7) for capsaicin; 
and at 7 dpf was 42.0 µm (SD = 12.5) for vehicle, and 33.4 µm (SD = 7.7) for 
capsaicin. There was no statistically significant difference between the two groups 
at any age (unpaired t-tests; 5 dpf p = 0.603; 7 dpf p = 0.288; vehicle n = 4, capsaicin 
n = 4). F) The number of sheaths (normalised to length of axon analysed) along RS 
axons without early born sheaths at 5 and 7 dpf treated with either vehicle or 1 µM 
capsaicin. The mean sheath number at 5 dpf was 2.6 /100 µm axon (SD = 0.8) for 
vehicle, 3.0 /100 µm axon (SD = 0.6) for capsaicin; and at 7dpf was 2.3 /100 µm 
(SD = 0.7) for vehicle, and 2.8 /100 µm (SD = 0.4) for capsaicin. There was no 
statistically significant difference between the two groups at any age (unpaired t-






4.2.8. Increasing Neuronal Activity Using TRPV1 Does Not Affect Node 
Length or Axon Diameter 
As discussed in Chapter 3, node length may also influence conduction 
properties. It is possible that a subtle difference in sheath length could 
significantly change the length of nodes, or that activity directly changes nodal 
architecture itself. I measured the length of nodes at 3, 5, and 7 dpf to see if 
chemogenetic stimulation affected nodal development during this time period. 
The reporter FP-Cntn1a labels unmyelinated gaps between myelin sheaths, 
including nodes of Ranvier. However, it does not specifically label mature 
nodes of Ranvier. Therefore, I cannot definitively identify which gaps between 
myelin sheaths are mature nodes of Ranvier, and which are simply larger 
regions of unmyelinated axon. To exclude larger unmyelinated gaps which 
were definitely not mature nodes, I only analysed gaps which were under 5 µm 
in length (these were termed nodal gaps).  
At 3 dpf, axons did not have sufficient myelin coverage to have any nodal gaps. 
There was no significant difference in nodal gap length at either 5 or 7 dpf 
between the unstimulated and stimulated axons (the median nodal gap length 
at 5 dpf was 1.23 µm for vehicle, and 1.13 µm for capsaicin; and at 7 dpf was 
0.90 µm for vehicle, and 1.08 µm for capsaicin; Mann-Whitney tests, 5 dpf p = 
0.875, 7 dpf p = 0.244, Figure 36B).  
Sheath growth may have an impact on the size of nodes of Ranvier, and so 
signals which impact sheath growth may impact node length. I have shown 
that neuronal activity promotes the growth of early born sheaths 3-5 dpf; this 
changes the myelin pattern formed along axons which have early born 
sheaths. It is possible that the enhancement of early born myelin sheath growth 
alters the length of nodes along axons with early born sheaths. Therefore, 
nodal gap length analysis was broken down into axons which had early born 
myelin sheaths and axons which did not have early born myelin sheaths. 
However, for axons with early born sheaths, there was no significant difference 
in the average nodal gap length with chemogenetic stimulation (median nodal 
gap length at 5 dpf was 1.02 µm for vehicle, 1.14 µm for capsaicin; and at 7 
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dpf was 0.91 µm for vehicle, and 1.07 µm for capsaicin; Mann-Whitney tests, 
5 dpf p = 0.905, 7 dpf p = 1.000; Figure 37B). For axons without early born 
sheaths, there was also no significant change in nodal gap length (the median 
nodal gap length at 5 dpf was 1.58 µm for vehicle, 1.48 µm for capsaicin; and 
at 7 dpf was 0.93 µm for vehicle, and 1.09 µm for capsaicin; unpaired t-tests, 
5 dpf p = 0.582, 7 dpf p = 0.249; Figure 37D). It is important to note that, due 
to limitations in image resolution, it was not possible to measure the nodal gap 
lengths of some axons at 7 dpf (hence, there are fewer n in Figure 37 than in 
Figure 35). 
Axon diameter is another parameter which may, in principal, be significantly 
altered by activity, in order to modulate conduction properties. In rodents, 
reducing activity in the auditory system using ear plugs leads to development 
of thinner axons in the trapezoid body (Sinclair et al., 2017). To investigate 
whether increasing the activity along single axons regulates axon size, axon 
diameter was measured using the same method as described in Chapter 3 (in 
brief: the area and length of a region of axon was measured and then used to 
calculate diameter). The diameter of unstimulated versus stimulated axons 
was not significantly different at any age (the mean axon diameter at 3 dpf was 
0.86 µm for vehicle, and 0.89 µm for capsaicin; at 5 dpf was 1.10 µm for 
vehicle, and 1.15 µm for capsaicin; and at 7 dpf was 1.16 µm for vehicle, and 
1.25 µm for capsaicin; unpaired t-tests, 3 dpf p = 0.332, 5 dpf p = 0.315, 7 dpf 
p = 0.153, Figure 36A).  
I have shown that axons with early born myelin sheaths have significantly 
different myelin patterns (fewer but longer myelin sheaths) upon chemogenetic 
stimulation, whereas axons without early born myelin sheaths did not exhibit 
these changes to myelin patterns. Axons with specific myelin patterns may 
exhibit differences in axon diameter growth. To investigate this, I analysed the 
diameter of axons with and without early born myelin sheaths over time. 
However, I found that there was no significant change to the diameter of axons 
with or without early born sheaths upon chemogenetic stimulation (for axons 
with early born sheaths: the mean axon diameter at 3 dpf was 0.94 µm for 
vehicle, 0.93 µm for capsaicin; at 5 dpf was 1.09 µm for vehicle, 1.21 µm for 
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capsaicin; and at 7 dpf was 1.14 µm for vehicle, and 1.28 µm for capsaicin; 
unpaired t-tests; 3 dpf p = 0.871, 5 dpf p = 0.250, 7 dpf p = 0.243; Figure 37A. 
For axons without early born sheaths: mean axon diameter at 3 dpf was 0.81 
µm for vehicle, 0.90 µm for capsaicin; at 5 dpf was 1.10 µm for vehicle, 1.16 
µm for capsaicin; and at 7 dpf was 1.14 µm for vehicle, and 1.23 µm for 
capsaicin; unpaired t-tests, 3 dpf p = 0.202, 5 dpf p = 0.541, 7 dpf p = 0.417; 
Figure 37C). Again, it should be noted that limitations in image resolution 
meant that axon diameter could not be measured for all axons at 7 dpf 
(therefore, there are fewer n in Figure 37 than in Figure 35). 
 
Figure 36 – axon diameter and nodal gap length of individual 
chemogenetically stimulated RS axons. 
A) The diameter of RS axons at 3, 5, and 7 dpf treated with either vehicle or 1 µM 
capsaicin. The mean axon diameter at 3 dpf was 0.86 µm (SD = 0.09) for vehicle, 
and 0.89 µm (SD = 0.08) for capsaicin; at 5 dpf was 1.10 µm (SD = 0.16) for vehicle, 
and 1.15 µm (SD = 0.13) for capsaicin; and at 7 dpf was 1.16 µm (SD = 0.15), and 
1.25 µm (SD = 0.17) for capsaicin. There was no statistically significant difference 
between the two groups at any age (unpaired t-tests; 3 dpf p = 0.332, n = 21, 
capsaicin n = 17; 5 dpf p = 0.315, n = 21, capsaicin n =17; 7 dpf p = 0.153, vehicle 
n = 16, capsaicin n = 12). B) The mean nodal gap length per RS axon at 3, 5, and 
7 dpf treated with either vehicle or 1 µM capsaicin. Nodal gap was defined as 
unmyelinated gaps between two sheaths which were < 5 µm in length. The median 
mean nodal gap length at 5 dpf was 1.23 µm (IQR = 0.93-1.46) for vehicle, and 1.13 
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µm (IQR = 0.96-1.56) for capsaicin; and at 7 dpf was 0.90 µm (IQR = 0.86-1.08) for 
vehicle, and 1.08 µm (IQR = 0.92-1.25) for capsaicin. There was no statistically 
significant difference between the two groups at any age (Mann-Whitney tests; 5 
dpf, p = 0.875, vehicle n = 14, capsaicin n = 9; 7 dpf p = 0.244, vehicle n = 14, 
capsaicin n = 9). 
 
 
Figure 37 – axon diameter and nodal gap length of chemogenetically 
stimulated RS axons with and without early born myelin sheaths. 
A) The diameter of RS axons with early born myelin sheaths at 3, 5, and 7 dpf 
treated with either vehicle or 1 µM capsaicin. The mean axon diameter at 3 dpf was 
0.94 µm (SD = 0.07) for vehicle, 0.93 µm (SD = 0.04) for capsaicin; at 5 dpf was 
1.09 µm (SD = 0.14) for vehicle, 1.21 µm (SD = 0.18) for capsaicin; and at 7 dpf 
was 1.14 µm (SD = 0.14) for vehicle, and 1.28 µm (SD = 0.20) for capsaicin. There 
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was no statistically significant differences between the two groups at any age 
(unpaired t-tests; 3 dpf p = 0.871, vehicle n = 6, capsaicin n = 5; 5 dpf p = 0.250, 
vehicle n = 6, capsaicin n = 5; 7 dpf p = 0.243, vehicle n = 6, capsaicin n = 4). B) 
The nodal gap length along RS axons with early born myelin sheaths at 5 and 7 dpf 
treated with either vehicle or 1 µM capsaicin. The median mean nodal gap length 
at 5 dpf was 1.02 µm (IQR = 0.77-1.31) for vehicle, 1.14 µm (IQR = 0.93-1.20) for 
capsaicin; and at 7 dpf was 0.91 µm (0.85-1.65) for vehicle, and 1.07 µm (IQR = 
0.82-1.46) for capsaicin. There was no statistically significant difference between 
the two groups at any age (Mann-Whitney tests; 5 dpf p = 0.905; 7 dpf p = 1.000; 
vehicle n = 5, capsaicin n = 4). C) The diameter of RS axons without early born 
myelin sheaths at 3, 5, and 7 dpf treated with either vehicle or 1 µM capsaicin. The 
mean axon diameter at 3 dpf was 0.81 µm (SD = 0.10) for vehicle, 0.90 µm (SD = 
0.08) for capsaicin; at 5 dpf was 1.10 µm (SD = 0.15) for vehicle, 1.16 µm (SD = 
0.10) for capsaicin; and at 7 dpf was 1.14 µm (SD = 0.13) for vehicle, and 1.23 µm 
(SD = 0.03) for capsaicin. There was no statistically significant differences between 
the two groups at any age (unpaired t-tests; 3 dpf p = 0.202, vehicle n = 4, capsaicin 
n = 4; 5 dpf p = 0.541, vehicle n = 4, capsaicin n = 4; 7 dpf p = 0.417, vehicle n = 4, 
capsaicin n = 2). D) The nodal gap length along RS axons with early born myelin 
sheaths at 5 and 7 dpf treated with either vehicle or 1 µM capsaicin. The median 
mean nodal gap length at 5 dpf was 1.58 µm (IQR = 1.43-2.15) for vehicle, 1.48 µm 
(IQR = 1.05-1.91) for capsaicin; and at 7 dpf was 0.93 µm (IQR = 0.88-1.10) for 
vehicle, and 1.09 µm (IQR = 1.08-1.10) for capsaicin. Non-parametric tests could 
not be used for statistical comparison due to insufficient sample size. However, 
there was no statistically significant difference between the two groups at any age 
using parametric tests (unpaired t-tests; 5 dpf p = 0.582, vehicle n = 4, capsaicin n 










Here, I have investigated how increasing the activity of individual RS neurons 
affects their myelination (Figure 38A). I have found that stimulating individual 
axons did not affect local oligodendrogenesis. Stimulating individual RS axons 
promoted the growth of early born myelin sheaths 3-5 dpf. After 5 dpf, 
stimulation had no significant effect on the growth or shrinkage of any myelin 
sheaths. Very few sheath retractions were observed 3-5 dpf; however, there 
was a reduction in the number of sheaths retracted from stimulated axons 
compared to unstimulated controls 5-7 dpf (although, this underpowered 
analysis did not reach statistical significance).  
Based on these phenotypes, chemogenetic stimulation changed the myelin 






Figure 38 – the effects of neuronal activity on myelinated axon development: 
a summary of this chapter’s results. 
A) A timeline showing the effects of neuronal activity on RS axon myelination in the 
zebrafish spinal cord. Increasing activity by chemogenetic stimulation has no effect 
on oligodendrocyte production, axon diameter growth, or node length 3-7 dpf. 
Chemogenetic stimulation increases the growth of myelin sheaths 3-5 dpf, but does 
not affect sheath growth after 5 dpf. Chemogenetic stimulation may reduce the rate 
of sheath retractions 5-7 dpf. B) Myelin pattern formation along axons with early 
born myelin sheaths, based on the phenotypes described above. Some RS axon 
begin myelination prior to 3 dpf. At 3 dpf, increased activity promotes the growth of 
the early born sheaths. By 5 dpf, stimulated axons have fewer myelin sheaths 
(possibly because there was less space for new sheaths to be formed 3-5 dpf). 
After 5 dpf, activity does not affect the growth dynamics of sheaths. By 7 dpf, 
stimulated axons have fewer but longer sheaths than unstimulated axons. C) Myelin 
pattern formation along axons without early born myelin sheaths, based on the 
phenotypes described above. Some RS axons are completely unmyelinated at 3 
dpf. By 5 dpf, there is no noticeable effect of activity on sheath number or sheath 
length. Activity may inhibit sheath retractions 5-7 dpf. By 7 dpf, stimulated axons 
may have more sheaths due to fewer sheath retractions, possibly leading to a 













4.3.1. Increasing Neuronal Activity of a Single Axon Promotes Sheath Growth 
3-5 dpf 
Research has shown that globally manipulating neuronal activity (either by 
administering TTX to inhibit activity, or using electrodes to increase activity) 
can affect the early growth of myelin sheaths in the zebrafish spinal cord 
(Krasnow et al., 2018). Whether the activity of a single axon could locally 
regulate the growth of its myelin sheaths was not known. Here, I have found 
that chemogenetically stimulating individual RS axons promotes the growth of 
their earliest born myelin sheaths 3-5 dpf. 
 Molecular Mechanism – Glutamate Signalling? 
The molecular mechanism by which neuronal activity promotes the growth of 
early born myelin sheaths along RS axons is not known. One hypothesis is 
that chemogenetic stimulation of RS axons triggers release of the 
neurotransmitter glutamate, which then signals to myelin sheaths in order to 
promote their growth. RS neurons are glutamatergic (Higashijima et al., 2004), 
and preventing neurotransmitter release in single RS axons inhibits their 
myelination by reducing both the number and length of myelin sheaths formed, 
suggesting that glutamate release does, indeed, play a role in myelination 
(Koudelka et al., 2016). There is significant evidence that oligodendroglial 
lineage cells express AMPA, NMDA, and mGlu receptors, and exhibit 
electrophysiological responses to glutamate signalling (as discussed in section 
‘1.6.2 Neurotransmitter Signalling from Neurons to Oligodendroglia’). Myelin 
sheaths may detect glutamate signals from the underlying axon and modulate 
their growth accordingly. 
It is not clear precisely where neurotransmitter release occurs along RS 
neurons in order to regulate myelination. Neurotransmitter release may occur 
along the main axon itself (Figure 39A), as well as at traditional presynaptic 
terminals. Both Kukley et al., 2007 and Ziskin et al., 2007 found that OPCs in 
rodent brain slice appear to form neuro-glial synapses directly with the axonal 
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membrane, so that axonal stimulation induces OPC current responses. 
Neurotransmitters may be released either adjacent to or underneath myelin 
sheaths to influence their growth (Figure 39A). Alternatively, neurotransmitter 
release at presynaptic terminals may signal to myelin sheaths (Figure 39B). 
There may even be some independent signalling mechanism from active 
synapses which then signals to myelin sheaths to regulate their growth (Figure 
39B). More detailed characterisation of where and when neurotransmitter 
vesicles are released is required to properly understand the relationship 
between neurotransmitter signalling and myelin sheath growth. 
The fluorescent reporter SypHy is a fusion of a pH-sensitive GFP (pHluorin) 
with the protein synaptophysin, which localises to synaptic vesicles (Granseth 
et al., 2006). Synaptic vesicles have an acidic pH, and so SypHy fluorescence 
is quenched during vesicle trafficking. However, once the vesicle fuses with 
the extracellular membrane to release vesicular cargo, the pH rapidly 
increases to neutral and SypHy fluorescence is emitted. This reporter has 
been used in RS neurons to quantify synaptic vesicle release from pre-
synapses of branching collaterals (Koudelka et al., 2016). SypHy reporter 
could be expressed in single RS neurons, and coupled with timelapse imaging, 
to identify sites of synaptic vesicle release along RS axons. By co-expressing 
the FP-Cntn1a reporter to visualise the location of growing myelin sheaths 
along an axon, one could correlate the location and rate of vesicular release 
with myelin sheath dynamics over time. It is possible that vesicular release at 
a specific developmental time point, at specific axonal sites, or specific rates 
of vesicular release, correlate with early myelin sheath growth. These 
questions are currently being investigated by Dr. Rafael Almeida in the Lyons 
group, University of Edinburgh. Preliminary results indicate that synaptic 
vesicles are, indeed, released along RS axons, both along unmyelinated 
regions and underneath myelin sheaths themselves. Interestingly, there is 
essentially no synaptic vesicular release associated with myelin sheaths which 
have no space into which to grow (Dr. Rafael Almeida, unpublished). This 
suggests that an axon can detect the growth dynamics of its myelin sheaths 
through some feedback signalling mechanism. Consequently, signals, such as 
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neurotransmitter release, are targeted to myelin sheaths which are still actively 
growing. 
To determine if synaptic vesicle release drives activity-mediated sheath 
growth, TeNT could be co-expressed with TRPV1-RFP in individual RS axons. 
Capsaicin treatment should still increase the electrical activity of the RS neuron 
(which could be assessed by Ca2+ imaging, as in Figure 24), but release of 
synaptic vesicles should be reduced (which could be assessed by SypHy 
imaging). The GFP-Cntn1a reporter could then be used to measure the 
dynamics of myelin sheaths along individual RS axons; if vesicular release 
drives activity-mediated sheath growth, then sheaths on TeNT-expressing 
capsaicin-treated axons should grow at the same rate as sheaths on TeNT-
expressing vehicle-treated axons 3-5 dpf. 
If synaptic vesicle release does occur along axons, and is required for activity-
mediated myelin sheath growth, the next step would be to determine if 
glutamate is the signalling molecule being released. iGluSnFR is a fusion 
between a circularly-permuted GFP and a glutamate-binding protein which can 
be used to live image glutamate levels (Marvin et al., 2013). When the 
GluSnFR protein binds to glutamate, a conformational change resulting in 
emission of fluorescence is induced. Different-coloured variants with faster 
kinetics are now available for detailed characterisation of glutamate transients 
in vivo (Marvin et al., 2018). Membrane-anchored iGluSnFR could be 
expressed on myelin sheaths; co-expressing this with SypHy in RS axons, and 
performing timelapse imaging, could identify whether synaptic vesicle release 
events near or under myelin sheaths corresponds with glutamate release in 
these regions. 
Whether oligodendrocyte expression of glutamate receptors is required for 
activity-mediated sheath growth could also be investigated. Differentiated 
oligodendrocytes express both ionotropic and metabotropic glutamate 
receptors (Berger et al., 1992; Deng et al., 2004; Káradóttir et al., 2005; Luyt 
et al., 2003; Patneau et al., 1994; Salter and Fern, 2005; Žiak et al., 1998). 
Studies have shown that oligodendrocyte-specific loss of AMPA or NMDA 
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receptor sub-units does not appear to affect long-term oligodendrocyte 
development or myelination (De Biase et al., 2011; Kougioumtzidou et al., 
2017; Saab et al., 2016). However, Saab et al., 2016 found that deletion of the 
NMDA receptor subunit NR1 in mice leads to a transient hypomyelination 
phenotype which recovers over time. They saw that NR1 knock-out mice have 
fewer myelinated axons and thinner myelin sheaths in the optic nerve at P18, 
but that both phenotypes recover by P70. In rodents, myelination begins at 
approximately P5-10 in the optic nerve, with extensive myelination occurring 
during the first post-natal month (Gyllensten and Malmfors, 1963). It is also 
known that experience can influence optic nerve myelination during early post-
natal life (Gyllensten and Malmfors, 1963; Tauber et al., 1980). Therefore, it 
may be that glutamate signalling regulates early myelination of the optic nerve 
during a critical developmental period, but that other signals can regulate 
myelination later. This would match my findings that chemogenetic stimulation 
of RS axons can promote sheath growth within a critical developmental period 
between 3 to 5 dpf.  
NMDA, AMPA, kainate, or mGlu receptors could be disrupted in 
oligodendrocytes using Crispr/Cas9 technology. Crispr/Cas9 systems allow 
targeting of random mutations in a gene of choice (Sander and Joung, 2014). 
They rely on two key components: a Cas9 nuclease enzyme, and a guide RNA. 
The guide RNA has a 20-nucleotide sequence at the 5’ end, which can be 
designed to complement the genomic site adjacent to where a mutation is 
desired. The Cas9 forms a complex with the guide RNA, which then guides 
the nuclease to the target site in the genome. Cas9 induces a double-stranded 
break in the DNA, which is then repaired by non-homologous end joining 
mechanisms; this typically results in random insertions and deletions into the 
genome, often leading to frame-shifts. Ablain et al., 2015 developed a 
Crispr/Cas9 system for inducing mutations in specific cells or tissues of interest 
in zebrafish. They generated a plasmid where a guide RNA is ubiquitously 
expressed, while Cas9 is expressed under a tissue-specific promoter of 
interest. This plasmid is then inserted into the genome using the well-
established Tol2 system to create a stable transgenic line. Driving Cas9 
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expression with OPC promoter sequences (such as olig1), or myelinating 
oligodendrocyte promoter sequences (such as myrf or mbp) would allow cell-
specific genetic targeting of the various glutamatergic receptors. Once 
oligodendrocyte-specific transgenic lines are generated, they could then be 
combined with the TRPV1-RFP system to see if chemogenetic stimulation of 
RS axons still promotes sheath growth in these mutants. 
Molecular Mechanism – BDNF Signalling? 
BDNF is another molecule which can be expressed in a neuronal activity-
dependent manner (Castrén et al., 1992), and which can regulate myelination 
(Vondran et al., 2010). TeNT has been shown to block both the release of 
BDNF and neurotransmitters (Shimojo et al., 2015), and so BDNF signalling 
could underlie the hypomyelination phenotype seen in TeNT-expressing RS 
axons (Koudelka et al., 2016) (Figure 39A). Optogenetic stimulation of cortical 
neurons promotes OPC proliferation  (Gibson et al., 2014). Inhibiting activity-
regulated BDNF expression, or knocking out the BDNF receptor TrkB 
specifically in oligodendroglial lineage cells, prevents optogenetic stimulation 
from increasing OPC proliferation (Geraghty et al., 2019). BDNF induces a 
switch to activity-dependent myelination in vitro; DRG-OPC co-cultures are 
normally unaffected by NMDA receptor inhibition, but when cultured in the 
presence of BDNF, myelination is significantly impaired by NMDA receptor 
inhibition (Lundgaard et al., 2013). Therefore, BDNF is another candidate 
molecule which may mediate the effects of neuronal activity on myelin sheath 
growth. 
Like synaptic vesicle release, BDNF release can be live imaged. BDNF-
pHluorin (a pH-sensitive indicator which fluoresces upon fusion of BDNF 
vesicles with extracellular membrane) has previously been used to study 
BDNF release in axons and dendrites (Matsuda et al., 2009; Shimojo et al., 
2015). BDNF-pHluorin could be expressed in single RS axons to characterise 
the location and rate of BDNF release during myelination. These experiments 
could be combined with the FP-Cntn1a tool to determine whether BDNF 
release correlates with myelin sheath growth. 
218 
 
If BDNF release does correlate with sheath growth, then BDNF receptors in 
oligodendrocytes could be targeted using the Crispr/Cas9 strategy above. 
BDNF is known to bind to two receptors; TrkB and p75 (Park and Poo, 2013). 
BDNF is initially synthesised as the precursor pro-BDNF, which has high 
affinity for p75 and contributes to synaptic long-term depression in the 
hippocampus (Woo et al., 2005). Pro-BDNF is cleaved to generate mature 
BDNF (mBDNF), which has high affinity for TrkB (Huang and Reichardt, 2001). 
TrkB is expressed by oligodendrocytes and is activated by BDNF treatment 
(Veer et al., 2009; Vondran et al., 2010). OPC expression of TrkB is required 
for activity-mediated OPC proliferation (Geraghty et al., 2019). 
Oligodendrocyte-specific loss of TrkB signalling in mice leads to 
hypomyelination in the corpus callosum and spinal cord at P30, but myelination 
recovers by P60 (Wong et al., 2013). It may be that BDNF-TrkB signalling 
regulates activity-mediated myelination during a critical developmental period 
(again, reminiscent of my findings in this chapter: that neuronal activity only 
promotes sheath growth within a critical period). By disrupting TrkB receptor 
expression specifically in oligodendrocytes, one could determine whether 
BDNF-TrkB signalling is required for activity-mediated sheath growth along RS 
axons 3-5 dpf. 
Molecular Mechanism – Another Signal? 
The activity-driven signal which regulates sheath growth may be something 
other than glutamate or BDNF. For example, neuronal stimulation of OPC-
DRG neuron co-cultures promotes the formation of myelin sheaths in an 
adenosine-dependent manner (Stevens et al., 2002). 
The signalling mechanism may even be indirect and involve other cell types. 
Myelination in OPC-DRG neuron co-cultures is significantly enhanced when 
astrocytes are added to the culture (Ishibashi et al., 2006; Watkins et al., 2008).  
In such co-cultures, astrocytes detect ATP release by active axons and release 
LIF which then promotes myelination (Ishibashi et al., 2006). Neuronal activity 
induces significant transcriptional changes in astrocytes (Hasel et al., 2017), 
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and, thus, there may be additional signals released by astrocytes in response 
to activity which could influence myelination (Figure 39C).  
If neither glutamate nor BDNF signalling regulates sheath growth, then a more 
unbiased approach could be taken to elucidate the signal responsible. First the 
receptor(s) which are activated on oligodendrocytes or myelin sheaths need to 
be identified. Neuronal activity could be robustly increased in a population of 
neurons (for example, all RS neurons) during early stages of myelination using 
chemogenetics or optogenetics, followed by isolation of oligodendrocytes and 
myelin for further analysis. Analysis of purified myelin using large-scale 
expression or phosphorylation assays could identify changes in the expression 
or phosphorylation of receptors in myelin sheaths with activity. Analysis of 
oligodendrocyte transcriptomes by RNA sequencing could identify 
downstream transcriptional changes in response to activity, which may 
suggest specific upstream receptors. Both data sets could be combined and 
coupled with literature searches to identify the most likely candidate signals. 
These could subsequently be targeted in oligodendrocytes using the cell-type 
specific Crispr/Cas9 strategy above, in order to confirm which signal is 




Figure 39 – possible signalling mechanisms for activity mediated sheath 
growth. 
A) Axonal vesicular release to the myelin sheath. Action potentials may trigger the 
exocytosis of vesicles along the axon, releasing their cargo either under or adjacent 
to myelin sheaths to activate appropriate receptors and induce sheath growth. For 
221 
 
example, release of neurotransmitters like glutamate (blue) could activate 
glutamate receptors (dark blue), or release of BDNF (orange) could activate TrkB 
receptors (red). B) Other signals from active axons to myelin sheaths. 
Neurotransmitter release at traditional synapses may ‘spill over’ to activate 
receptors on neighbouring myelin sheaths and induce sheath growth (black arrow). 
Alternatively, active synapses may trigger some other signalling mechanism within 
the presynaptic cell which signals to myelin sheaths to induce sheath growth 
(orange arrows). C) Indirect signalling from active axon to myelin sheaths via 
astrocytes. Active neuron may signal to astrocytes (yellow cell), which then signal 
to myelin sheaths to induce sheath growth. 
 
Ca2+ Signalling in Myelin Sheaths 
Local Ca2+ signalling may play an important role in activity-mediated sheath 
growth. Ca2+ imaging in the zebrafish spinal cord demonstrates that localised 
Ca2+ transients occur within myelin sheaths, with neuronal activity regulating 
approximately half of these transients (Krasnow et al., 2018). Long-duration 
high-amplitude events mediate sheath retraction in a calpain-dependent 
manner (Baraban et al., 2018). Shorter lower-amplitude events may regulate 
sheath elongation; high Ca2+ transient rates correlate with sheath growth, while 
Ca2+ transient rates below 1 transient / 30 mins correlate with sheath shrinkage 
(Baraban et al., 2018; Krasnow et al., 2018). Particular types and rates of Ca2+ 
signalling in myelin sheaths may act as codes to control whether a sheath 
grows, shrinks, or retracts.  
Precisely how activity of the underlying axon (rather than global neuronal 
activity) relate to the particular Ca2+ codes in sheaths remains unknown. Ca2+ 
imaging in myelin sheaths could be coupled with TRPV1-RFP chemogenetic 
stimulation of RS axons to study whether stimulating a single axon correlates 
with Ca2+ signalling in its myelin sheaths. The specific firing rate of an 
underlying axon may, in turn, tune the sheath Ca2+ transient rate, and 
subsequently control sheath growth. Chemogenetic systems such as TRPV1-
RFP cannot be used to tightly control neuronal firing rates. Instead, 
optogenetic systems provide more intricate control of neuronal firing 
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properties. The activity of individual RS neurons expressing 
channelrhodopsins could be tightly controlled using different frequencies of 
light stimulation. Using an optogenetic approach, one could test if specific 
neuronal firing frequencies correspond to specific sheath Ca2+ codes and 
sheath growth. 
The molecular signal which triggers Ca2+ transients in myelin sheaths should 
also be investigated. Expressing TeNT in single RS axons and then assessing 
sheath Ca2+ dynamics would confirm whether activity-mediated vesicular 
release contributes to sheath Ca2+ signalling. If axonal TeNT-expression 
reduces sheath Ca2+ signalling, either neurotransmitter or BDNF release could 
be responsible. Coupling SypHy or BDNF-pHluorin imaging in RS axons with 
Ca2+ imaging in myelin sheaths could test whether release of either of these 
molecules correlates with sheath Ca2+ dynamics. When the candidate 
oligodendrocyte receptor(s) responsible for detecting neuronal activity are 
identified, Ca2+ imaging could be performed in oligodendrocyte-specific 
receptor mutants to determine whether this receptor(s) mediates activity-
induced Ca2+ transients in myelin sheaths.  
4.3.2. Increasing Neuronal Activity of a Single Axon Does Not Affect Myelin 
Sheath Growth after 5 dpf 
Although chemogenetic stimulation promotes sheath growth along RS axons 
3-5 dpf, it does not affect the growth of myelin sheaths after 5 dpf. This was 
regardless of whether the sheath was born early (before 3 dpf) or later (after 3 
dpf). The lack of effect on sheath growth was not due to a lack of space, as 
there was no effect of chemogenetic stimulation on sheath growth even when 
analysis was restricted to sheaths that still had at least 20µm adjacent 
unmyelinated axonal space at 7 dpf (Figure 31). 
One possibility for this lack of phenotype is that the chemogenetic system no 
longer increases neuronal activity at 5 dpf onwards. However, I showed, using 
Ca2+ imaging, that RS axons expressing TRPV1-RFP continue to respond to 
capsaicin treatment at 5 dpf (Figure 24). Despite my evidence that capsaicin-
treated TRPV1 axons had increased activity at 5 dpf, the level of increase may 
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not be as sustained. Capsaicin was applied for four hours daily, but it is not 
clear whether activity remains elevated after this treatment period, and for how 
long. Furthermore, another possibility is that only a particular firing frequency 
leads to sheath growth. Although RS axons were still stimulated at 5 dpf, the 
firing frequency upon capsaicin treatment 5-7 dpf may be significantly different 
compared to the firing frequency upon capsaicin treatment 3-5 dpf. There is a 
need to investigate how specific neuronal firing frequencies correspond to 
myelin sheath growth. The precise firing frequencies of TRPV1-RFP-
expressing RS axons induced by capsaicin treatment 3-7 dpf could be 
measured by electrophysiology. If the firing frequency induced by capsaicin 
treatment significantly changes over time, then daily optogenetic stimulation of 
RS neurons at the same firing frequency 3-7 dpf could elucidate whether 
activity-mediated sheath growth is possible after 5 dpf.  
Another explanation for sheath growth being affected by activity within a 
defined period could be that myelin sheaths do not detect or respond to 
neuronal activity after 5 dpf. The machinery required for oligodendrocytes or 
myelin sheaths to detect neuronal activity may be downregulated as 
oligodendrocytes mature. In support of this, the expression levels of AMPA, 
NMDA, and mGlu receptors (glutamate sensing machinery) are much lower in 
mature oligodendrocytes than in OPCs (De Biase et al., 2010; Deng et al., 
2004; Kukley et al., 2010). First, the receptor(s) in oligodendrocytes which 
detect neuronal activity and mediate sheath growth 3-5 dpf must be identified, 
as discussed above in section ‘4.3.1 Increasing Neuronal Activity of a Single 
Axon Promotes Sheath Growth 3-5 dpf’. Once candidate receptor(s) have 
been identified, the expression of this receptor(s) in myelin sheaths along RS 
axons should be assessed via immunohistochemistry or immunogold electron 
microscopy 3-7 dpf. If expression levels do decline after 5 dpf, then the 
receptor(s) of interest could be overexpressed in oligodendrocytes (using a 
myelin-specific promoter sequence such as mbp) to see if this promotes 
activity-mediated sheath growth along RS axons after 5 dpf. 
There is some evidence that oligodendrocytes require multiple signals to 
detect and respond to neuronal activity. Lundgaard et al., 2013 found that 
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treating OPC-DRG co-cultures with either BDNF or Nrg1 induces a switch to 
NMDA receptor-dependent myelination. Therefore, expression of BDNF, Nrg1 
or both in RS neurons may control when activity can influence sheath growth. 
Quantifying BDNF release along RS neurons using BDNF-pHluorin could 
determine whether BDNF signalling is restricted to 3-5 dpf. Any changes in the 
expression or localisation of Nrg1 along RS axons could be broadly measured 
by immunohistochemistry on larvae aged 3-7 dpf. If either BDNF or Nrg1 
signalling appears to change after 5 dpf, then they could be inducibly 
overexpressed from 5 dpf onwards to see if increasing signal levels promotes 
activity-mediated sheath growth at these time points. Several strategies have 
been developed for inducible transgene expression in zebrafish. A tamoxifen-
inducible form of the transcriptional activator Gal4 has previously been used 
to activate UAS-driven transgene expression upon tamoxifen or 4-OH-
tamoxifen treatment (Akerberg et al., 2014). Similarly, the TetON system relies 
on activation of a TetActivator by doxycycline treatment; this then drives the 
expression of Tetracycline responsive element (TRE) driven transgenes 
(Knopf et al., 2010). 
Why would neuronal activity only influence myelin sheath growth within a 
limited developmental time period? If existing myelin sheaths could be 
remodelled by neuronal activity throughout life, then the myelin patterns along 
active axons would be constantly changing. Such changes to myelin patterns 
would likely lead to constantly changing conduction speeds within circuits. 
Neuronal activity might only regulate the initial formation of myelin patterns by 
enhancing production of new oligodendrocytes and promoting early sheath 
growth. Therefore, activity-mediated myelination may only be important 
throughout life for axons which are unmyelinated or sparsely myelinated, such 
as in the cortex (Gao et al., 2019; Hill et al., 2018; Tomassy et al., 2014). 
However, the responses of myelin sheaths to activity may differ depending on 
the neuronal subtype. Myelin sheaths along RS axons may only exhibit 
activity-mediated growth 3-5 dpf, but sheaths on other axon subtypes may 
continue to respond to activity for a longer period of time or even throughout 
life. The role of neuronal activity in shaping myelination may vary from circuit 
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to circuit. Further characterisation of which neuron subtypes use activity to 
regulate their myelination, and how or when activity affects myelin sheath 
growth dynamics in different circuits, is required. For example, global reduction 
of synaptic vesicle release inhibits the myelination of both RS and 
circumferential descending (CiD) axons in the zebrafish spinal cord (Mensch, 
2014). Individual CiD neurons could be chemogenetically stimulated to assess 
how increasing their activity affects myelin sheath dynamics over time. 
4.3.3. Neuronal Activity may Inhibit Sheath Retractions 
In Chapter 3, I showed that myelin sheaths can be retracted from RS axons, 
but that only sheaths under 10 µm can be retracted. Sheath stability appears 
to correspond with sheath length, as shorter (< 5 µm) sheaths exhibit more 
instability than longer (5-10 µm) sheaths. Here, I quantified the number of 
sheath retractions which occurred on stimulated and unstimulated RS axons 
5-7 dpf, focusing only on axons which had sheaths under 10 µm (axons which 
had sheaths that could be retracted). I found that there was a 57% reduction 
in the number of sheath retractions along stimulated axons compared to 
control axons (Figure 33); however, this was not statistically significant, likely 
because this statistical analysis is underpowered (41% power, with a sample 
size of 16 per group required to reach 80% power). Therefore, it is possible 
that repeating this experiment would show that chemogenetic stimulation does 
reduce the retraction of myelin sheaths 5-7 dpf.  
Furthermore, neuronal activity may regulate sheath retractions prior to 5 dpf. 
Only one of 17 sheaths present at 3 dpf was retracted by 5 dpf. However, it is 
possible that many sheaths or contacts were formed and then retracted 
between 3 and 5 dpf. Timelapse analysis 3-5 dpf should be performed to more 
rigorously assess whether activity affects the rate of sheath retractions during 
this time period. 
Research has shown that inhibiting synaptic vesicle release increases the 
number of sheath retractions in the zebrafish spinal cord (Hines et al., 2015); 
whereas, Mensch et al., 2015 showed that global inhibition of synaptic vesicle 
release had no effect on the retraction of sheaths over 5 µm. Collectively, this 
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suggests that neuronal activity may play a specific role in the retraction of 
shortest unstable sheaths (< 5 µm). Both of these studies used TeNT light 
chain to globally block vesicular release, which can actually inhibit the release 
of various signals including neurotransmitter and BDNF release (Shimojo et 
al., 2015). TeNT may also affect the release of other signals throughout the 
body; for example, TeNT can inhibit VAMP2-mediated catecholamine release 
from chromaffin cells of the adrenal medulla (Höne-Zell et al., 1994). More 
precise manipulations are required to identify the specific signal which may 
regulate sheath retraction. If chemogenetic stimulation does reduce sheath 
retraction, then SypHy/BDNF-pHluorin imaging (as described in section 4.3.1) 
could determine whether neurotransmitter release, or BDNF release, 
correlates with a sheath’s fate. Oligodendrocyte-specific disruption of 
glutamate or TrkB receptors could confirm whether glutamate or BDNF 
signalling is involved in sheath stabilisation. An activity-driven signal other than 
glutamate or BDNF may control sheath stabilisation or retraction; it will be 
important to follow up on any such candidate signals in the context of sheath 
retractions if and when they arise.  
4.3.4. Increased Activity can Affect Myelin Pattern Formation along RS Axons 
My data indicate that neuronal activity can affect the myelination of RS axons 
by regulating sheath growth and, possibly, sheath retraction at different 
developmental stages (see Figure 38A). How neuronal activity affects the 
myelin pattern established may, thus, depend on when an axon is myelinated. 
For example, some RS axons began myelination before 3 dpf (axons with early 
born sheaths). For these axons, chemogenetic stimulation changed the myelin 
pattern by increasing sheath length and reducing sheath number by 7 dpf. This 
change in myelin pattern is likely because increased activity promoted the 
growth of early born myelin sheaths 3-5 dpf, which, in turn, may have reduced 
the available axonal space for new sheaths to form (Figure 38B).  
Other RS axons were still completely unmyelinated at 3 dpf (axons without 
early born myelin sheaths). Along these axons, chemogenetic stimulation did 
not change sheath length by 5 dpf; however, it was not possible to properly 
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assess how activity affects 3-5 dpf sheath growth along these axons because 
I cannot determine exactly when the sheaths were made. More detailed 
timelapse analysis may reveal that activity can transiently promote the growth 
of sheaths born along these axons 3-5 dpf, but not enough to permanently 
increase sheath length. 
By 7 dpf, chemogenetic stimulation may change the myelin pattern formed 
along axons without early born sheaths by reducing sheath length and 
increasing sheath number compared to controls. Such a phenotype can be 
explained if activity inhibits the retraction of short, unstable myelin sheaths 
between 5 to 7 dpf; stimulated axons would therefore have more sheaths 
competing for the same axonal space, leading to shorter sheaths overall. 
Although these changes to the myelin pattern were not statistically significant, 
the statistical comparisons had a lower n number (4 per group), and so are 
likely to be underpowered. For example, the comparison between 
unstimulated and stimulated axons in Figure 35F has only 11% power, and 
would require an n of 63 per group to reach 80% power. Therefore, the sample 
size should be increased to confirm whether or not chemogenetic stimulation 
changes the myelin patterns along RS axons without early born sheaths. 
Why would the myelin patterns along RS axons with and without early born 
sheaths be differentially affected by chemogenetic stimulation? There may be 
a change in all RS axons (such as reduced BDNF release, or reduced Nrg1 
expression) which prevents activity from regulating sheath growth after 5 dpf. 
For axons which did not start myelination until after 3 dpf, there may not be 
enough time for activity to significantly influence sheath growth before this 
mechanism is lost at 5 dpf. It may be that oligodendrocytes, or myelin sheaths, 
only express the appropriate receptors to detect neuronal activity at 3-5 dpf, 
and so again there is not enough time for activity to affect the growth of myelin 
sheaths along RS axons without early born sheaths. Alternatively, RS axons 
without early born sheaths may represent a specific subset of RS neurons 
which use activity to regulate their myelin pattern in a different way compared 
to RS axons with early born sheaths. Given that there are many different 
subtypes of RS neuron, further investigation into these different subtypes is 
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required. Whether RS axons with and without early born sheaths truly 
represent distinct populations should be investigated; the specific RS neuron 
subtypes in these axonal populations should be identified, and signals thought 
to be involved in activity-mediated myelination characterised in more detail. 
For example, do RS axons with early born sheaths have consistently different 
levels of BDNF release or Nrg1 expression than RS axons without early born 
sheaths? Such analyses could begin to elucidate the properties of circuits 
which use activity to regulate their myelination. 
4.3.5. How Does Activity-mediated Sheath Growth and Pattern Formation 
Affect Circuit Function? 
As discussed in Chapter 1, changing the myelin pattern along an axon will, in 
theory, change its conduction properties. Does the altered myelin pattern along 
stimulated RS axons affect conduction? The conduction timings of RS axons, 
and the recruitment and activity of their post-synaptic neurons, could be 
assessed by electrophysiology. This could be done either by directly recording 
the current/voltage properties of individual neurons using electrodes, or using 
optical techniques such as genetically-encoded voltage indicators, as 
discussed in section ‘3.3.6. How Do Myelin Patterns Affect Overall Circuit 
Function?’ (Gong et al., 2015). 
There are many different subsets of RS axons in the zebrafish, several of 
which are known to underlie specific locomotor behaviours. It is not known if 
the RS axons which have altered myelin patterns in response to chemogenetic 
stimulation represent a particular set of RS neurons. The identity of these RS 
axons should be characterised in more detail to determine if they mediate a 
particular behaviour. For example, MeLr and MeLc RS neurons mediate prey 
capture behaviour, and RoV3/MiV1/MiV2 RS neurons mediate direction 
changes in the optomotor response. If these RS neurons mediate a particular 
behaviour, the success rates and kinematics of that behaviour could be 
compared between stimulated and unstimulated animals to assess how 
changing myelin patterns affects behavioural output. However, it would be 
important to consider that chemogenetic stimulation may have effects on the 
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circuit other than changing the myelin pattern. Neither the axon diameter nor 
the length of nodal gaps were significantly changed by chemogenetic 
stimulation. However, the number or size of synapses along the collaterals of 
RS axons may have been altered; such synaptic changes would influence 
post-synaptic recruitment and activity, and behaviours, independently from 
myelination. The synapses of RS neurons should also be measured and 
correlated with any effects on circuit function; this could be done by staining 
for pre-synaptic proteins such as synaptophysin. 
4.3.6. Increased Activity of Single Axons Does Not Affect Local 
Oligodendrogenesis 
Research has shown that either experience or experimental neuronal 
stimulation increases OPC proliferation and differentiation (Gibson et al., 2014; 
Hughes et al., 2018; Mitew et al., 2018; Xiao et al., 2016). It is not clear whether 
neuronal activity has separate effects on both OPC proliferation and 
differentiation, or whether it promotes one process and the other is 
subsequently upregulated to maintain a balance in the OPC population. 
Regardless, neuronal activity does seem to promote overall oligodendrocyte 
production. However, it was not known whether the activity of a single axon 
can affect local oligodendrogenesis, or whether an entire population or tract 
needs to be activated to have significant impact on oligodendrocyte 
production. Here, I have shown that sparse chemogenetic stimulation of RS 
axons (rather than the entire population) does not affect the local production 
of oligodendrocytes 3-7 dpf. 
BDNF signalling is thought to play a role in activity-mediated OPC proliferation. 
Optogenetic stimulation of pyramidal cortical neurons increases OPC 
proliferation, but this effect is lost in animals which do not express BDNF in 
response to activity or which lack TrkB receptors in oligodendroglial lineage 
cells (Geraghty et al., 2019; Gibson et al., 2014). This suggests that BDNF 
release from active axons promotes OPC proliferation, and may subsequently 
increase oligodendrocyte production. Neurotransmitter signalling may also 
play a role in oligodendrogenesis, as global inhibition of synaptic vesicle 
230 
 
release reduces the number of oligodendrocytes in the larval zebrafish spinal 
cord by approximately 10% (Mensch et al., 2015). Individual active neurons 
may not release enough BDNF or neurotransmitter to affect OPCs, whereas a 
larger population of neurons may release sufficient levels of BDNF or 
neurotransmitter to promote OPC proliferation, differentiation, or both. For the 
experiments in this chapter, only animals where very few RS neurons 
expressed TRPV1-RFP were selected. However, one could use animals with 
a larger number of RS neurons labelled with TRPV1-RFP to see if stimulating 
a larger population of RS axons affects local oligodendrocyte number in the 
spinal cord. If this did increase the production of oligodendrocytes, then 
performing the same experiment in oligodendrocyte-specific TrkB or glutamate 
receptor mutants would confirm whether BDNF or neurotransmitter signalling 
regulates the oligodendrocyte population. 
Alternatively, perhaps only certain patterns of activity promote 
oligodendrogenesis. Nagy et al., 2017 showed that lower firing frequencies 
promote OPC differentiation in the mouse corpus callosum, whereas higher 
firing frequencies promote OPC proliferation. It is possible that chemogenetic 
stimulation does not induce firing frequencies that promote the production of 
oligodendrocytes. Optogenetic stimulation of individual RS axons at various 
firing frequencies could determine whether the activity of a single axon can 
promote local oligodendrocyte production.  
4.3.7. How Does Increased Activity Affect Sheath Thickness? 
In this chapter, I have assessed how chemogenetic stimulation of single RS 
neurons affects the number and length of myelin sheaths along axons. 
However, research has shown that neuronal stimulation can also increase 
sheath thickness. Chemogenetic stimulation of pyramidal cortical neurons in 
both the juvenile and adult mouse leads to increased sheath thickness, 
specifically on active axons themselves (Mitew et al., 2018). Although 
chemogenetic stimulation of RS axons does not affect longitudinal growth after 
5 dpf, it is still possible that activity promotes radial growth at these time points. 
Sheath thickness should be assessed along individual TRPV1-RFP 
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expressing RS axons at 3, 5, and 7 dpf to see how chemogenetic stimulation 
affects radial growth during these stages. As discussed in section ‘3.3.5. 
Remodelling of Sheath Thickness over Time’, there are several techniques 
which may give sufficient resolution to measure sheath thickness of an 
individually labelled axon. Larvae expressing membrane-tethered GFP in 
myelin sheaths and TRPV1-RFP in individual RS axons could be live imaged 
using super-resolution microscopy to assess how individual sheaths change in 
thickness along a single axon over time. I have preliminarily tested such live 
imaging approaches using a 63x lens on a Zeiss LSM880 Airyscan confocal 
microscope, and found that I was able to follow individual sheaths until 7 dpf 
(data not shown). However, with the maximum resolution possible by Airyscan 
microscopy, the smallest change in sheath thickness that could be detected is 
a change of g-ratio from 0.8 to 0.73 (for an axon 1.2 µm in diameter; the 
average diameter of RS axons at 7 dpf). Measuring smaller changes in sheath 
thickness would require higher imaging resolution. An alternative approach 
could be to fix and process larvae for expansion microscopy, which has 
recently been used to measure sheath thickness along individual axons at a 
similar resolution as electron microscopy (Gao et al., 2019). Expansion 
microscopy could be used to measure the average sheath thickness along 
stimulated RS axons at 3, 5, and 7 dpf. Either of these strategies could help 
us to understand how and when a single axon’s activity affects the dynamics 
of myelin sheath growth. 
4.3.8. How Does Neuronal Activity Affect Sheath Growth and Myelin Patterns 
after Myelin Disruption? 
As discussed in section ‘3.3.7. Disruption to Myelin Patterns’, myelin patterns 
along axons can be changed by demyelination which occurs in injury, disease, 
or with age. Myelin loss affects the conduction of the underlying axons (for 
example, demyelination causes conduction block in the cat spinal cord (Smith 
et al., 1981)). New myelin sheaths can be made; remyelination has been 
reported in spinal cord injury (Lasiene et al., 2008; Totoiu and Keirstead, 2005), 
after toxin-induced demyelination (Blakemore, 1974; Blakemore and Murray, 
1981), and in the demyelinating disease Multiple Sclerosis (Prineas et al., 
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1993; Prineas and Connell, 1979). However, myelin sheaths made during 
remyelination are thought to be thinner and shorter than myelin sheaths in the 
healthy CNS, which could further change myelin patterns.  
If de- and remyelination changes myelin patterns and, potentially, conduction 
speeds and overall circuit function, identifying signals which can promote 
efficient and complete myelin regeneration could be of significant therapeutic 
benefit. Given that neuronal activity can increase the production of 
oligodendrocytes and promote the growth of myelin sheaths, it is possible that 
neuronal activity could also improve remyelination. Gautier et al., 2015 showed 
that neuronal activity may already contribute to remyelination in the CNS in 
vivo. Rats with ethidium bromide-induced demyelination in the cerebellum 
were treated with either vehicle or TTX (voltage-gated Na+ channel blocker) 
from three days post-lesion to see how activity within the lesion area affects 
remyelination (Gautier et al., 2015). The authors found that TTX treatment after 
demyelination leads to increased OPC proliferation, reduced differentiation 
into oligodendrocytes, and a slight increase in the death of oligodendroglial 
lineage cells. There are fewer remyelinated axons in TTX-treated animals by 
three weeks post-lesion, and those that are myelinated generally have thinner 
myelin sheaths than saline-treated animals (Gautier et al., 2015). Glutamate 
signalling may be the molecular mechanism by which neuronal activity 
promotes remyelination, as OPCs in lesions can detect glutamate via 
AMPA/kainate receptors, and treating lesions with NBQX (AMPA/kainate 
receptor antagonist) also impairs remyelination (Gautier et al., 2015).  
Enhancing neuronal activity beyond basal levels could improve the 
endogenous remyelination response to regenerate myelin sheaths of normal 
length and thickness. Ortiz et al., 2019 attempted to investigate this by 
optogenetically stimulating axons in the mouse corpus callosum which were 
demyelinated by lysolecithin. They found that a single bout of stimulation 
transiently increases OPC proliferation, while daily stimulation for one week 
increases the production of oligodendrocytes and the number of remyelinated 
axons in the lesion. In unstimulated animals, they found that sheath thickness 
within the remyelinated lesion is consistently thinner than in normal appearing 
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white matter (NAWM). In optogenetically stimulated animals, sheath thickness 
within the remyelinated lesion is thinner than NAWM for axons under 0.793 µm 
in diameter. However, axons over 0.793 µm in the remyelinated lesion had 
myelin sheaths of thickness comparable to NAWM, suggesting that 
optogenetic stimulation enhances radial sheath growth along larger diameter 
axons during remyelination. It was suggested that these larger diameter axons 
were the axons expressing channelrhodopsin, and so increased activity 
promotes remyelination specifically on the active axons themselves (however, 
this was not confirmed by immunostaining for channelrhodopsin expression). 
The authors did investigate whether remyelination specifically targeted active 
axons by quantifying the proportion of MBP-positive axons which were 
channelrhodopsin-positive. They found that stimulation does not increase the 
proportion of channelrhodopsin-positive remyelinated axons. Whether 
optogenetic stimulation promotes the longitudinal growth of myelin sheaths 
along channelrhodopsin expressing axons in order to increase remyelinated 
sheath length is not known. There is a need to investigate how the activity of 
a single axon affects sheath growth dynamics during remyelination.  
Optogenetic or chemogenetic systems could be combined with a 
demyelination model to assess how a single axon’s activity affects its 
remyelination. In the zebrafish, an individual RS axon could be labelled with 
TRPV1-RFP or channelrhodopsins and GFP-Cntn1a, and then demyelination 
could be induced using a model such as the nitroreductase ablation model 
(Karttunen et al., 2017) or my novel Tg(mbp:TRPV1-RFP) ablation model (see 
Appendix 1: A Novel Zebrafish Model of Demyelination – Tg(mbp:TRPV1-
RFP)). After demyelination, the RS axon could be chemogenetically or 
optogenetically stimulated and the formation of new myelin sheaths could be 
followed over time in stimulated and unstimulated animals. Larval zebrafish 
already exhibit remarkable remyelinating capacity, with new myelin sheaths 
being of similar length and thickness to normal sheaths in the healthy zebrafish 
CNS (Karttunen et al., 2017). However, neuronal activity may accelerate the 
remyelination process. Similar tools could be combined with toxin-induced 
demyelination in rodents, where two-photon microscopy and cranial windows 
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could be used to live image myelinated axons in the cortex (Hill et al., 2018; 
Hughes et al., 2018). Using this set-up, one could determine whether activity 
promotes the formation of sheaths with normal length and thickness along 
active axons during remyelination in the mammalian CNS. 
Research has shown that, although myelin sheaths are remarkably stable after 
initial formation, rapid growth and remodelling can be induced by loss of 
neighbouring myelin sheaths (Auer et al., 2018). Identifying strategies to 
promote the growth or remodelling of surviving myelin sheaths may also 
provide therapeutic benefit, especially in the context of old age or later stages 
of MS, where the production of new myelinating oligodendrocytes seems to 
fail. The re-initiation of rapid growth in surviving sheaths suggests that these 
sheaths may detect and respond to growth cues when myelin patterns are 
disrupted. Chemogenetic or optogenetic stimulation of single RS axons in a 
zebrafish demyelination model could also be used to determine if neuronal 
activity promotes the growth or remodelling of surviving myelin sheaths.  
If activity does promote the growth of both new and surviving myelin sheaths 
during remyelination, then identifying the molecular mechanism would be of 
significant therapeutic interest. Circuit stimulation, or drugs which target the 
appropriate receptor on oligodendrocytes or myelin sheaths, could promote 
the recovery of myelin patterns along demyelinated axons in injury or disease. 
These approaches could even help prevent age-associated cognitive decline 
by rescuing the loss of myelin with old age. Behaviour-driven treatments, such 
as cognitive training, task learning, or exercise, have been suggested as 
potential strategies to enhance remyelination (Jensen and Yong, 2016). In fact, 
exercise is sufficient to promote oligodendrogenesis and remyelination in a 
rodent model of demyelination (Jensen et al., 2018). Remyelination could be 
targeted by engaging in tasks which use specific parts of the CNS (for 





4.3.9. Alternative Roles for Activity-mediated Myelination? 
I hypothesise that activity-driven changes to myelin patterns serve to modulate 
circuit output. However, it is possible that activity-mediated changes to myelin 
patterns do not significantly affect conduction properties, post-synaptic neuron 
recruitment and activity, or behaviour. Could there be other functions for 
activity-driven myelination? 
Myelinating oligodendrocytes are known to provide metabolic support to 
axons. Lactate produced by glycolysis in oligodendrocytes is shuttled to axons 
through the lactate transporter MCT1 (Fünfschilling et al., 2012; Y. Lee et al., 
2012). Stimulation of oligodendrocyte NMDA receptors upregulates their 
expression of the glucose transporter GLUT1, leading to an increase in both 
glucose uptake and lactate release by oligodendrocytes (Saab et al., 2016). 
Oligodendrocyte-specific loss of NMDA receptors reduces the expression of 
GLUT1 in myelin sheaths and reduces the recovery of axons from oxygen-
glucose deprivation, which can be rescued by lactate treatment (Saab et al., 
2016). These findings suggest that electrically active axons increase the 
metabolic support they receive from oligodendrocytes in an activity-dependent 
manner. From an energetic perspective, increasing the myelin coverage along 
an axon would boost metabolic reserves required for function and survival. 
Activity-driven myelin sheath growth may have evolved as a mechanism to 
accelerate or even enhance the myelination of active axons, and subsequently 
increase metabolic support for the axons that need it most. In the larval 
zebrafish, activity-mediated acceleration of myelin sheath growth may provide 
a slight benefit by ensuring that active axons have sufficient metabolic support 
to fire optimally as soon as possible. Such optimisation could confer a slight 
competitive advantage, which, nevertheless, could be the difference between 
life and death. The altered myelin pattern along RS axons might just be a by-
product. 
ATP dynamics can now be live imaged to measure cellular metabolism in vivo. 
Imamura et al., 2009 developed a range of fluorescence resonance energy 
transfer-based (FRET) ATP sensors which can be used to measure ATP levels 
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in living cells. Trevisiol et al., 2017 used this tool to measure cytosolic ATP 
levels in axons of the optic nerve, and found that the ATP levels measured 
correlated with compound action potentials recorded by electrophysiology. 
ATP sensors could be used to measure metabolism along RS axons 
throughout myelination, and to determine whether axons with accelerated 
myelination have increased metabolic support, or reach optimal metabolic 
support levels sooner than control axons. Performing electrophysiology, or 
appropriate behavioural tests for the RS subtype being analysed, could 
determine whether changes in axonal ATP levels with myelination correlates 
with changes in circuit function.  
If there is a correlation between glial metabolic support and circuit function, the 
next step would be to determine if metabolic support is required for changes 
in circuit function. It is hypothesised that lactate is shuttled out of 
oligodendrocytes by MCT1 channels, and then into the axon by neuronal 
MCT2 channels (Fünfschilling et al., 2012; Y. Lee et al., 2012). Cell-type 
specific Crispr techniques could be used to delete MCT1 from 
oligodendrocytes, or MCT2 from RS neurons, to disrupt oligodendroglial 
metabolic support of axons. These cell-type specific mutants could be tested 
to see if activity-driven myelination still correlates with changes in axonal 
metabolism and circuit function. If activity-driven myelination serves to 
enhance metabolic support then sheath growth should still be enhanced along 
active axons, but there would be no correlation between myelination and 
axonal metabolism or circuit function 
4.3.10. Testing Other Tools to Investigate the Role of Activity and 
Activity-related Signals in Myelin Sheath Growth 
During my project, I tested several other transgenic tools to look at the role of 
neuronal activity in regulating the dynamics of sheath growth and maintenance 
in more detail. I tested several neurotoxins, which either inhibit or enhance 
synaptic vesicle release (TeNT, BoNT and glycerotoxin). I tested the inward-
rectifying K+ channel tool eGFP-Kir2.1 as a means of inhibiting the overall 
activity of individual axons. I also tested KalTA4-ERT2, a zebrafish-optimised 
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protein which drives the expression of UAS-driven transgenes in a tamoxifen-
inducible manner, with the aim of expressing transgenic proteins at specific 
developmental stages (for example, after sheath formation, after myelin pattern 
establishment). The results of these tool tests are summarised in Table 6.  
None of the tools tested were suitable to investigate the role of neuronal activity 
in regulating myelination along single axons over time according to my stated 
aims, and further optimisation of these tools is needed. For KalTA4-ERT2, it 
may be that a different neuronal promoter sequence leads to lower expression 
levels in neurons, which could prevent ‘leaky’ activation of UAS-driven 
transgene expression. Otherwise, a different inducible system should be used 
(such as the TetON system (Knopf et al., 2010)). For TeNT and BoNT, different 
neuronal Gal4/KalTA4 driver lines should be tested to identify which line drives 
expression at sufficient levels to completely inhibit synaptic vesicle release in 
single axons. For glycerotoxin and eGFP-Kir2.1, testing different neuronal 
promoters may identify expression levels which do not affect neuronal 
development but still affect neuronal activity. Alternatively, these tools may 
need to be combined with an inducible expression system to prevent adverse 
effects on early neurodevelopment.  
4.3.11. Summary 
In this chapter, I have shown that chemogenetic stimulation of individual RS 
neurons using the TRPV1-RFP system promotes myelin sheath growth within 
a critical period (3-5 dpf). As a result, chemogenetic stimulation changes the 
myelin pattern established along some RS axons by increasing sheath length 
and reducing sheath number. Future work should: determine how and when 
neuronal activity affects radial sheath growth along an individual axon; identify 
the molecular mechanism underpinning activity-mediated sheath growth; and 
assess the impact of activity-mediated sheath growth on circuit function in the 




Table 6 – summary of the other transgenic tools tested to manipulate neuronal activity throughout myelination. 
Tool Tested Description Summary of Experiment Results and Evaluation 
KalTA4-ERT2 A tamoxifen-inducible 
transcriptional activator to 
temporally control expression 
of UAS:transgenes. From Dr. 
Yi Feng. 
Generated NBT:KalTA4-ERT2 
transgenic line (pan-neuronal 
expression of KalTA4-ERT2). Tested 
whether UAS:transgene expression 
could be induced by 4-OH-tamoxifen 
treatment. 
Often led to ‘leaky’ expression (neuronal expression of 
UAS:transgenes in the absence of tamoxifen). Not 
suitable for inducible expression in the nervous system. 
TeNT-
tdTomato 
Inhibits synaptic vesicle 
release by cleaving the 
SNARE protein VAMP2. 
Attempted to replicate findings from 
Koudelka et al. 2016 (expressed in 
single RS axons, assessed their 
myelination at 5 dpf). 
RS axon myelination was unaffected. Struggled to 
achieve similar levels of expression as Dr. Sigirid 
Koudelka. After discussion, we hypothesise that 
epigenetic changes in transgenic lines used prevent 
sufficient levels of TeNT expression to generate 
hypomyelination phenotype. The effectiveness of 
vesicular release inhibition was not quantified. 
BoNT-B-eGFP Zebrafish-optimised version 
of BoNT-B (Sternberg et al., 
2016). Inhibits synaptic 
vesicle release by cleaving 
the SNARE protein VAMP2. 
From Dr. Claire Wyart. 
Attempted to verify that this zebrafish-
optimised tool was equivalent to TeNT 
(globally expressed to assess effects 
on single oligodendrocyte morphology; 
expressed in single RS axons and 
assessed their myelination at 5 dpf). 
Global expression paralysed zebrafish embryos and 
reduced myelinating potential per oligodendrocyte 
(replicating TeNT findings from Mensch et al., 2015). 
Expression in single axons did not affect myelination at 
5 dpf – however, the effectiveness of vesicular release 
inhibition was not quantified. 
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Glycerotoxin Increases synaptic vesicular 
release by activating Cav2.2 
channels. From Dr. Rafael 
Almeida. 
Globally expressed to assess effects on 
single oligodendrocyte morphology; 
expressed in single RS axons and 
assessed their myelination at 5 dpf. 
Global expression increased myelinating potential per 
oligodendrocyte. Expression in single axons disrupted 
neuronal development (Dr. Rafael Almeida, 
unpublished). 
eGFP-Kir2.1 Inward-rectifying K+ channel 
which hyperpolarises neurons 
by allowing K+ influx. 
Tested various plasmids to express in 
neurons (NBT: eGFP-Kir2.1 and HuC: 
eGFP-Kir2.1 for pan-neuronal 
expression; UAS:eGFP-Kir2.1 
combined with RS:KalTA4 for RS 
neuron expression). 
Could not consistently express in single axons (levels of 
expression may severely disrupt neuron development). 
Requires further optimisation to determine non-toxic 































5.1. A Critical Period for the Establishment of Myelin Patterns 
In this thesis, I set out to investigate the dynamics myelinated axon formation 
in the CNS, and how this is regulated by the activity of the underlying axons. 
Myelin patterns along axons (the number, length, thickness, and distribution of 
myelin sheaths) vary extensively throughout the CNS (Chong et al., 2012; Gao 
et al., 2019; Murray and Blakemore, 1980; Remahl and Hildebrand, 1990; 
Tomassy et al., 2014). Given that changes to sheath parameters are predicted 
modulate the conduction speed of the underlying axon (Waxman, 1980), it is 
hypothesised that establishing and refining specific myelin patterns might 
precisely control conduction timing within circuits. For instance, specific 
patterns of sheath length are seen in the auditory system of gerbils, which are 
predicted to facilitate precise sound localisation (Ford et al., 2015).  
How and when the myelin patterns are established along individual axons was 
not fully understood prior to the beginning of this project. Using single cell live 
imaging in the larval zebrafish spinal cord, I investigated how myelin patterns 
are formed and remodelled along individual axons in vivo. I found that the 
number and length of myelin sheaths along an axon are generally established 
within the first few days after the onset of myelination (by 5 dpf for the specific 
axons that I investigated). After 5 dpf, there is some remodelling (where 
sheaths can either grow or shrink in length, or be fully retracted from the axon), 
but very little happens after 7 dpf, with no significant change in overall sheath 
number, sheath length, sheath length variability, or nodal gap length after 7 dpf.  
If myelin patterns are tuned to the function of individual circuits, then it is 
plausible that axons from different circuits would exhibit different myelin 
patterns. I characterised the myelin pattern formation and remodelling along 
two different types of axons, which are known to use different signals to 
regulate their initial myelination. My hypothesis was that they would exhibit 
different myelin patterns and extents of myelin remodelling. Surprisingly, I 
found that both RS and CoPA axons establish remarkably similar myelin 
patterns and exhibit very little difference in the degree of myelin remodelling.  
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There is significant evidence to suggest that experience and learning can 
shape white matter development and myelination throughout life (Bengtsson 
et al., 2005; Eluvathingal et al., 2006; Hill et al., 2014; Hughes et al., 2018; 
Makinodan et al., 2012; Sampaio-Baptista et al., 2013; Scholz et al., 2009; 
Steele et al., 2013; Xiao et al., 2016). Experience-driven neuronal activity may 
influence the formation of myelin patterns and sheath remodelling to tune 
conduction timing in circuits. Neuronal activity can influence many aspects of 
oligodendrocyte development including OPC proliferation, differentiation, and 
targeting myelination (Barres and Raff, 1993; Demerens et al., 1996; Gibson 
et al., 2014; Mitew et al., 2018). Here, I investigated how neuronal activity 
affects the dynamics of myelin sheath growth during the period of myelin 
pattern establishment. RS neurons have previously been shown to be 
myelinated in a synaptic vesicle release-dependent manner, suggesting that 
they use activity-related signals to regulate their myelination (Koudelka et al., 
2016). I found that increasing the activity of individual RS axons during 
myelination promotes the early growth of myelin sheaths 3-5 dpf, but has no 
effect on sheath dynamics after 5 dpf. Nevertheless, this transient effect on 
sheath growth was enough to alter the myelin pattern established along the 
first myelinated RS axons (which had fewer, but longer, myelin sheaths at 7 
dpf than unstimulated control axons). My findings suggest that signals like 
neuronal activity can shape the myelination of axons, but only within a critical 
developmental window, after which myelin sheaths become stable in number 
and length irrespective of circuit activity. 
Why is activity-driven myelin pattern establishment restricted to a critical 
period? Critical periods for neuronal plasticity have been well-described 
throughout CNS development. Columns in the visual cortex are shaped by 
visual input within a critical period during post-natal development, which is 
regulated by an excitatory-inhibitory balance (this has been reviewed 
elsewhere by Hensch, 2005). In the auditory cortex, cortical maps of sound 
frequencies are established during a critical period (between P11-15 in 
rodents); this critical period is regulated by adenosine signalling in the auditory 
thalamus, which increases with age (Blundon et al., 2017). Adult-born neurons 
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also have critical periods; newly-born dentate granule cells exhibit enhanced 
synaptic plasticity approximately one month after cell birth, which declines by 
four months after cell birth (Ge et al., 2007). It is hypothesised that these critical 
periods exist so that circuit function can be adapted by the external 
environment and then stably maintained throughout life. Likewise, a critical 
period for myelin pattern formation would allow conduction properties along an 
axon to be tuned by a period of learning, and then stabilised thereafter to 
maintain optimal circuit function throughout life. 
What defines the critical period for myelin pattern establishment? It may relate 
to a specific developmental stage of the animal. Juvenile rodents, which are 
socially isolated from P21-65, have severe hypomyelination in the medial 
prefrontal cortex (mPFC) due to fewer sheaths being made per 
oligodendrocyte (sheath length was not measured in this study) (Makinodan et 
al., 2012). Isolated animals are antisocial and have impaired working memory. 
Interestingly, isolation from P21-35 is sufficient to impair myelination and 
behaviour, while isolation from P35-P65 does not have any effect. Neuronal 
activity driven by social experience may shape the formation of particular 
myelin patterns in mPFC circuits within the critical period of P21-35. After P35, 
the myelin patterns along these circuits may be stabilised, much like how the 
myelin patterns along RS and CoPA axons in the zebrafish spinal cord are 
stabilised after 7 dpf. Resocialisation after P35 does not rescue the 
hypomyelination or behavioural phenotypes (Makinodan et al., 2012). This 
suggests that circuit activity driven by experience cannot affect the myelination 
along mPFC circuits after the critical period, similar to how neuronal activity 
cannot affect the growth of myelin sheaths along RS axons in the zebrafish 
spinal cord after 5 dpf. Thus, there may be defined developmental windows 
when activity can influence myelination in the CNS and shape myelin pattern 
establishment, after which the myelin patterns cannot be changed regardless 
of experience. 
However, there is evidence that experience and activity can alter white matter 
or myelin development in adulthood. In adult humans (aged 18-33), task 
learning correlates with structural alterations in the white matter of associated 
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brain areas detected by DTI (Schlegel et al., 2012; Scholz et al., 2009). 
Similarly, DTI in adult mice (P120-150) trained in a skilled reaching task shows 
correlations between learning rate and white matter structure, as well as 
between learning rate and expression of myelin basic protein (Sampaio-
Baptista et al., 2013). Both running on a complex wheel (at P85-115 – Xiao et 
al., 2016) and sensory stimulation (at P365 – Hughes et al., 2018) increases 
the production of new oligodendrocytes in relevant cortical areas of adult mice.  
How does this fit with the evidence that myelin patterns are stabilised after a 
critical period? Myelination is a protracted process which continues throughout 
life (Yakovlev and Lecours, 1967; Yeung et al., 2014). Some circuits are 
myelinated during early post-natal development, while other circuits continue 
to be myelinated many years into adulthood. Live imaging in the mouse cortex 
identifies sparsely myelinated axons where myelin coverage gradually 
increases over several months during adulthood (between P64-148) (Hill et al., 
2018). The critical period for myelin pattern establishment may depend on the 
timescale over which a specific circuit is myelinated. Additionally, neuronal 
activity may only signal to oligodendrocytes or myelin sheaths at a certain 
cellular developmental stage. Expression of glutamatergic receptors 
significantly declines with oligodendroglial lineage progression (De Biase et 
al., 2010; Deng et al., 2004; Kukley et al., 2010). Consequently, 
oligodendrocytes or myelin sheaths may only detect and respond to neuronal 
activity within a short time period after differentiation, after which they are 
unaffected by circuit activity. This would be in line with observations that myelin 
sheaths become remarkably stable in length after initial formation (Auer et al., 
2018; Hill et al., 2018; Hughes et al., 2018), even when the underlying circuits 
are stimulated (Hughes et al., 2018). In circuits which are myelinated during 
earlier post-natal development, the myelin patterns along axons may be 
established by activity within this time frame. Whereas, in circuits which exhibit 
more protracted myelination throughout adulthood, the myelin patterns along 
axons may be shaped by activity over a longer period of time. Previous studies 
showing experience-driven oligodendrogenesis in the adult cortex have not 
then followed these new oligodendrocytes to confirm that they produce myelin 
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sheaths (Hughes et al., 2018; Xiao et al., 2016). It will be crucial to follow such 
newly-generated oligodendrocytes in stimulated and unstimulated animals to 
see if experience affects the initial growth of myelin sheaths formed in 
adulthood. 
The investigation of myelin sheath dynamics over time performed by myself 
and others (Auer et al., 2018; Hill et al., 2018; Hughes et al., 2018) has focused 
on sheath length. There is a clear need to characterise how sheath thickness 
changes over time, as this may be a parameter of myelin patterns which is 
remodelled beyond the critical period observed for sheath length. For example, 
Hughes et al., 2018 demonstrated that sensory stimulation does not affect the 
length of existing myelin sheaths in the sensory cortex. However, Liu et al., 
2012 found that eight weeks of social isolation in adult mice (specific age 
unknown) leads to thinner myelin sheaths in the mPFC. Whether these thin 
myelin sheaths have been remodelled in thickness, or are simply new sheaths 
which are thinner than normal, is not clear as the authors assessed sheath 
thickness at a single time point by transmission electron microscopy. 
Techniques to repeatedly measure sheath thickness in living animals (see 
section ‘3.3.5 Remodelling of Sheath Thickness over Time’) are required to 
fully understand when myelin patterns are established, and whether they can 
be remodelled. It may be that basal levels of circuit activity are required to 
maintain a specific myelin pattern long-term, and so prolonged periods of 
inactivity or deprivation can eventually alter circuit myelin patterns. 
Not all types of axon use activity-related signals to regulate their initial 
myelination (Koudelka et al., 2016); despite this, I found very little difference in 
the myelin patterns or extent of sheath remodelling between axons that are 
myelinated in an activity-dependent (RS) and independent (CoPA) manner. 
However, CoPA axons may still be capable of using experience to shape their 
myelin patterns; other signals may simply take over when CoPA synaptic 
vesicle release is inhibited, whereas RS axons may rely more heavily on 
activity-driven signals to control myelin pattern formation. Whether CoPA 
axons are capable of using activity to regulate their myelination could be tested 
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by chemogenetically stimulating TRPV1-RFP-expressing CoPA axons during 
the period of myelin pattern formation.  
Whether some circuits use experience to shape their myelin patterns while 
other circuits do not requires further investigation. Previous studies have not 
identified specific neuron subtypes when investigating myelin sheath dynamics 
(Auer et al., 2018; Hill et al., 2018; Hughes et al., 2018). Future work live 
imaging myelin sheath dynamics in vivo should include the characterisation of 
specific neuron subtypes and their circuitry to increase our understanding of 
experience-dependent myelination. For example, two recent studies have 
shown that different types of experience can increase oligodendrocyte 
production in the motor (Xiao et al., 2016) and sensory (Hughes et al., 2018) 
cortices. Characterising the specific neuron subtypes which are then 
myelinated by these oligodendrocytes, and comparing how experience affects 
sheath growth dynamics in both motor and sensory cortices, could reveal 
specifically which neurons and circuits use experience-driven activity to shape 
their myelination. 
5.2. Functional Implications of Experience-driven Myelin Patterns 
Activity-dependent sheath growth along RS axons between 3-5 dpf was 
sufficient to change the myelin patterns established, leading to longer but 
fewer sheaths per axon. Experience within critical myelination periods could 
similarly shape the myelin patterns formed along circuits. The functional 
consequence of such activity-driven myelination is not yet known. 
Mathematical modelling predicts that changes in sheath length can have a 
significant impact on conduction speeds along an axon (Brill et al., 1977; 
Waxman, 1980). For example, for an axon 1 µm in diameter, changing sheath 
length from 10 µm to 20 µm is predicted to change conduction velocity from 
50% of maximum to ~65% of maximum (Waxman, 1980). Smaller changes in 
sheath length may not yield drastic changes in conduction speeds, but even a 
small change in conduction timing could significantly affect the synchronisation 
of signals in a circuit.  
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In order to dissect the role of myelin patterns in overall circuit function, there is 
a need to analyse single cells, intact circuits, overall CNS activity, and 
behavioural outputs within the same model system. Such a multi-level 
experimental system would allow correlation of experience or neuronal activity 
with myelin sheath dynamics, conduction speeds, post-synaptic target 
recruitment and activity, overall circuit activity, and associated behaviour 
kinematics. Larval zebrafish are already established as a model for correlating 
cellular resolution imaging of circuit activity with behaviour (Ahrens et al., 2012; 
Mu et al., 2019; Orger et al., 2008). Whole-brain Ca2+ imaging can even be 
performed in freely-behaving larvae using tracking microscope tools (Cong et 
al., 2017; Kim et al., 2017; Symvoulidis et al., 2017). Whole circuit Ca2+ 
imaging and behavioural analysis could be combined with single cell activity 
manipulations, high-resolution cellular imaging of myelin sheath dynamics, and 
electrophysiology to assess how activity-driven myelin pattern formation 
affects function on the level of cells, circuits, and behaviour. For instance, MeLr 
and MeLc RS neurons (the RS neurons responsible for prey capture 
behaviour) could be selectively stimulated to alter their myelin patterns by 7 
dpf. The conduction velocities of stimulated and unstimulated axons, and the 
activity of post-synaptic motor- and inter-neurons, could be measured during 
prey capture behaviour, and correlated with success rate and behaviour 
kinematics such as tail bend angles during orienting swims. Multiscale 
analyses could be expanded to other neurons and circuits as the specific 
circuitry underlying particular behaviours are dissected. Hildebrand et al., 2017 
performed whole-brain serial-section electron microscopy to reconstruct the 
connectome (all myelinated axons) in the 5 dpf zebrafish brain; while Kunst et 
al., 2019 has produced a cellular-resolution neuron atlas of the 6 dpf zebrafish 
brain, showing the projection morphology of different cells and clustering them 
into “morphotypes”. These resources could be correlated with brain-wide Ca2+ 
imaging to identify specific neurons and circuits involved in different 
behaviours; the myelin patterns along identified axons of interest can then be 




Studying larval zebrafish can tell us about the role of myelin patterns in circuit 
function during early development, but may not inform us about the role of 
myelin pattern formation in a more mature nervous system. Zebrafish become 
progressively less transparent as they grow in size; once they are several 
weeks old, high-resolution cellular live imaging is no longer possible. 
Mammalian models, such as rodents, are more suited for investigation of 
myelin sheath dynamics and circuit function in the adult CNS. Previous studies 
have demonstrated that, by making a cranial window in the skull of adult mice, 
oligodendrocytes and myelin sheaths in the upper cortex can be repeatedly 
imaged by two-photon microscopy (Hill et al., 2018; Hughes et al., 2018). 
Miniature two-photon microscopes have been developed to perform CNS live 
imaging in freely-behaving mice, identifying activity in individual dendritic 
spines during behavioural paradigms such as tail suspension and social 
interaction (Zong et al., 2017). Three-photon microscopy shows promise for 
imaging deeper sub-cortical regions without removing the overlaying cortical 
tissue (Ouzounov et al., 2017). Live imaging of oligodendrogenesis, myelin 
sheath formation, and growth should be coupled with assessment of 
underlying circuit activity and behaviour. A combination of these strategies 
could elucidate the role of experience-dependent myelination on circuit 
function in adulthood. 
It is important to consider alternative explanations for the role of activity-driven 
myelination during learning and experience. The metabolic support provided 
to axons from oligodendroglia can be regulated by NMDA receptor signalling, 
indicating that neurons can increase energy supply during periods of activity 
(Saab et al., 2016). Active axons may promote their myelination not to adjust 
conduction speeds, but simply to ensure that there is sufficient metabolic 
transfer to support increased activity during learning. This may explain why 
such sparsely myelinated axons have been reported throughout the CNS 
(Auer et al., 2018; Gao et al., 2019; Hill et al., 2018; Tomassy et al., 2014). 
The large unmyelinated gaps between sheaths along these axons are not 
likely to facilitate saltatory conduction (as this requires clustering of voltage-
gated Na+ channels to short regions separated by insulating myelin sheaths) 
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and so may not significantly affect conduction velocities. However, these 
sheaths may provide enough lactate to meet the energetic demands of the 
underlying axon. Perhaps, on fully myelinated axons, activity-driven myelin 
sheath growth serves to both increase metabolic support and adjust 
conduction speeds. Uncoupling the metabolic support role from the insulating 
role of myelinating cells (see section ‘4.3.9 Alternative Roles for Activity-
mediated Myelination?’) could tell us the relative contributions of each in 
regulating the function of different circuits.  
5.3. Investigating the Disruption of Myelin Patterns 
Understanding how myelin patterns contribute to circuit function is particularly 
important in situations where myelin patterns are disrupted. Axons can 
become demyelinated in CNS injury (Kakulas, 1999; Totoiu and Keirstead, 
2005), in diseases such as MS (Albert et al., 2007; Newcombe et al., 1991), 
and with old age (Hill et al., 2018). Loss of myelin sheaths will disrupt both 
conduction and metabolic support to axons; it is hypothesised that 
remyelination is required for long-term axonal survival (Irvine and Blakemore, 
2008; Mei et al., 2016). Remyelination does restore conduction along 
demyelinated axons (Smith et al., 1981), but remyelinated sheaths are 
believed to be thinner and shorter than sheaths in a healthy CNS (Blakemore, 
1974; Blakemore and Murray, 1981; Lasiene et al., 2008; Prineas et al., 1993; 
Prineas and Connell, 1979; Totoiu and Keirstead, 2005).  
How changes to the myelin patterns along axons after remyelination affects 
conduction and alters circuit function requires further investigation. 
Remyelination may subtly alter conduction velocities along axons, 
desynchronising signals in circuits and changing behavioural outputs. If so, 
then identifying signals which promote the regeneration of sheaths of normal 
length and thickness would be of significant therapeutic value. Single axon de- 
and remyelination needs to be characterised in detail to determine whether 
there is a critical period for the recovery of myelin patterns during 
remyelination. Characterisation could also reveal whether experience-driven 
neuronal activity within such a critical period could promote complete 
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remyelination. Again, the ideal model system would integrate detailed cellular 
imaging with measurement of circuit activity and behaviour over time. A 
recently-developed larval zebrafish model of demyelination has shown that 
zebrafish exhibit efficient remyelination (Karttunen et al., 2017). In this model, 
myelinating cells express the enzyme nitroreductase, which converts the pro-
drug metronidazole into a cytotoxic by-product. Treatment of nitroreductase-
expressing larvae with metronidazole kills two thirds of oligodendrocytes and 
causes demyelination, which recovers by 16 days post-treatment. Other 
demyelination models could also be used to investigate changes and recovery 
of myelin patterns. In addition to the work performed in Chapters 3 and 4, I 
have generated a novel transgenic model of demyelination (see ‘Appendix 1: 
A Novel Zebrafish Model of Demyelination – Tg(mbp:TRPV1-RFP)’), which 
allows a much more rapid induction of demyelination in the zebrafish CNS. 
Although this remains to be fully-characterised, it and other model systems of 
demyelination could be used to investigate how the myelin patterns along 
specific axon subtypes change through de- and remyelination in zebrafish. 
Changes to myelin patterns could then be correlated with measurements of 
circuit activity and behavioural outputs. Neurotoxins or channelrhodopsins 
could be expressed in single axons to see whether manipulating activity during 
the de- and remyelination process alters the repair of myelin patterns. 
Dissecting how remyelination affects single axons, intact circuits, overall CNS 
activity, and behaviour will test whether specific myelin patterns are required 
for healthy nervous system function. 
5.4. Overall Summary 
Investigating the dynamics of myelination along single axons, and determining 
what signals regulate this process, are crucial steps in understanding the 
emergence of circuit function at the cellular level. Here, I have characterised 
the formation of myelin patterns and myelin sheath remodelling along different 
axon subtypes within a critical period in the larval zebrafish spinal cord. I have 
shown how the activity of an axon affects the dynamics of its myelination during 
this critical period. Future work should expand these analyses to different 
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circuits, and correlate measurement of myelin sheath dynamics with nervous 
system function on the level of single cells, intact circuits, and overall 
behaviour. A multiscale approach will inform us how the dynamics of 
myelination influence the emergence of nervous system function, and may 
reveal therapeutic avenues to promote complete functional recovery in 
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Appendix 1: A Novel Zebrafish Model of Demyelination – 
Tg(mbp:TRPV1-RFP) 
As discussed in Chapter 1, the formation of particular myelin patterns (the 
number, length, thickness, and distribution of myelin sheaths) along axons 
may be critical for circuit function through the precise regulation of conduction 
timing. Demyelination in injury, disease, or old age will likely change the myelin 
patterns along axons and could potentially impact circuit function. Although 
axons can be remyelinated, it is thought that the myelin sheaths generated 
during remyelination are shorter and thinner than sheaths in a healthy CNS 
(Blakemore, 1974; Blakemore and Murray, 1981; Lasiene et al., 2008; Prineas 
et al., 1993; Prineas and Connell, 1979; Totoiu and Keirstead, 2005). 
Therefore, even repair after demyelination could change myelin patterns, 
conduction properties, and subsequently impact circuit function. To 
understand precisely how de- and remyelination impacts circuit function, one 
must investigate de- and remyelination along single axons in intact circuits 
over time.  
The larval zebrafish is an ideal model for following the myelination of single 
axons in identified circuits over time (as discussed in Chapter 3). A recent 
study described a transgenic larval zebrafish model of demyelination where 
myelinating cells express the enzyme nitroreductase and are ablated by 
treatment with the pro-drug metronidazole (Karttunen et al., 2017). 
Metronidazole treatment kills two thirds of oligodendrocytes and causes wide-
spread demyelination. Efficient remyelination occurs by 16 days post-
treatment, with the new sheaths being of similar length and thickness to 
sheaths in a healthy CNS. Whether zebrafish always exhibit such efficient 
remyelination, of if this efficient remyelination is a characteristic of this 
particular demyelination model, remains unknown. There is a need to test 
additional models of demyelination in larval zebrafish, not only to confirm the 
efficiency of remyelination, but to see whether different extents of 
demyelination can be induced. Additionally, a more rapid model of 
demyelination would be practically beneficial as it could reduce the time 
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duration of experiments and allow for higher resolution imaging (as larvae age, 
their increase in size impedes the quality of live imaging). 
In addition to the experiments shown in Chapters 3 and 4, I generated a novel 
zebrafish transgenic model of demyelination where myelinating cells express 
the fusion protein TRPV1-tagRFPt. As noted in Chapter 4, mammalian TRPV1 
is a cation channel which is activated by the ligand capsaicin to allow cation 
influx (with a strong preference for Ca2+ (Caterina et al., 1997; Munns et al., 
2015)). Zebrafish TRPV1 channels are insensitive to capsaicin (Gau et al., 
2013). Chen et al., 2016 showed that, in larval zebrafish, cells which express 
mammalian TRPV1-RFP can be ablated by treatments with high 
concentrations of capsaicin (discussed in more detail in section ‘4.1 
Introduction’). By expressing TRPV1-RFP in myelinating cells 
(oligodendrocytes and Schwann cells), I reasoned that I could ablate these 
myelinating cells and damage myelin sheaths by bath application of high doses 
of capsaicin. 
First I cloned a plasmid where TRPV1-RFP is expressed under the myelin 
basic protein (MBP) promoter (Figure 40A), to induce expression of TRPV1-
RFP in oligodendrocytes and Schwann cells. I then used this plasmid to 
generate a stable transgenic zebrafish line where all myelinating cells express 
TRPV1-RFP – Tg(mbp:TRPV1-RFP) (Figure 40B).  
TRPV1-RFP-expressing cells are ablated when treated with high 
concentrations of capsaicin, as demonstrated by Chen et al., 2016 and by 
myself (Figure 23). Indeed, treating Tg(mbp:TRPV1-RFP) larvae with 10 µM 
capsaicin for just two hours was sufficient to induce significant demyelination 
in the spinal cord (Figure 40C, D). Neuronal RFP-Cntn1a expression labels 
unmyelinated regions along the axon; however, it was unclear whether this 
could be used to observe demyelination along an individual axon over time 
(Figure 40D). Along a fully myelinated axon, RFP-Cntn1a is localised to the 
gaps between myelin sheaths (nodes of Ranvier). When myelin sheaths are 
lost during demyelination, RFP-Cntn1a does indeed become more diffusely 
localised along the axon. Therefore, this tool could be used to see how the 
289 
 
number and length of myelin sheaths along an individual axon changes 
throughout the de- and remyelination process. 
More robust characterisation is required to determine whether changing 
concentrations or durations of capsaicin treatment can alter the extent of 
demyelination in the CNS. For example, some oligodendrocytes and myelin 
sheaths appear to survive two hours of 10 µM capsaicin, particularly in the 
ventral spinal cord (Figure 40C). De- and remyelination should be 
characterised in more detail. This should include: the severity of demyelination; 
the dynamics of the immune response; the timing of remyelination; and the 
morphology of sheaths generated during remyelination. The model is currently 
being characterised by PhD student Ms. Sarah Neely. 
Once characterised, the Tg(mbp:TRPV1-RFP) demyelination model could be 
used to investigate how myelin patterns change along individual neuronal 
subtypes through de- and remyelination, and determine if and how surviving 
myelin sheaths along different axons remodel in response to loss of their 
neighbours. Demyelination models could also be combined with manipulations 
of neuronal activity (using neurotoxins or optogenetics) to see how individual 






Figure 40 – the Tg(mbp:TRPV1-RFP) demyelination model to investigate the 
disruption and remodelling of myelin patterns along individual axons in vivo. 
A) A simplified plasmid map of the mbp:TRPV1-tagRFPt plasmid used to generate 
the transgenic line Tg(mbp:TRPV1-tagRFPt) (TRPV1-RFP). TRPV1-RFP is under 
the control of the myelin basic protein (MBP) promoter sequence, so that 
expression of TRPV1-RFP occurs only in myelinating cells. B) TRPV1-RFP is 
expressed in myelinating cells. Crossing Tg(mbp:TRPV1-RFP) with Tg(mbp:eGFP-
CAAX), a transgenic line which labels all myelinating cells with membrane-tethered 
eGFP, shows that oligodendrocytes in the spinal cord co-express both markers 
(shown by the yellow arrows). C) Capsaicin treatment induces rapid demyelination 
in Tg(mbp:TRPV1-RFP); Tg(mbp:eGFP-CAAX) larvae. Before treatment, 
Tg(mbp:TRPV1-RFP) larvae have myelinated axons in the dorsal and ventral spinal 
cord tracts, as labelled by eGFP-CAAX. After a 2 hour treatment with vehicle (1% 
DMSO), there is no significant change to myelin in the spinal cord up to 16 hours 
post-treatment. After a 2 hour treatment with 10 µM capsaicin, there is significant 
disruption to oligodendrocytes and myelin sheaths. 16 hours post-treatment, there 
is significant demyelination in both the dorsal and ventral tracts. However, some 
oligodendrocytes and myelin sheaths appear to survive the demyelination. D) 
Following single axons through demyelination. An individual RS neuron was 
labelled with RFP-Cntn1a to measure the myelination pattern along the axon 
(outlined by dotted lines). Prior to any treatment, RFP-Cntn1a is localised to the 
node (blue arrow) between eGFP-CAAX expressing myelin sheaths. 20 hours post-
treatment (10 µM capsaicin), RFP-Cntn1a expression along the axon shows that 
there has been demyelination (which is confirmed by loss of eGFP-CAAX 
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